
<html lang="en"     class="pb-page"  data-request-id="1c18eb56-5c36-4658-af19-925e777c9b32"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-3;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm401144z;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface" /></meta><meta name="dc.Creator" content="Huameng  Li" /></meta><meta name="dc.Creator" content="Hui  Xiao" /></meta><meta name="dc.Creator" content="Li  Lin" /></meta><meta name="dc.Creator" content="David  Jou" /></meta><meta name="dc.Creator" content="Vandana  Kumari" /></meta><meta name="dc.Creator" content="Jiayuh  Lin" /></meta><meta name="dc.Creator" content="Chenglong  Li" /></meta><meta name="dc.Description" content="The IL-6/GP130/STAT3 pathway is critical for the progression of multiple types of cancers. We report here the discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 protein–prot..." /></meta><meta name="Description" content="The IL-6/GP130/STAT3 pathway is critical for the progression of multiple types of cancers. We report here the discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 protein–prot..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 31, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401144z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401144z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401144z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401144z" /></link>
        
    
    

<title>Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401144z" /></meta><meta property="og:title" content="Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0012.jpeg" /></meta><meta property="og:description" content="The IL-6/GP130/STAT3 pathway is critical for the progression of multiple types of cancers. We report here the discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 protein–protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning approaches. Multiple drug scaffolds were simultaneously docked into hot spots of GP130 D1 domain by MLSD to compete with the key interacting residues of IL-6, followed by tethering to generate virtual hit compounds. Similarity searches of virtual hits on drug databases identified raloxifene and bazedoxifene as potential inhibitors of IL-6/GP130 interaction. In cancer cell assays both compounds bind to GP130 and demonstrated selective inhibition of IL-6 induced STAT3 phosphorylation and were significantly more potent than the previously reported natural product inhibitor MDL-A. The identified drugs represent a new class of lead compounds with piperidine, benzothiophene, and indole scaffolds to inhibit IL-6 induced homodimerization of GP130. Besides potential direct usage for clinic trials, the two compounds can also serve as lead compounds for optimization to speed the development of drugs selectively targeting the IL-6/GP130/STAT3 cancer signaling pathway." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401144z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401144z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401144z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401144z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401144z&amp;href=/doi/10.1021/jm401144z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 632-641</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401138v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401837e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huameng++Li">Huameng Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Xiao">Hui Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Lin">Li Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Jou">David Jou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vandana++Kumari">Vandana Kumari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiayuh++Lin">Jiayuh Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chenglong++Li">Chenglong Li</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Biophysics Graduate Program, The Ohio State University, Columbus, Ohio 43210, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Center for Childhood Cancer, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio 43205, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 614-247-8786. Fax: 614-292-2435. E-mail: <a href="/cdn-cgi/l/email-protection#214d480f161319614e52540f444554"><span class="__cf_email__" data-cfemail="9ff3f6b1a8ada7dff0eceab1fafbea">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401144z&amp;href=/doi/10.1021%2Fjm401144z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 632–641</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 23, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 July 2013</li><li><span class="item_label"><b>Published</b> online</span>31 January 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401144z" title="DOI URL">https://doi.org/10.1021/jm401144z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D632%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHuameng%2BLi%252C%2BHui%2BXiao%252C%2BLi%2BLin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D3%26contentID%3Djm401144z%26title%3DDrug%2BDesign%2BTargeting%2BProtein%25E2%2580%2593Protein%2BInteractions%2B%2528PPIs%2529%2BUsing%2BMultiple%2BLigand%2BSimultaneous%2BDocking%2B%2528MLSD%2529%2Band%2BDrug%2BRepositioning%253A%2BDiscovery%2Bof%2BRaloxifene%2Band%2BBazedoxifene%2Bas%2BNovel%2BInhibitors%2Bof%2BIL-6%252FGP130%2BInterface%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D641%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401144z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4285</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">83</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401144z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Huameng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Jou&quot;},{&quot;first_name&quot;:&quot;Vandana&quot;,&quot;last_name&quot;:&quot;Kumari&quot;},{&quot;first_name&quot;:&quot;Jiayuh&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Chenglong&quot;,&quot;last_name&quot;:&quot;Li&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;632-641&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401144z&quot;},&quot;abstract&quot;:&quot;The IL-6/GP130/STAT3 pathway is critical for the progression of multiple types of cancers. We report here the discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 protein–protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning approaches. Multiple drug scaffolds were simultaneously docked into hot spots of GP130 D1 domain by MLSD to compete with the key interacting residues of IL-6, followed by tethering to generate virtual hit compounds. Similarity searches of virtual hits on drug databases identified raloxifene and bazedoxifene as potential inhibitors of IL-6/GP130 interaction. In cancer cell assays both compounds bind to GP130 and demonstrated selective inhibition of IL-6 induced STAT3 phosphorylation and were significantly more potent than the previously reported natural product inhibitor MDL-A. The identified drugs represent a new class of lead compounds with piperidine, benzothiophene, and indole scaffolds to inhibit IL-6 induced homodim&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401144z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401144z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401144z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401144z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401144z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401144z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401144z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401144z&amp;href=/doi/10.1021/jm401144z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401144z" /></input><a href="/doi/pdf/10.1021/jm401144z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401144z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401144z%26sid%3Dliteratum%253Aachs%26pmid%3D24456369%26genre%3Darticle%26aulast%3DLi%26date%3D2014%26atitle%3DDrug%2BDesign%2BTargeting%2BProtein%25E2%2580%2593Protein%2BInteractions%2B%2528PPIs%2529%2BUsing%2BMultiple%2BLigand%2BSimultaneous%2BDocking%2B%2528MLSD%2529%2Band%2BDrug%2BRepositioning%253A%2BDiscovery%2Bof%2BRaloxifene%2Band%2BBazedoxifene%2Bas%2BNovel%2BInhibitors%2Bof%2BIL-6%252FGP130%2BInterface%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D3%26spage%3D632%26epage%3D641%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jmcmar.2014.57.issue-3/production/jmcmar.2014.57.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The IL-6/GP130/STAT3 pathway is critical for the progression of multiple types of cancers. We report here the discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 protein–protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning approaches. Multiple drug scaffolds were simultaneously docked into hot spots of GP130 D1 domain by MLSD to compete with the key interacting residues of IL-6, followed by tethering to generate virtual hit compounds. Similarity searches of virtual hits on drug databases identified raloxifene and bazedoxifene as potential inhibitors of IL-6/GP130 interaction. In cancer cell assays both compounds bind to GP130 and demonstrated selective inhibition of IL-6 induced STAT3 phosphorylation and were significantly more potent than the previously reported natural product inhibitor MDL-A. The identified drugs represent a new class of lead compounds with piperidine, benzothiophene, and indole scaffolds to inhibit IL-6 induced homodimerization of GP130. Besides potential direct usage for clinic trials, the two compounds can also serve as lead compounds for optimization to speed the development of drugs selectively targeting the IL-6/GP130/STAT3 cancer signaling pathway.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Interleukin-6 (IL-6) is a cytokine involved in various inflammatory and immune responses, cellular apoptosis, and proliferation, etc.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> IL-6 binds to IL-6Rα to form a binary complex and then recruits GP130 to form the IL-6/IL-6Rα/GP130 heterotrimer. Furthermore, homodimerization of the IL-6/IL-6Rα/GP130 heteotrimers occurs by interactions between IL-6 of one trimer and the D1 domain of GP130 of the other trimer, forming a hexamer (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The reciprocal homodimerization of the IL-6/IL-6Rα/GP130 trimers triggers a signaling cascade of phosphorylation of Janus kinases (JAKs) and a downstream effector STAT3, followed by reciprocal dimerization of the Tyr705-phosphorylated STAT3, resulting in STAT3 nucleus translocation, DNA binding, and multiple oncogene transcriptions.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">Previous studies indicated that IL-6 and the major downstream effector STAT3 are protumorigenic agents in many cancers,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> supporting both as attractive therapeutic targets. Madindoline A (MDL-A), a natural product compound, was reported as a highly selective, non-peptide antagonist to GP130.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> It was confirmed that MDL-A binds to the extracellular domain of GP130 and inhibits IL-6 dependent STAT3 tyrosine phosphorylation in HepS2 (hepatocellular carcinoma) cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, this natural product cannot be developed into an effective drug because (a) it is no longer available from natural resources, (b) the total synthesis involves many steps, and the low yield makes it not economically practical, and (c) its binding to GP130 is relatively weak (<i>K</i><sub>d</sub> of 288 μM).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Although a few MDL-A analogues were identified to inhibit the homodimerization of GP130 via virtual screening and structure based drug design,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> synthesis of these analogues requires many steps, resulting in yields too low to be practical for drug development. Therefore, it is highly desirable to design and identify novel, small molecule drugs to disable this dimerization of the IL-6/IL-6R/GP130 heterotrimers, offering new options for anticancer therapy.</div><div class="NLM_p">Small molecule inhibitor design targeting protein–protein interactions (PPIs) is an emerging and challenging area.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9-12)</a> We previously developed a novel computational strategy for fragment-based drug design and discovery by combining MLSD and drug repositioning.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Our method could be applied to effectively design and identify potential small molecule drugs to disrupt the more challenging IL-6/GP130 protein–protein interface. In the IL-6/GP130 hexameric complex, IL-6, serving as a ligand, binds to the GP130 D1 domain through a few hot spot residues. With the hot spot residues of IL-6 envisioned as multiple fragments, the MLSD method could nicely fit to simulate the multiple residues of IL-6 binding to GP130. The workflow of our approach proceeds as follows:<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Focused libraries of drug scaffolds are simultaneously docked into the binding hot spots of target protein (GP130 D1 domain) interface via MLSD.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">The multiple fragments bound can simultaneously displace or mimic multiple hot spot residues in protein–protein (IL-6/GP130) interface. Virtual template compounds can then be generated by linking the multiple fragments docked.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Structural or chemical similarity search of the docked fragments and virtual template compounds on drug databases can potentially reposition existing drugs as novel, off-target inhibitors of the new target GP130.</p></td></tr></table></div><div class="NLM_p">Herein we report the use of our approach to aid the rapid identification of novel inhibitors of the IL-6/GP130 PPI target. We demonstrate the efficiency and efficacy of our approach through the discovery of safe drug compounds with the potential to disrupt the dimerization of GP130. The identified compounds are raloxifene and bazedoxifene. These drugs primarily target the human estrogen receptor (ER), which involve estrogenic actions on bone but antiestrogenic actions on uterus and breast.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> They are commonly used in the prevention of osteoporosis. Our computational prediction has been validated by assays of pancreatic cancer cell lines that express GP130 but not ER. Cell line assays confirmed that raloxifene and bazedoxifene selectively inhibit IL-6 induced STAT3 phosphorylation in the GP130/JAK/STAT3 signaling pathway. IC<sub>50</sub> values of raloxifene and bazedoxifene in pancreatic cancer (MIA-PACA-2) cell viability assays were 26.3 and 9.7 μM, respectively. Both raloxifene and bazedoxifene demonstrated significantly more potency than the known inhibitor MDL-A (IC<sub>50</sub> > 250 μM). Since raloxifene and bazedoxifene are approved drugs that have excellent safety profiles and few side effects, they show great potential as drug leads for the development of the much needed, new cancer therapeutics relevant to the IL-6 mediated GP130/JAK/STAT3 signal pathway.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IL-6/GP130/STAT3 signal transduction. IL-6 first binds to IL-6Rα to form the binary complex through site I interactions. The IL-6/IL-6Rα complex then binds to D2 and D3 domains of GP130 through site II interactions and forms trimeric complex IL-6/IL-6Rα/GP130. The subsequent site III reciprocal interaction of IL-6 of one trimer with the D1 domain of GP130 of the other trimer leads to homodimerization of the heterotrimer into heterohexamer complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1P9M">1P9M</a>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> MDL-A binds to the GP130 D1 domain and inhibits hexameric complex formation by disrupting interactions between IL-6 and the GP130 D1 domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Analysis of Binding “Hot Spots” at Interface between IL-6 and D1 Domain of GP130</h3><div class="NLM_p">Examining the interface between IL-6 and the D1 domain of GP130 in the crystal structure of the hexameric complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1P9M">1P9M</a>) shows that residues (Leu57, Ala58, Glu59, Asn60, Leu62, Trp157, and Leu158) of IL-6 interact with the D1 domain of GP130. The dimerization of GP130 is mainly hydrophobic as supported by a large increase of entropy from isothermal titration calorimetric (ITC) measurements.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Previous mutagenesis studies showed Trp157 of IL-6 as the critical aromatic residue at the IL-6/GP130 D1 domain interface.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Additional molecular dynamics (MD) simulation using the crystal structure of IL-6 and D1 domain of GP130 complex revealed that Leu57 and Trp157 of IL-6 are the most important “hot spot” residues of IL-6, which contribute most toward the binding free energy for IL-6 and the D1 domain of GP130 interactions.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Leu57 is mainly involved in hydrophobic interactions with D1-domain residues. Trp157 shows both polar and nonpolar interactions with the D1-domain residues of GP130. These results helped to define the hydrophobic Leu57 binding site and aromatic Trp157 binding site as the two binding “hot spots” at the interface of IL-6 and the GP130 D1 domain (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). In addition, extra subpocket near Trp157 binding site can be used to design more potent and specific inhibitors.</div><div class="NLM_p">To characterize the binding sites and binding modes of the known inhibitor MDL-A on the GP130 surface, MDL-A was globally docked to the GP130 extracellular D1, D2, and D3 modular domains using AutoDock4. Interestingly, MDL-A only binds to the D1 domain but not the D2 and D3 domains, thus suggesting that the compound disrupts only GP130 dimerization. Further analysis of the binding modes of MDL-A indicated that both binding hot spots between IL-6 and GP130 are disrupted by MDL-A (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). On hot spot 1, the hydrophobic Leu57 of IL-6 is displaced by the MDL-A aliphatic butyl tail. On hot spot 2, the indoline moiety of MDL-A mimics the Trp157 indole side chain of IL-6.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeling of binding hot spots at the IL-6/GP130 D1 domain interface. (A) D1 domain is represented as electrostatic potential surface (red, negatively charged; blue, positively charged; white, hydrophobic). IL-6 is in ribbon representation. The two larger yellow eclipses indicate the two main binding “hot spots”, Leu57 binding site and Trp157 binding site, between IL-6 and GP130. (B) Binding modeling of MDL-A to the GP130 D1 domain. D1 domain is in ribbon representation, and MDL-A is in thick ball-and-stick rendering. Hydrogen bonds are shown as red dotted lines. MDL-A disrupts both binding spots of the GP130 D1 domain. MDL-A forms three hydrogen bonds with Asn92, Cys6, and the carbonyl backbone of Val93 residues of GP130. The modeling indicates that the long butyl tail of MDL-A displaces Leu57 (thin red line), and the indoline moiety partially disrupts Trp157 (thin red line) of the helix D of IL-6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Identifying Privileged Drug Scaffolds for the Binding Hot Spots of D1 Domain of GP130</h3><div class="NLM_p last">We built a small library of feature fragments from the key interacting residues (Leu57 and Trp157) of IL-6, inhibitor MDL-A, and its analogues.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> The feature fragments are listed in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A. To avoid fragments with undesired drug ADMET properties, drug scaffolds structurally or chemically similar to the feature fragments were identified by substructure or similarity searches on a drug scaffold database and DrugBank.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B lists the drug scaffolds identified, which were grouped into two pools: aromatic and nonpolar. The aromatic scaffolds in pool 1 may favor binding to the Trp157 site, and the nonpolar scaffolds in pool 2 are for the Leu57 site or the extra subpocket. The hydrophobic piperidine and cyclohexane, very common six-member rings in drugs, were selected to potentially improve the binding affinity for the Leu57 binding pocket on the GP130 D1 domain.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Simultaneous Docking of Two Fragments to Binding Hot Spots of GP130 D1 Domain</h3><div class="NLM_p">To improve binding affinity, we applied MLSD to dock two drug scaffolds, one from pool 1 and the other from pool 2, to the two binding hot spots of GP130 in order to effectively disrupt multiple key residues of IL-6. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> lists the top sets of drug scaffolds binding to the hot spots of the GP130 D1 domain from MLSD docking screening. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A illustrates the binding modeling of top fragments to the hot spots of GP130.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Feature fragments from Trp157 and Leu57 residues of IL-6, inhibitor MDL-A, and its analogues to mimic the hot spot residues of IL-6. (B) Structures of drug scaffolds identified for the binding hot spots of GP130.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Predicted Docking Energies (Δ<i>E</i>) of the Top Combinations of Drug Scaffolds to the Hot Spots of GP130 D1 Domain</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">scaffold set</th><th class="colsep0 rowsep0" align="center" char=".">docking Δ<i>E</i> (kcal/mol)</th><th class="colsep0 rowsep0" align="center">binding modes (mimicking hot spots)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S1 (fb1, f2)</td><td class="colsep0 rowsep0" align="char" char=".">–9.4</td><td class="colsep0 rowsep0" align="left">Leu57 (fb1), Trp157 site, and extra pocket (f2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S2 (fb1, f5)</td><td class="colsep0 rowsep0" align="char" char=".">–9.5</td><td class="colsep0 rowsep0" align="left">Leu57 (fb1), Trp157 site, and extra pocket (f5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S3 (fb2, f5)</td><td class="colsep0 rowsep0" align="char" char=".">–9.3</td><td class="colsep0 rowsep0" align="left">Leu57 (fb2), Trp157 site, and extra pocket (f5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S4 (fb2, f2)</td><td class="colsep0 rowsep0" align="char" char=".">–9.2</td><td class="colsep0 rowsep0" align="left">Leu57 (fb2), Trp157 site, and extra pocket (f2)</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Linking Fragments for Hits and Designing Virtual Template Compounds</h3><div class="NLM_p">To obtain possible virtual lead compounds, we linked the two fragments in hits S1 and S2 using different chemical linkers. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> lists structures and docking binding energies of the top two template compounds T1 and T2. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B shows the docking simulation of T1 and T2 to GP130 D1 domain.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and Docking Energies (Δ<i>E</i>) of Template Compounds Obtained by Linking Fragments in Hits S1 (fb1 and f2) and S2 (fb1 and f5)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0010.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Inhibitor MDL-A is listed here for comparison.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Drug Repositioning: Raloxifene and Bazedoxifene Identified as Potential Novel GP130 Inhibitors</h3><div class="NLM_p">The docked fragments define a blueprint for possible binders. We performed structure similarity searches of the top fragments or virtual template compounds on DrugBank database to identify FDA approved drugs or experimental drugs with a certain degree of similarity (Tanimoto similarity coefficient of ≥0.5).<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19, 21)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> lists the top hits ranked by docking energy (Δ<i>E</i>) and visual inspection of binding modes. Existing drugs raloxifene and bazedoxifene were identified as the top two hits. The rest of the candidates in the list are experimental drugs. Raloxifene matched T2 virtual compounds as a top hit. Interestingly, similarity or substructure search of the best two fragments S2 (fb1, f5) on drug database could also identify raloxifene as a drug candidate in this case. Bazedoxifene was identified because it is a close analogue of hit DB07991, which has a structure similar to the template compound T1. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D show the docking of raloxifene and bazedoxifene to GP130 D1 domain. Both raloxifene and bazedoxifene are known as selective estrogen receptor modulators (SERMs) and commonly used as treatment for osteoporosis.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structures and Docking Energies of Top Hits Identified by Drug Repositioning Search with Virtual Template Compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0011.gif" alt="" id="fx2" /></img><div></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking modeling of the best drug scaffolds, the virtual templates, and drug candidates to GP130. (A) In top hits of fragment sets S1 (red) and S2 (green color), fragment fb1 (phenylpiperdinyl) occupied the Leu57 hot spot while f2 (2-phenylindole) and f5 (2-phenyl-1-benzothiophene) bound to the Trp157 binding site of GP130 with binding energies of −9.4 and −9.5 kcal/mol, respectively. (B) Tethering fragments in hits S1 and S2 gave virtual template compounds T1 (red) and T2 (green), respectively. Docking free energies and binding modes of template compounds T1 (−9.1 kcal/mol) and T2 (−9.3 kcal/mol) are close to the corresponding fragments in hits S1 and S2. (C) Drug raloxifene was identified as a novel inhibitor of GP130 D1 by similarity searching for T2 in DrugBank. Docking of raloxifene (thick gray ball-and-stick) to GP130 D1 showed that piperidinyl and 1-benzothiophene moieties mimic the native Leu57 and Trp157 (in white lines) of IL-6 in the hot spots, respectively. (D) Docking of drug candidate bazedoxifene (thick gray ball-and-stick) to GP130 D1 domain. The indole moiety and seven-membered ring azepanyl of bazedoxifene almost overlap with the native Trp157 and Leu57 residues (white lines) of IL-6, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Docking Modeling of the Best Drug Scaffolds, the Virtual Template, Aand Drug Candidates to GP130</h3><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A shows the top fragment sets S1 (fb1 and f2, red) and S2 (fb1 and f5, green) docked to the hot spots of the GP130 D1 domain, with similar binding energies. In both hits, the aromatic fragment f2 (2-phenylindole in S1) or f5 (2-phenyl-1-benzothiophene in S2) occupied the Trp157 subpocket and partially occupied the extra pocket. In addition, the indole moiety of f2 and benzothiophene of f5 had aromatic interactions with Tyr94 of GP130. The hydrophobic fragment fb1 (phenylpiperdinyl) occupied the main Leu57 binding pocket formed by surrounding residues Cys6, Phe36, Ile83, and Val94. Also piperdinyl formed a hydrogen bond with the backbone of Asn92. Further binding mode clustering analysis revealed that with similar binding energies, the binding modes of f2, f5, and fb1 could be dynamic and slightly different in the hot spots. These docking results suggest that indole and benzothiophene are privileged scaffolds mimicking the Trp157 residue of IL-6, and the piperdinyl can be a more effective replacement of the flexible aliphatic tail for displacing the Leu57 residue.</div><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B illustrates docking of the linked template compounds T1 and T2 to the GP130 D1 domain. The top hit T2 had binding modes and binding energy (Δ<i>E</i> of −9.3 kcal/mol) very close to that of the fragments fb1 and f5 in hit S2. Hit T1 also bound well to Leu57 and Trp157 binding sites, as well as part of the extra subpocket, with a binding energy Δ<i>E</i> of −9.1 kcal/mol. They have better docking binding energies and binding modes than MDL-A. Here the virtual compounds designed have much simpler structures than the MDL-A and its analogues and could be easier to synthesize. In addition, the templates are made of real drug scaffolds, which could potentially maintain their good drug property profiles.</div><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C shows docking of drug candidate raloxifene (gray ball-and-stick) to the GP130 D1 domain. Compared with the native binding of IL-6, the piperidinyl and aromatic 1-benzothiophene fragments of raloxifene almost overlapped with that of the native hot spot residues Leu57 and Trp157 (shown in white lines) of IL-6, respectively. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> shows the detailed binding interactions of raloxifene with the key active site residues of GP130 D1 domain. Asn92 and Cys6 formed two hydrogen bonds with the N and O of the piperidinylethoxy moiety of raloxifene, respectively. The binding modeling suggests that raloxifene could effectively disrupt the native IL-6 binding interaction with the GP130 D1 domain and thus block the homodimerization of GP130. Raloxifene has better binding modes and significantly improved binding energy (Δ<i>E</i> = −8.8 kcal/mol) than the known inhibitor MDL-A (Δ<i>E</i> = −6.6 kcal/mol).</div><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D depicts that bazedoxifene (gray ball-and-stick) has similar binding modes compared with raloxifene. The docking simulation shows that the indole fragment of bazedoxifene superimposed almost perfectly with the native Trp157 residue of IL-6 in hot spot 2. The azepanyl, a seven-membered heterocyclic tertiary amine, could effectively displace the Leu57 of IL-6 in binding hot spot 1 of the GP130 D1 domain to disable IL-6/GP130 D1 interactions. The binding mode of bazedoxifene was similar to that of template T1 (red line).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Modeling of binding interactions of raloxifene with the key residues in the active site in the GP130 D1 domain. Raloxifene is in thick ball-and-stick representation. Native residues Leu57 and Trp157 of IL-6 are thin red lines. Residues of GP130 are labeled in blue color. Asn92 and Cys6 form hydrogen bonds (green dotted lines) with raloxifene.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Detection of the Binding of Raloxifene and Bazedoxifene to GP130 by Drug Affinity Responsive Target Stability (DARTS) Assay</h3><div class="NLM_p">DARTS is a general method for studying the specific protein–ligand binding interactions.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> This method is based on the principle that the target protein structure might be stabilized and become less susceptible to proteolysis by proteases upon drug binding. DARTS assay can be performed using complex protein mixtures such as cell lysates without the need of purified proteins. In a recent report, this method was successfully used to assess the direct binding of potential inhibitor SC144 to target GP130 in human ovarian cells.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> To investigate the binding of drug candidates to GP130, we performed DARTS assays using human RH30 sarcoma cell lysates treated with raloxifene and bazedoxifene separately, following the protocol as previously described.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, we found an increase in abundance of GP130 band with increasing dose of raloxifene or bazedoxifene, which demonstrates that target GP130 was protected from proteolysis upon drug binding. Particularly, in the presence of raloxifene or bazedoxifene (100 and 1000 μM), the abundance of GP130 increased significantly compared with the no drug control. These results show the direct binding of raloxifene or bazedoxifene to GP130 and suggest that the binding interactions may induce structure changes in GP130 and cause differential proteolysis by pronase.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. DARTS assay to estimate raloxifene and bazedoxifene binding to target GP130. In RH30 sarcoma cell lysates, the proteolysis of GP130 by pronase is decreased by the treatment of raloxifene (Evista) or bazedoxifene (100 and 1000 μM). The results suggest that the direct binding of raloxifene or bazedoxifene to GP130 stabilizes the structure of GP130 and therefore protects it from proteolytic digestion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Raloxifene Selectively Down-Regulates the IL-6 Induced STAT3 Phosphorylation in a Dose-Dependent Manner</h3><div class="NLM_p">Raloxifene is commonly known as a selective estrogen receptor α (ERα) inhibitor. To exclude interference of ER, human pancreatic cancer cell line (PANC-1) that expresses GP130, but not ER, was used in our study. To examine the inhibition of IL-6 induced downstream STAT3 phosphorylation, we performed Western blot assays to detect the amount of phosphorylated STAT3 (P-STAT3) after PANC-1 cells were incubated with IL-6 and treated with raloxifene (10–50 μM).<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A, the amount of P-STAT3 stimulated by IL-6 in PANC-1 cells decreased with increasing doses of compound raloxifene. Significant reduction of phosphorylation of STAT3 induced by IL-6 was observed by treatment of 25 μM raloxifene. By contrast, raloxifene showed little inhibition on STAT3 phosphorylation induced by leukemia inhibitory factor (LIF). Also raloxifene had little inhibitory effect on STAT1 phosphorylation induced by IFN-γ. Previous reports have found that IL-6 induces the formation of IL-6/IL-6Rα/GP130 heterotrimer. Further reciprocal interactions of IL-6 and the GP130 D1 domain of the two IL-6/IL-6Rα/GP130 trimers led to homodimerization of GP130 into the hexamer via D1 domain, which triggers downstream STAT3 phosphorylation.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> In contrast, LIF activates the formation of LIF/LIFR/GP130 heterotrimer for STAT3 phosphorylation, which does not require the D1 domain of GP130 to form a hexamer for signaling.<a onclick="showRef(event, 'ref25 ref26 ref31'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref31">(25, 26, 31)</a> Mechanistically, raloxifene could most likely disrupt the IL-6/GP130 D1 interface to block the homodimerization of GP130 into hexamer, resulting in inhibition of the downstream STAT3 phosphorylation. The reasons are three-fold: (1) DARTS assay proves that raloxifene binds to GP130; (2) IL-6 signaling requires D1/D2/D3 domains, and LIF signaling requires only D2/D3 domains; (3) raloxifene only disrupts IL-6 signaling but not LIF signaling. Our finding also supports the previously proposed mechanism of the known inhibitor MDL-A, which down-regulates IL-6 activity through prevention of homodimerization of GP130 to form the hexamer.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Raloxifene appears to be more potent than the natural product compound MDL-A, which is consistent with our binding modeling results.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Selective inhibition of the IL-6 induced P-STAT3 by raloxifene (Evista) and bazedoxifene. (A) In human pancreatic cancer cells (PANC-1, ER negative) with treatment of IL-6 and raloxifene (25 μM), the downstream STAT3 phosphorylation (P-STAT3 at Y705) stimulated by IL-6 was significantly inhibited. In contrast, the P-STAT3 induced by LIF or P-STAT1 induced by IFN-γ was not suppressed. (B) Bazedoxifene (25 μM) selectively inhibited P-STAT3 induced by IL-6 but not P-STAT3 induced by LIF or P-STAT1 induced by IFN-γ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Bazedoxifene Selectively Inhibited STAT3 Phosphorylation (Y705) Stimulated by IL-6</h3><div class="NLM_p last">We also investigated whether bazedoxifene could inhibit STAT3 phosphorylation induced by IL-6/GP130 dimerization in human pancreatic cancer cell line (PANC-1). Following the same protocol, a Western blot was performed to detect the amount of phosphorylated STAT3 (P-STAT3) after PANC-1 cells were incubated with 50 ng/mL IL-6 or IFN-γ for 30 min, followed by the treatment of bazedoxifene at 15 or 25 μM.<a onclick="showRef(event, 'ref14 ref29'); return false;" href="javascript:void(0);" class="ref ref14 ref29">(14, 29)</a> Similar to the results of raloxifene, Western blot assay showed that bazedoxifene inhibited the STAT3 phosphorylation (P-STAT3) induced by IL-6 but had little effect on STAT3 phosphorylation induced by LIF and on STAT1 phosphorylation induced by IFN-γ (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B). These results suggest that bazedoxifene could possibly disrupt the IL-6/GP130 D1 domain interface that triggers the homodimerization of GP130 and the downstream STAT3 phosphorylation, similar to raloxifene.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Assay on Constitutive STAT3 Activity Level in Cancer Cell Lines with Treatment of Raloxifene, Bazedoxifene, and MDL-A</h3><div class="NLM_p">We investigated the inhibitory effects of raloxifene and bazedoxifene on the constitutive STAT3 activity level with human breast cancer cells (SUM159) that express elevated levels of IL-6 but not ER. Following the same protocol as described before, we performed Western blot assays to detect the inhibition of persistent STAT3 phosphorylation (P-STAT3) level after SUM159 cells were treated with raloxifene (15 or 50 μM) or bazedoxifene (10–30 μM) separately. Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a> shows that both raloxifene and bazedoxifene significantly inhibited constitutive STAT3 activity (P-STAT3) induced by IL-6 and GP130 in SUM159 cancer cells.</div><div class="NLM_p">In STAT3 signaling pathway, the constitutive STAT3 phosphorylation activity triggers a cascade of dimerization, nuclear translocation, and DNA binding to stimulate cancer cell proliferation. Furthermore, we performed cancer cell viability assays using the same SUM159 cancer cell culture to examine the inhibitory effects of raloxifene, bazedoxifene, and MDL-A. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> shows that raloxifene, bazedoxifene, and MDL-A inhibited the cancer cell proliferation in the presence of IL-6. IC<sub>50</sub> values are as follows: raloxifene, 43.2 μM; bazedoxifene, 24.9 μM; MDL-A, >250 μM.</div><div class="NLM_p">Since SUM159 does not express ER, it is clear that the inhibitions of constitutive P-STAT3 level and cell proliferation by these drug candidates are not through modulation of the ER target. Previous studies indicate that IL-6/GP130/STAT3 is one of the major cancer proliferation pathways. Our finding that raloxifene and bazedoxifene inhibit the constitutive P-STAT3 activity and downstream cell proliferation in the presence of IL-6 and GP130 would provide supportive evidence that the inhibition might be due to attenuation of IL-6/GP130/STAT3 signaling. In our computational simulation, binding hot spots of raloxifene and bazedoxifene are the same as the known IL-6/GP130 inhibitor MDL-A, which could further support our hypothesis.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of raloxifene and bazedoxifene on constitutive STAT3 activity level in SUM159 cancer cells. (A) In human breast cancer cells (SUM159, ER negative) expressing IL-6 and GP130, raloxifene (15–50 μM) down-regulated the constitutive STAT3 phosphorylation (P-STAT3) activity level. (B) Bazedoxifene (10–30 μM) inhibited the constitutive P-STAT3 activity levels induced by the expressed IL-6 and GP130.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Docked Binding Energies and IC<sub>50</sub> Values of Raloxifene, Bazedoxifene, and MDL-A in SUM159 Cell Viability Assays</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">docking energy Δ<i>E</i> (kcal/mol)</th><th class="colsep0 rowsep0" align="center" char=".">SUM159 (ER negative)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">raloxifene</td><td class="colsep0 rowsep0" align="char" char=".">–8.8</td><td class="colsep0 rowsep0" align="char" char=".">43.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bazedoxifene</td><td class="colsep0 rowsep0" align="char" char=".">–8.2</td><td class="colsep0 rowsep0" align="char" char=".">24.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDL-A</td><td class="colsep0 rowsep0" align="char" char=".">–6.6</td><td class="colsep0 rowsep0" align="char" char=".">>250.0</td></tr></tbody></table></div></div><div class="NLM_p last">IL-6 is a cytokine involved in initialization and maintenance of inflammatory, autoimmune response, osteoporosis, and proliferation. Raloxifene is commonly used as a selective estrogen receptor modulator (SERM) for treatment of osteoporosis. However, several reports also demonstrated that raloxifene can modulate osteoclast activity by, at least in part, an IL-6 and TNF-α dependent mechanism. Raloxifene can simultaneously stimulate osteoprotegerin and inhibit IL-6 production in human trabecular osteoblasts.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32-35)</a> IL-6 may also be a key factor associated with osteoporosis in patients with rheumatoid arthritis (RA). In a mouse model of RA, raloxifene decreased the IL-6 levels and protected both RA and the associated osteoporosis.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35-38)</a> The mechanism of IL-6 inhibition by raloxifene is not clear. Raloxifene could directly inhibit IL-6 expression or alternatively inhibit the IL-6/GP130 interface; both mechanisms could down-regulate the IL-6/GP130/STAT3 pathway. It is interesting that the known IL-6/GP130 inhibitor MDL-A also prevents the bone resorption and loss by a mechanism different from that of 17β-estradiol acting on ER in an experimental model of postmenopausal osteoporosis in vivo.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These findings suggest that modulation of cytokine IL-6 by raloxifene might be an alternative and secondary mechanism of osteoporosis prevention. One of the off-target effects of raloxifene could be inhibiting IL-6 related signaling pathways, one of which could be the IL6/GP130/STAT3 crosstalk signaling pathway for cancer. We attempted to repurpose raloxifene to target IL-6/GP130/STAT3 signaling pathway of cancer cells. Cancer cell line assays provide indirect, yet supportive evidence for the proposed mechanism and suggest it seems likely that raloxifene or bazedoxifene selectively disrupts the IL-6/GP130 interface and the homodimerization to inhibit constitutive P-STAT3 activity stimulated by IL-6.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">It is challenging to design small molecules to disrupt multiple binding “hot spots” on the interface of protein–protein interaction. Our MLSD method could serve to dock multiple fragments to these binding hot spots on the interface to simultaneously interfere with the binding of multiple key residues among the protein binding partners. In this work, the combined MLSD and drug repositioning approach quickly identified that raloxifene and bazedoxifene, two known selective estrogen receptor modulator drugs for osteoporosis, show potential for disrupting IL-6/GP130/STAT3 cancer signaling pathway through disruption of the IL-6/GP130 D1 interface. They represent a new class of lead compounds with piperidine, benzothiophene, and indole scaffolds to inhibit homodimerization of GP130. Thus, the discovery of raloxifene and bazedoxifene could speed up the development of clinical therapies for the IL-6/GP130/STAT3 dependent cancers. And of course, they can also be used as leads for further optimization for IL-6 signaling inhibition. Our approach to combine multiple fragment simultaneous docking and drug repositioning could potentially help to design novel inhibitors targeting other protein–protein interactions.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemical reagents and solvents were purchased from commercial sources and used without further purification. Compounds raloxifene·HCl and bazedoxifene·HCl were purchased from Selleckchem with 99.8% purity. Other compounds have ≥95% purity as determined by HPLC.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Privileged Drug Scaffolds Preparation for GP130</h3><div class="NLM_p last">To prepare the drug scaffold library for GP130, the known inhibitors MDL-A and its analogues were used to generate a set of feature fragments for the binding hot spots of the D1 domain of GP130. These known inhibitors were fragmented by a retro-synthetic approach. In addtion, the key interacting residues Leu57 and Trp157 of IL-6 were included as feature fragments. Two databases were used to identify drug scaffolds for binding to the GP130 D1 domain. One was the top drug scaffold database generated from FDA approved drugs (AD) and extended drugs (Ed) as reported by Wang et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The other database was DrugBank, which contains 6707 drug entries including 1436 FDA approved small molecule drugs, and 5086 experimental drugs.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Drug scaffolds for GP130 were then identified by structure or chemical feature search of the obtained feature fragments on top drug scaffolds library and by substructure search on DrugBank. The chemical features of a fragment include aromatic ring, polarity, hydrogen bonding, and hydrophobicity. The privileged drug scaffolds library identified for the GP130 D1 domain was used for multifragment docking screening (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Multiple Fragment Simultaneous Docking Screening and Drug Repositioning</h3><div class="NLM_p last">The crystal structure of the GP130 D1 domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1P9M">1P9M</a>) was used as the receptor for docking. MLSD docking screening and drug repositioning were employed as previously described.<a onclick="showRef(event, 'ref13 ref14 ref27'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref27">(13, 14, 27)</a> Privileged drug scaffolds in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B were used as fragments in MLSD screening. In multifragment docking, two fragments from the two pools of the drug scaffolds were used to probe binding subpockets of the GP130 D1 domain. Systematic multifragment docking screening with the combinations of drug scaffolds was ranked by the predicted binding energy. The docked fragments with a predicted binding energy of <−7.0 kcal/mol (better than MDL-A docking energy of −6.6 kcal/mol) were considered for further visual inspection of binding modes analysis. A set of fragments with good binding energies and binding modes were selected as hits. Previously reported procedure and parameter settings were used for multiple fragments simultaneous docking.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Hybrid particle swarm optimization (PSO) or Lamarckian genetic algorithm (LGA) was used as a searching method in MLSD docking screening. A time decreasing inertia weighted PSO (<i>w</i> from 0.9 to 0.4) algorithm was used. The cognitive (<i>c</i><sub>1</sub>) and social (<i>c</i><sub>2</sub>) acceleration factors of PSO were set as <i>c</i><sub>1</sub> = <i>c</i><sub>2</sub> = 2.0. Virtual template compounds were obtained by linking docked fragments using various types of tethers. The candidates were optimized for the two major drug properties: octanol–water partition coefficient (log <i>P</i>) and polar surface area (PSA). Chemical 2D structure and 3D structures were generated by Molinspiration WebME Editor and Web service. Drug properties were calculated using Molinspiration molecular property service (<a href="http://www.molinspiration.com" class="extLink">http://www.molinspiration.com</a>). The linked compounds were re-docked to the GP130 D1 domain and ranked by binding energies and binding mode closeness to its corresponding fragments docked. To apply the drug repositioning concept, similarity searches for virtual compound hits in DrugBank (<a href="http://www.drugbank.ca/" class="extLink">http://www.drugbank.ca/</a>) and PubChem (<a href="http://pubchem.ncbi.nlm.nih.gov/" class="extLink">http://pubchem.ncbi.nlm.nih.gov/</a>) databases were performed to identify potential drug analogues of hit compounds.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> SMILES encoding and Tanimoto similarity coefficient cutoff of 0.5 were used for similarity search. The identified hit compounds were verified by computational re-docking using MLSD and ranked by predicted binding energies and visual inspection of binding modes before selection for purchase to perform cell line assays.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The MLSD program and source code are available for free upon request.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Cancer Cell Assays</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Cell Lines and Cell Culture</h4><div class="NLM_p last">Human pancreatic cancer cell (PANC-1) and human breast cancer cell (SUM159, ER negative) lines were purchased from the American Type Culture Collection (ATCC). Cancer cell lines were cultured in DMEM medium supplemented with 10% FBS and 100 U/mL penicillin/streptomycin B, in a humidified 37 °C incubator with 5% CO<sub>2</sub>.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Western Blot Analysis</h4><div class="NLM_p last">PANC-1 and SUM159 cells were treated with raloxifene (10–50 μM), bazedoxifene (10–30 μM), or DMSO control at 60–80% confluence in the presence of 10% fetal bovine serum (FBS) for 24 h and lysed in cold RIPA lysis buffer containing a cocktail of protease inhibitors to prepare whole-cell extracts.<a onclick="showRef(event, 'ref14 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref14 ref28 ref29">(14, 28, 29)</a> Lysates were then centrifuged at 14 000 rpm for 10 min to remove insoluble materials. Then 30–100 protein samples were separated by SDS–PAGE and transferred onto a PVDF membrane. After being blocked with 5% nonfat milk, the proteins were immunoblotted overnight at 4 °C with 1:1000 dilution of primary antibodies (Cell Signaling Technology) against phospho-STAT3 (pTyr705), STAT3, phospho-STAT1 (tyrosine 701), STAT1, and GAPDH, respectively, and 1:10,000 dilution of HRP conjugated secondary antibody for 1 h at room temperature. The target proteins were visualized by chemiluminescence (Cell Signaling Technology).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> DARTS Assay</h4><div class="NLM_p last">The drug affinity responsive target stability (DARTS) assay was used to detect the binding of raloxifene and bazedoxifene to GP130 target by following the procedure previously described.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> Human RH30 sarcoma cells were lysed using M-PER (Thermo Scientific, Inc.) supplemented with protease and phosphatase inhibitors. Lysates were then incubated with escalating concentrations (10–1000 μM) of raloxifene, bazedoxifene, or DMSO control at room temperature for 1 h. Proteolysis was followed by adding protease pronase solution at a ratio of 1 mg of pronase to 1000 mg of lysate for 30 min at room temperature. To stop proteolysis, 5× SDS sample loading buffer was added at 1:4 ratio to each sample and boiled at 100 °C. The resulted protein samples were separated by 8% SDS–PAGE gel and analyzed by Western blotting as previously described.<a onclick="showRef(event, 'ref21 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref24">(21, 24)</a></div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Cell Viability Assay</h4><div class="NLM_p last">SUM159 cells were seeded in 96-well plates at a density of 3000 cells per well. Escalating concentrations (5–100 μM) of raloxifene and bazedoxifene were added in triplicate to the plates in the presence of 10% FBS.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> The cells were incubated at 37 °C for a period of 72 h. 3-(4,5-Dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) viability assay was done according to the manufacturer’s protocol (Roche Diagnostics, Mannheim, Germany).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The absorbance was read at 595 nm. Half-maximal inhibitory concentrations (IC<sub>50</sub>) were determined using Sigma Plot 9.0 software (Systat Software Inc., San Jose, CA).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm401144z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chenglong Li</span> - <span class="hlFld-Affiliation affiliation">Biophysics
Graduate Program, The Ohio State University, Columbus, Ohio 43210, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f29e9bdcc5c0cab29d8187dc979687"><span class="__cf_email__" data-cfemail="e38f8acdd4d1dba38c9096cd868796">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huameng Li</span> - <span class="hlFld-Affiliation affiliation">Biophysics
Graduate Program, The Ohio State University, Columbus, Ohio 43210, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Xiao</span> - <span class="hlFld-Affiliation affiliation">Center
for Childhood Cancer, The Research Institute
at Nationwide Children’s Hospital, Columbus, Ohio 43205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Lin</span> - <span class="hlFld-Affiliation affiliation">Division
of Cardiology, Department of Internal Medicine, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Jou</span> - <span class="hlFld-Affiliation affiliation">Center
for Childhood Cancer, The Research Institute
at Nationwide Children’s Hospital, Columbus, Ohio 43205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vandana Kumari</span> - <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiayuh Lin</span> - <span class="hlFld-Affiliation affiliation">Center
for Childhood Cancer, The Research Institute
at Nationwide Children’s Hospital, Columbus, Ohio 43205, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2056e861-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">C.L. thanks the Ohio Supercomputer Center (OSC) for awarding CPU research units on the Glenn Cluster. The study is partially funded by a DOD/CDMRP BCRP award to C.L. (Grant W81XWH-10-1-0996).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> Abbreviations Used</h2><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin 6</p></td></tr><tr><td class="NLM_term">GP130</td><td class="NLM_def"><p class="first last">glycoprotein 130</p></td></tr><tr><td class="NLM_term">MDL-A</td><td class="NLM_def"><p class="first last">madindoline A</p></td></tr><tr><td class="NLM_term">MLSD</td><td class="NLM_def"><p class="first last">multiple ligand simultaneous docking</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6-diamidino-2-phenylindole</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">INF-γ</td><td class="NLM_def"><p class="first last">interferon γ</p></td></tr><tr><td class="NLM_term">LIF</td><td class="NLM_def"><p class="first last">leukemia inhibitory factor</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span> </span><span class="NLM_article-title">Interleukin-6 and its receptor: a paradigm for cytokines</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=593-597&author=T.+Kishimotoauthor=S.+Akiraauthor=T.+Taga&title=Interleukin-6+and+its+receptor%3A+a+paradigm+for+cytokines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DInterleukin-6%2520and%2520its%2520receptor%253A%2520a%2520paradigm%2520for%2520cytokines%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D593%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span> </span><span class="NLM_article-title">IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">1808</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1993&pages=1808-1810&author=M.+Murakamiauthor=M.+Hibiauthor=N.+Nakagawaauthor=T.+Nakagawaauthor=K.+Yasukawaauthor=K.+Yamanishiauthor=T.+Tagaauthor=T.+Kishimoto&title=IL-6-induced+homodimerization+of+gp130+and+associated+activation+of+a+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DHibi%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DN.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DYamanishi%26aufirst%3DK.%26aulast%3DTaga%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DIL-6-induced%2520homodimerization%2520of%2520gp130%2520and%2520associated%2520activation%2520of%2520a%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D1993%26volume%3D260%26spage%3D1808%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Boulanger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brevnova, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">2101</span><span class="NLM_x">–</span> <span class="NLM_lpage">2104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=2101-2104&author=M.+J.+Boulangerauthor=D.+C.+Chowauthor=E.+E.+Brevnovaauthor=K.+C.+Garcia&title=Hexameric+structure+and+assembly+of+the+interleukin-6%2FIL-6+alpha-receptor%2Fgp130+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoulanger%26aufirst%3DM.%2BJ.%26aulast%3DChow%26aufirst%3DD.%2BC.%26aulast%3DBrevnova%26aufirst%3DE.%2BE.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DHexameric%2520structure%2520and%2520assembly%2520of%2520the%2520interleukin-6%252FIL-6%2520alpha-receptor%252Fgp130%2520complex%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D2101%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">Cytokine receptor signaling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=591-594&author=J.+N.+Ihle&title=Cytokine+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DCytokine%2520receptor%2520signaling%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D591%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Darnell, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">STATs and gene regulation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1630-1635&author=J.+E.+Darnell&title=STATs+and+gene+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26atitle%3DSTATs%2520and%2520gene%2520regulation%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1630%26epage%3D1635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of Stat3 signaling pathway</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.2174%2F156800907780006922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=17305481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=91-107&author=J.+Dengauthor=F.+Grandeauthor=N.+Neamati&title=Small+molecule+inhibitors+of+Stat3+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of Stat3 signaling pathway</span></div><div class="casAuthors">Deng, Jinxia; Grande, Fedora; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-107</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Constitutive activation of the Signal Transducers and Activators of Transcription 3 (Stat3) meditated signaling pathway is very important for cell growth and survival.  Compelling evidence from mechanistic studies with antisense, RNA interference (RNAi), peptides, and small mol. inhibitors indicate that blocking Stat3 signaling can lead to successful suppression of tumor cell growth and apoptosis.  Thus, Stat3 is an attractive mol. target for the development of novel cancer therapeutics.  In this article, we present the 1st comprehensive review focusing on small mol. inhibitors that effectively block the Stat3 signaling pathway.  These inhibitors, from a structural point of view, are divided into 5 classes of compds.  They include (1) natural products and derivs., such as curcumin, resveratrol and others, (2) tyrphostins, (3) platinum-contg. complexes, (4) peptidomimetics, and (5) azaspiranes.  Some compds. may have multiple targets including Stat3 protein, therefore these compds. need further optimization and validation.  The purpose of this review is to provide a resource for researchers interested in Stat3 targeted small mols. which will be beneficial for database development and template design for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFbtKVwWNFBLVg90H21EOLACvtfcHk0li71yWPKP65Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOgtrs%253D&md5=b5cfd418452ffc185f585577bb170cbb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F156800907780006922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907780006922%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520Stat3%2520signaling%2520pathway%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D91%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rho, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunazuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, S.</span><span> </span><span class="NLM_article-title">Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">14728</span><span class="NLM_x">–</span> <span class="NLM_lpage">14733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=14728-14733&author=M.+Hayashiauthor=M.+C.+Rhoauthor=A.+Enomotoauthor=A.+Fukamiauthor=Y.+P.+Kimauthor=Y.+Kikuchiauthor=T.+Sunazukaauthor=T.+Hiroseauthor=K.+Komiyamaauthor=S.+Omura&title=Suppression+of+bone+resorption+by+madindoline+A%2C+a+novel+nonpeptide+antagonist+to+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DRho%26aufirst%3DM.%2BC.%26aulast%3DEnomoto%26aufirst%3DA.%26aulast%3DFukami%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DY.%2BP.%26aulast%3DKikuchi%26aufirst%3DY.%26aulast%3DSunazuka%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DKomiyama%26aufirst%3DK.%26aulast%3DOmura%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520bone%2520resorption%2520by%2520madindoline%2520A%252C%2520a%2520novel%2520nonpeptide%2520antagonist%2520to%2520gp130%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D14728%26epage%3D14733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Saleh, A. Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenman, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vranken, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolewski, J. J.</span><span> </span><span class="NLM_article-title">Binding of madindoline A to the extracellular domain of gp130</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">10822</span><span class="NLM_x">–</span> <span class="NLM_lpage">10827</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi050439%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10822-10827&author=A.+Z.+M.+Salehauthor=K.+L.+Greenmanauthor=S.+Billingsauthor=D.+L.+Van+Vrankenauthor=J.+J.+Krolewski&title=Binding+of+madindoline+A+to+the+extracellular+domain+of+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi050439%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050439%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSaleh%26aufirst%3DA.%2BZ.%2BM.%26aulast%3DGreenman%26aufirst%3DK.%2BL.%26aulast%3DBillings%26aufirst%3DS.%26aulast%3DVan%2BVranken%26aufirst%3DD.%2BL.%26aulast%3DKrolewski%26aufirst%3DJ.%2BJ.%26atitle%3DBinding%2520of%2520madindoline%2520A%2520to%2520the%2520extracellular%2520domain%2520of%2520gp130%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10822%26epage%3D10827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kumari, V.</span> Ph.D. Dissertation, The Ohio State University,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>unpublished data.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kumari%2C+V.+Ph.D.+Dissertation%2C+The+Ohio+State+University%2C+2011%3B+unpublished+data."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DV.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein–protein interfaces</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein%E2%80%93protein+interfaces"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein%25E2%2580%2593protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">White, A. W.; Westwell, A. D.; Brahemi, G.</span><span> </span><span class="NLM_article-title">Protein–protein interactions as targets for small-molecule therapeutics in cancer</span>.  <span class="citation_source-journal">Expert Rev. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e8</span>, DOI: <span class="refDoi"> DOI: 10.1017/S1462399408000641</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1017%2FS1462399408000641" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=e8&author=A.+W.+White&author=A.+D.+Westwell&author=G.+Brahemi&title=Protein%E2%80%93protein+interactions+as+targets+for+small-molecule+therapeutics+in+cancer&doi=10.1017%2FS1462399408000641"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1017%2FS1462399408000641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399408000641%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BW.%26atitle%3DProtein%25E2%2580%2593protein%2520interactions%2520as%2520targets%2520for%2520small-molecule%2520therapeutics%2520in%2520cancer%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2008%26volume%3D10%26spage%3De8%26doi%3D10.1017%2FS1462399408000641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bienstock, R. J.</span><span> </span><span class="NLM_article-title">Computational drug design targeting protein–protein interactions</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.2174%2F138161212799436449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=22316151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1240-1254&author=R.+J.+Bienstock&title=Computational+drug+design+targeting+protein%E2%80%93protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Computational drug design targeting protein-protein interactions</span></div><div class="casAuthors">Bienstock, Rachelle J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1240-1254</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Novel discoveries in mol. disease pathways within the cell, combined with increasing information regarding protein binding partners has lead to a new approach in drug discovery.  There is interest in designing drugs to modulate protein-protein interactions as opposed to solely targeting the catalytic active site within a single enzyme or protein.  There are many challenges in this new approach to drug discovery, particularly since the protein-protein interface has a larger surface area, can comprise a discontinuous epitope, and is more amorphous and less well defined than the typical drug design target, a small contained enzyme-binding pocket.  Computational methods to predict modes of protein-protein interaction, as well as protein interface hot spots, have garnered significant interest, in order to facilitate the development of drugs to successfully disrupt and inhibit protein-protein interactions.  This review summarizes some current methods available for computational protein-protein docking, as well as tabulating some examples of the successful design of antagonists and small mol. inhibitors for protein-protein interactions.  Several of these drugs are now beginning to appear in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrecmci1x1FD7Vg90H21EOLACvtfcHk0li95EjGRVjK8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbo%253D&md5=55b00723ce8b41d3098805f8088ac1a4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161212799436449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436449%26sid%3Dliteratum%253Aachs%26aulast%3DBienstock%26aufirst%3DR.%2BJ.%26atitle%3DComputational%2520drug%2520design%2520targeting%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1240%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Multiple ligand simultaneous docking (MLSD): orchestrated dancing of ligands in binding sites of protein</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2014</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=2014-2022&author=H.+Liauthor=C.+Li&title=Multiple+ligand+simultaneous+docking+%28MLSD%29%3A+orchestrated+dancing+of+ligands+in+binding+sites+of+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DMultiple%2520ligand%2520simultaneous%2520docking%2520%2528MLSD%2529%253A%2520orchestrated%2520dancing%2520of%2520ligands%2520in%2520binding%2520sites%2520of%2520protein%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D2014%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of STAT3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5592</span><span class="NLM_x">–</span> <span class="NLM_lpage">5596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101330h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5592-5596&author=H.+Liauthor=A.+Liuauthor=Z.+Zhaoauthor=Y.+Xuauthor=J.+Linauthor=D.+Jouauthor=C.+Li&title=Fragment-based+drug+design+and+drug+repositioning+using+multiple+ligand+simultaneous+docking+%28MLSD%29%3A+identifying+celecoxib+and+template+compounds+as+novel+inhibitors+of+STAT3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm101330h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101330h%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DJou%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DFragment-based%2520drug%2520design%2520and%2520drug%2520repositioning%2520using%2520multiple%2520ligand%2520simultaneous%2520docking%2520%2528MLSD%2529%253A%2520identifying%2520celecoxib%2520and%2520template%2520compounds%2520as%2520novel%2520inhibitors%2520of%2520STAT3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5592%26epage%3D5596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jevnikar, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, J. A.</span><span> </span><span class="NLM_article-title">Antiestrogens. 2. Structure–activity studies in a series of 3-aroyl-2-arylbenzo[<i>b</i>]thiophene derivatives leading to (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00374a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=1057-1066&issue=8&author=C.+D.+Jonesauthor=M.+G.+Jevnikarauthor=A.+J.+Pikeauthor=M.+K.+Petersauthor=L.+J.+Blackauthor=A.+R.+Thompsonauthor=J.+F.+Falconeauthor=J.+A.+Clemens&title=Antiestrogens.+2.+Structure%E2%80%93activity+studies+in+a+series+of+3-aroyl-2-arylbenzo%5Bb%5Dthiophene+derivatives+leading+to+%28LY+156758%29%2C+a+remarkably+effective+estrogen+antagonist+with+only+minimal+intrinsic+estrogenicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00374a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00374a021%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DJevnikar%26aufirst%3DM.%2BG.%26aulast%3DPike%26aufirst%3DA.%2BJ.%26aulast%3DPeters%26aufirst%3DM.%2BK.%26aulast%3DBlack%26aufirst%3DL.%2BJ.%26aulast%3DThompson%26aufirst%3DA.%2BR.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DClemens%26aufirst%3DJ.%2BA.%26atitle%3DAntiestrogens.%25202.%2520Structure%25E2%2580%2593activity%2520studies%2520in%2520a%2520series%2520of%25203-aroyl-2-arylbenzo%255Bb%255Dthiophene%2520derivatives%2520leading%2520to%2520%2528LY%2520156758%2529%252C%2520a%2520remarkably%2520effective%2520estrogen%2520antagonist%2520with%2520only%2520minimal%2520intrinsic%2520estrogenicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26issue%3D8%26spage%3D1057%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Biskobing, D. M.</span><span> </span><span class="NLM_article-title">Update on bazedoxifene: a novel selective estrogen receptor modulator</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=18044180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=299-303&issue=3&author=D.+M.+Biskobing&title=Update+on+bazedoxifene%3A+a+novel+selective+estrogen+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Update on bazedoxifene: a novel selective estrogen receptor modulator</span></div><div class="casAuthors">Biskobing, Diane M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-303</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  In the elderly population, osteoporosis is a significant clin. problem leading to disability and even death.  Many patients remain untreated, despite effective therapies, because of patients' unwillingness to take current therapies or inability to tolerate the therapies.  For this reason, ongoing research continues to search for more effective and tolerable osteoporosis agents.  Bazedoxifene is a selective estrogen receptor modulator (SERM) currently in development for osteoporosis prevention was recently submitted to the FDA.  Preclin. and clin. studies with bazedoxifene demonstrate more tissue selectivity than other SERMs.  In particular, bazedoxifene has minimal if any agonist activity in the uterus and is able to antagonize effects of estrogen on the uterus.  Animal studies and early clin. studies suggest effects in the bone similar to other SERMs with prevention of postmenopausal bone loss.  Until more data on efficacy and safety are published, however, its role in osteoporosis is unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZX945tpaALVg90H21EOLACvtfcHk0lgm9TQB_c8CKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrJ&md5=34159432bbf900fbca5d17947e954847</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiskobing%26aufirst%3DD.%2BM.%26atitle%3DUpdate%2520on%2520bazedoxifene%253A%2520a%2520novel%2520selective%2520estrogen%2520receptor%2520modulator%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26issue%3D3%26spage%3D299%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Barton, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, J. K.</span><span> </span><span class="NLM_article-title">Identification of three distinct receptor binding sites of murine interleukin-11</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">5755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=5755&author=V.+A.+Bartonauthor=K.+R.+Hudsonauthor=J.+K.+Heath&title=Identification+of+three+distinct+receptor+binding+sites+of+murine+interleukin-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DV.%2BA.%26aulast%3DHudson%26aufirst%3DK.%2BR.%26aulast%3DHeath%26aufirst%3DJ.%2BK.%26atitle%3DIdentification%2520of%2520three%2520distinct%2520receptor%2520binding%2520sites%2520of%2520murine%2520interleukin-11%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D5755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T. J.</span><span> </span><span class="NLM_article-title">Drug and drug candidate building block analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci900398f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOisrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=55-67&author=J.+Wangauthor=T.+J.+Hou&title=Drug+and+drug+candidate+building+block+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Drug and Drug Candidate Building Block Analysis</span></div><div class="casAuthors">Wang, Junmei; Hou, Tingjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-67</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug likeness anal. is widely used in modern drug design.  However, most drug likeness filters, represented by Lipinski's "Rule of 5", are based on drugs' simple structural features and some physiochem. properties.  In this study, we conducted thorough structural analyses for two drug datasets.  The first dataset, ADDS, is composed of 1240 FDA-approved drugs, and the second drug dataset, EDDS, is a nonredundant collection of FDA-approved drugs and exptl. drugs in different phases of clin. trials from several drug databases (6932 entries).  For each mol., all possible fragments were enumerated using a brutal force approach.  Three kinds of building blocks, namely, the drug scaffold, ring system, and the small fragment, were identified and ranked according to the frequencies of their occurrence in drug mols.  The major finding is that most top fragments are essentially common for both drug datasets; the top 50 fragments cover 52.6% and 48.6% drugs for ADDS and EDDS, resp.  The identified building blocks were further ranked according to their relative hit rates in the drug datasets and in a screening dataset, which is a nonredundant collection of screening compds. from many resources.  In comparison with the previous reports in the field, we have identified many more high-quality building blocks.  The results obtained in this study could provide useful hints to medicinal chemists in designing drug-like compds. as well as prioritizing screening libraries to filter out those mols. lack of functional building blocks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUmeynz19y1LVg90H21EOLACvtfcHk0lgxGT__xPft_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOisrbI&md5=9981fa62c5476e8063370bb7a659a752</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fci900398f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900398f%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DT.%2BJ.%26atitle%3DDrug%2520and%2520drug%2520candidate%2520building%2520block%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D55%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolkis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banco, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neveu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djoumbou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, D. S.</span><span> </span><span class="NLM_article-title">DrugBank 3.0: a comprehensive resource for “omics” research on drugs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D1035-D1041&author=C.+Knoxauthor=V.+Lawauthor=T.+Jewisonauthor=P.+Liuauthor=S.+Lyauthor=A.+Frolkisauthor=A.+Ponauthor=K.+Bancoauthor=C.+Makauthor=V.+Neveuauthor=Y.+Djoumbouauthor=R.+Eisnerauthor=A.+C.+Guoauthor=D.+S.+Wishart&title=DrugBank+3.0%3A+a+comprehensive+resource+for+%E2%80%9Comics%E2%80%9D+research+on+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DLaw%26aufirst%3DV.%26aulast%3DJewison%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DFrolkis%26aufirst%3DA.%26aulast%3DPon%26aufirst%3DA.%26aulast%3DBanco%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DNeveu%26aufirst%3DV.%26aulast%3DDjoumbou%26aufirst%3DY.%26aulast%3DEisner%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DWishart%26aufirst%3DD.%2BS.%26atitle%3DDrugBank%25203.0%253A%2520a%2520comprehensive%2520resource%2520for%2520%25E2%2580%259Comics%25E2%2580%259D%2520research%2520on%2520drugs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD1035%26epage%3DD1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bolton, E; Wang, Y; Thiessen, P. A; Bryant, S. H.</span><span> </span><span class="NLM_article-title">PubChem: Integrated Platform of Small Molecules and Biological Activities</span>. In  <span class="citation_source-book">Annual Reports in Computational Chemistry</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">4</span>, Chapter 12.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1016%2FS1574-1400%2808%2900012-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E+Bolton&author=Y+Wang&author=P.+A+Thiessen&author=S.+H.+Bryant&title=Annual+Reports+in+Computational+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1574-1400%2808%2900012-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1574-1400%252808%252900012-1%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DE%26atitle%3DPubChem%253A%2520Integrated%2520Platform%2520of%2520Small%2520Molecules%2520and%2520Biological%2520Activities%26btitle%3DAnnual%2520Reports%2520in%2520Computational%2520Chemistry%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2008%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlschlegel, J. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span> </span><span class="NLM_article-title">Target identification using drug affinity responsive target stability (DARTS)</span> <span class="citation_source-journal">Curr. Protoc. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=163-180&author=B.+Lomenickauthor=G.+Jungauthor=J.+A+Wohlschlegelauthor=J.+Huang&title=Target+identification+using+drug+affinity+responsive+target+stability+%28DARTS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DJung%26aufirst%3DG.%26aulast%3DWohlschlegel%26aufirst%3DJ.%2BA%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DTarget%2520identification%2520using%2520drug%2520affinity%2520responsive%2520target%2520stability%2520%2528DARTS%2529%26jtitle%3DCurr.%2520Protoc.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D3%26spage%3D163%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span> </span><span class="NLM_article-title">Identification of direct protein targets of small molecules</span> <span class="citation_source-journal">ACS Chem Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100294v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=34-46&author=B.+Lomenickauthor=R.+W.+Olsenauthor=J.+Huang&title=Identification+of+direct+protein+targets+of+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Direct Protein Targets of Small Molecules</span></div><div class="casAuthors">Lomenick, Brett; Olsen, Richard W.; Huang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-46</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Small-mol. target identification is a vital and daunting task for the chem. biol. community as well as for researchers interested in applying the power of chem. genetics to impact biol. and medicine.  To overcome this "target ID" bottleneck, new technologies are being developed that analyze protein-drug interactions, such as drug affinity responsive target stability (DARTS), which aims to discover the direct binding targets (and off targets) of small mols. on a proteome scale without requiring chem. modification of the compd.  Here, the authors review the DARTS method, discuss why it works, and provide new perspectives for future development in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGootJ9jC5FFCrVg90H21EOLACvtfcHk0ljcUAAmLZ2XRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsrrN&md5=f7878ba616630f1bb09f3d6f1af37f47</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb100294v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100294v%26sid%3Dliteratum%253Aachs%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DR.%2BW.%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520direct%2520protein%2520targets%2520of%2520small%2520molecules%26jtitle%3DACS%2520Chem%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D34%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aghajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warburton, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Target identification using drug affinity responsive target stability (DARTS)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">21984</span><span class="NLM_x">–</span> <span class="NLM_lpage">21989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1073%2Fpnas.0910040106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=19995983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1aiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=21984-21989&author=B.+Lomenickauthor=R.+Haoauthor=N.+Jonaiauthor=R.+M.+Chinauthor=M.+Aghajanauthor=S.+Warburton&title=Target+identification+using+drug+affinity+responsive+target+stability+%28DARTS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Target identification using drug affinity responsive target stability (DARTS)</span></div><div class="casAuthors">Lomenick, Brett; Hao, Rui; Jonai, Nao; Chin, Randall M.; Aghajan, Mariam; Warburton, Sarah; Wang, Jianing; Wu, Raymond P.; Gomez, Fernando; Loo, Joseph A.; Wohlschlegel, James A.; Vondriska, Thomas M.; Pelletier, Jerry; Herschman, Harvey R.; Clardy, Jon; Clarke, Catherine F.; Huang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21984-21989, S21984/1-S21984/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Identifying the mol. targets for the beneficial or detrimental effects of small-mol. drugs is an important and currently unmet challenge.  We have developed a method, drug affinity responsive target stability (DARTS), which takes advantage of a redn. in the protease susceptibility of the target protein upon drug binding.  DARTS is universally applicable because it requires no modification of the drug and is independent of the mechanism of drug action.  We demonstrate use of DARTS to identify known small-mol.-protein interactions and to reveal the eukaryotic translation initiation machinery as a mol. target for the longevity-enhancing plant natural product resveratrol.  We envisage that DARTS will also be useful in global mapping of protein-metabolite interaction networks and in label-free screening of unlimited varieties of compds. for development as mol. imaging agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBFsvOPfmmaLVg90H21EOLACvtfcHk0ljcUAAmLZ2XRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1aiug%253D%253D&md5=0f14bce633a1ce0af6d95ad13876e405</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0910040106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0910040106%26sid%3Dliteratum%253Aachs%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DR.%26aulast%3DJonai%26aufirst%3DN.%26aulast%3DChin%26aufirst%3DR.%2BM.%26aulast%3DAghajan%26aufirst%3DM.%26aulast%3DWarburton%26aufirst%3DS.%26atitle%3DTarget%2520identification%2520using%2520drug%2520affinity%2520responsive%2520target%2520stability%2520%2528DARTS%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D21984%26epage%3D21989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande1, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1158%2F1535-7163.MCT-12-1082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=23536726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=937-949&author=S.+Xuauthor=F.+Grande1author=A.+Garofaloauthor=N.+Neamati&title=Discovery+of+a+novel+orally+active+small-molecule+gp130+inhibitor+for+the+treatment+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer</span></div><div class="casAuthors">Xu, Shili; Grande, Fedora; Garofalo, Antonio; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-949</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Interleukin (IL)-6 and Stat3 play key roles in ovarian cancer progression.  However, the role of glycoprotein 130 (gp130), the signal transducer of this signaling axis, is not well-established.  Currently, there are no small-mol. inhibitors of gp130 under clin. development.  In this study, we show that gp130 is an attractive drug target in ovarian cancer due to its role in promoting cancer progression via the activation of its downstream Stat3 signaling.  We also present preclin. studies of SC144, the 1st-in-class orally active small-mol. gp130 inhibitor.  SC144 shows greater potency in human ovarian cancer cell lines than in normal epithelial cells.  SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, abrogates Stat3 phosphorylation and nuclear translocation, and further inhibits the expression of downstream target genes.  In addn., SC144 shows potent inhibition of gp130 ligand-triggered signaling.  Oral administration of SC144 delays tumor growth in a mouse xenograft model of human ovarian cancer without significant toxicity to normal tissues.  Mol Cancer Ther; 12(6); 937-49. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjGt-WKRmr7Vg90H21EOLACvtfcHk0ljryNKfNN0Ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOks7s%253D&md5=789989a2a5cf8c4e68657e5521d7e831</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-1082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-1082%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DGrande1%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520orally%2520active%2520small-molecule%2520gp130%2520inhibitor%2520for%2520the%2520treatment%2520of%2520ovarian%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D937%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.</span><span> </span><span class="NLM_article-title">Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation</span> <span class="citation_source-journal">Reproduction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=341-349&issue=2&author=H.+Songauthor=H.+Lim&title=Evidence+for+heterodimeric+association+of+leukemia+inhibitory+factor+%28LIF%29+receptor+and+gp130+in+the+mouse+uterus+for+LIF+signaling+during+blastocyst+implantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DH.%26atitle%3DEvidence%2520for%2520heterodimeric%2520association%2520of%2520leukemia%2520inhibitory%2520factor%2520%2528LIF%2529%2520receptor%2520and%2520gp130%2520in%2520the%2520mouse%2520uterus%2520for%2520LIF%2520signaling%2520during%2520blastocyst%2520implantation%26jtitle%3DReproduction%26date%3D2006%26volume%3D131%26issue%3D2%26spage%3D341%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gearing, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thut, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VandeBos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimpel, S. D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, P. B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckmann, M. P.</span><span> </span><span class="NLM_article-title">Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1991&pages=2839&issue=10&author=D.+P.+Gearingauthor=C.+J.+Thutauthor=T.+VandeBosauthor=S.+D+Gimpelauthor=P.+B+Delaneyauthor=J.+Kingauthor=V.+Priceauthor=D.+Cosmanauthor=M.+P.+Beckmann&title=Leukemia+inhibitory+factor+receptor+is+structurally+related+to+the+IL-6+signal+transducer%2C+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGearing%26aufirst%3DD.%2BP.%26aulast%3DThut%26aufirst%3DC.%2BJ.%26aulast%3DVandeBos%26aufirst%3DT.%26aulast%3DGimpel%26aufirst%3DS.%2BD%26aulast%3DDelaney%26aufirst%3DP.%2BB%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DV.%26aulast%3DCosman%26aufirst%3DD.%26aulast%3DBeckmann%26aufirst%3DM.%2BP.%26atitle%3DLeukemia%2520inhibitory%2520factor%2520receptor%2520is%2520structurally%2520related%2520to%2520the%2520IL-6%2520signal%2520transducer%252C%2520gp130%26jtitle%3DEMBO%2520J.%26date%3D1991%26volume%3D10%26issue%3D10%26spage%3D2839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Li, H.</span><span> </span><span class="NLM_article-title">Multiple Ligand Simultaneous Docking (MLSD) and Its Applications to Fragment Based Drug Design and Drug Repositioning</span>. Ph.D. Dissertation, The Ohio State University,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Li&title=Multiple+Ligand+Simultaneous+Docking+%28MLSD%29+and+Its+Applications+to+Fragment+Based+Drug+Design+and+Drug+Repositioning"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26atitle%3DMultiple%2520Ligand%2520Simultaneous%2520Docking%2520%2528MLSD%2529%2520and%2520Its%2520Applications%2520to%2520Fragment%2520Based%2520Drug%2520Design%2520and%2520Drug%2520Repositioning%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4700</span><span class="NLM_x">–</span> <span class="NLM_lpage">4705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4700-4705&author=H.+Songauthor=R.+Wangauthor=S.+Wangauthor=J.+Lin&title=A+low-molecular-weight+compound+discovered+through+virtual+database+screening+inhibits+Stat3+function+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520low-molecular-weight%2520compound%2520discovered%2520through%2520virtual%2520database%2520screening%2520inhibits%2520Stat3%2520function%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D4700%26epage%3D4705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutzen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foust, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhasin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A novel small molecule, LLL12, inhibits STAT3. Phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=39-50&author=L.+Linauthor=B.+Hutzenauthor=P.+K.+Liauthor=S.+Ballauthor=M.+Zuoauthor=S.+DeAngelisauthor=E.+Foustauthor=M.+Soboauthor=L.+Friedmanauthor=D.+Bhasinauthor=L.+Cenauthor=C.+Liauthor=J.+Lin&title=A+novel+small+molecule%2C+LLL12%2C+inhibits+STAT3.+Phosphorylation+and+activities+and+exhibits+potent+growth-suppressive+activity+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DHutzen%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DBall%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DM.%26aulast%3DDeAngelis%26aufirst%3DS.%26aulast%3DFoust%26aufirst%3DE.%26aulast%3DSobo%26aufirst%3DM.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DCen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small%2520molecule%252C%2520LLL12%252C%2520inhibits%2520STAT3.%2520Phosphorylation%2520and%2520activities%2520and%2520exhibits%2520potent%2520growth-suppressive%2520activity%2520in%2520human%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D39%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Reed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=450-455&author=S.+Reedauthor=H.+Liauthor=C.+Liauthor=J.+Lin&title=Celecoxib+inhibits+STAT3+phosphorylation+and+suppresses+cell+migration+and+colony+forming+ability+in+rhabdomyosarcoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DCelecoxib%2520inhibits%2520STAT3%2520phosphorylation%2520and%2520suppresses%2520cell%2520migration%2520and%2520colony%2520forming%2520ability%2520in%2520rhabdomyosarcoma%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D407%26spage%3D450%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Boulanger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankovich, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortemme, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=577-589&author=M.+J.+Boulangerauthor=A.+J.+Bankovichauthor=T.+Kortemmeauthor=D.+Bakerauthor=K.+C.+Garcia&title=Convergent+mechanisms+for+recognition+of+divergent+cytokines+by+the+shared+signaling+receptor+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoulanger%26aufirst%3DM.%2BJ.%26aulast%3DBankovich%26aufirst%3DA.%2BJ.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DConvergent%2520mechanisms%2520for%2520recognition%2520of%2520divergent%2520cytokines%2520by%2520the%2520shared%2520signaling%2520receptor%2520gp130%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26spage%3D577%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Jochems, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerquist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkansson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsten, H.</span><span> </span><span class="NLM_article-title">Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1111%2Fj.1365-2249.2008.03660.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=18435803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVOiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2008&pages=593-597&issue=3&author=C.+Jochemsauthor=M.+Lagerquistauthor=C.+H%C3%A5kanssonauthor=C.+Ohlssonauthor=H.+Carlsten&title=Long-term+anti-arthritic+and+anti-osteoporotic+effects+of+raloxifene+in+established+experimental+postmenopausal+polyarthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis</span></div><div class="casAuthors">Jochems, C.; Lagerquist, M.; Haakansson, C.; Ohlsson, C.; Carlsten, H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-597</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Both estrogen deficiency and the inflammatory disease contribute to the generalized bone loss seen in postmenopausal rheumatoid arthritis (RA).  Oestradiol and the selective estrogen receptor modulator raloxifene have been shown to ameliorate the disease in collagen-induced arthritis (CIA), a well-established animal model for human RA.  The aim of this study was to investigate whether raloxifene-treatment would be beneficial in long-term treatment of established CIA, both regarding anti-arthritic and anti-osteoporotic properties.  Female dil. brown agouti mice were ovariectomized and CIA was induced.  Raloxifene or vehicle treatment was administered 5 days per wk, and the clin. arthritis score was evaluated continuously.  At termination, bone mineral d. was analyzed, paws were collected for histol. examn. and sera were analyzed for markers of bone and cartilage turnover, as well as antibodies to type II collagen and levels of interleukin (IL)-6.  Treatment with raloxifene is beneficial in long-term treatment of established CIA.  It hampers the disease severity and frequency, protects the joints from destruction and protects against the development of osteoporosis.  The proinflammatory cytokine IL-6 was down-regulated in raloxifene-treated mice compared with controls.  The serum levels of antibodies to collagen were not affected by raloxifene-treatment.  Long-term treatment with raloxifene has both anti-arthritic and anti-osteoporotic effects in established exptl. postmenopausal polyarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtOOWA2BVgj7Vg90H21EOLACvtfcHk0ljni-oPbil4-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVOiu74%253D&md5=640fb9961ffdfd5f38291efdd44e6120</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2008.03660.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2008.03660.x%26sid%3Dliteratum%253Aachs%26aulast%3DJochems%26aufirst%3DC.%26aulast%3DLagerquist%26aufirst%3DM.%26aulast%3DH%25C3%25A5kansson%26aufirst%3DC.%26aulast%3DOhlsson%26aufirst%3DC.%26aulast%3DCarlsten%26aufirst%3DH.%26atitle%3DLong-term%2520anti-arthritic%2520and%2520anti-osteoporotic%2520effects%2520of%2520raloxifene%2520in%2520established%2520experimental%2520postmenopausal%2520polyarthritis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2008%26volume%3D152%26issue%3D3%26spage%3D593%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Gianni, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzaniga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietropaolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandurra, R.</span><span> </span><span class="NLM_article-title">Raloxifene modulates interleukin-6 and tumor necrosis factor-α synthesis in vivo: results from a pilot clinical study</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">6097</span><span class="NLM_x">–</span> <span class="NLM_lpage">6099</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1210%2Fjc.2004-0795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=15579764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSit77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=6097-6099&author=W.+Gianniauthor=A.+Ricciauthor=P.+Gazzanigaauthor=M.+Bramaauthor=M.+Pietropaoloauthor=S.+Votanoauthor=R.+Scandurra&title=Raloxifene+modulates+interleukin-6+and+tumor+necrosis+factor-%CE%B1+synthesis+in+vivo%3A+results+from+a+pilot+clinical+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Raloxifene modulates interleukin-6 and tumor necrosis factor-α synthesis in vivo: Results from a pilot clinical study</span></div><div class="casAuthors">Gianni, Walter; Ricci, Andrea; Gazzaniga, Paola; Brama, Marina; Pietropaolo, Maria; Votano, Sergio; Patane, Francesco; Agliano, Anna Maria; Spera, Giovanni; Marigliano, Vincenzo; Ammendola, Sergio; Agnusdei, Donato; Migliaccio, Silvia; Scandurra, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6097-6099</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Raloxifene (RAL), a selective estrogen receptor modulator, is indicated for the prevention and treatment of postmenopausal osteoporosis.  RAL, by decreasing bone turnover, prevents bone loss and microarchitecture damage, reducing the incidence of osteoporotic fractures.  Our previous in vitro data demonstrated that RAL modulates osteoclast activity by, at least in part, an IL-6- and TNF-α-dependent mechanism.  In this study we evaluated the effects of RAL treatment (60 mg/d) on circulating levels of these cytokines in 14 postmenopausal women with osteoporosis.  Lumbar bone d. (detd. by dual energy x-ray absorptiometry) and IL-6 and TNF-α levels were measured before and after 6 and 24 mo of therapy.  After 24 mo, RAL increased bone d.  IL-6 and TNF-α expression, elevated before treatment, significantly decreased (50% and 30%, resp.) after 6 mo.  This effect was sustained up to the end of the treatment (75% and 35%, resp.).  Thus, our data show that RAL can modulate circulating levels of cytokines involved in osteoclastogenesis and bone resorption, suggesting that modulation of sol. factors could play a pivotal role in the mechanisms of the osteoprotective effect of RAL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV24SJrBuhBLVg90H21EOLACvtfcHk0lhqIvhK837x_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSit77F&md5=c76624bf35b0c2089d3351c0d30542bc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1210%2Fjc.2004-0795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2004-0795%26sid%3Dliteratum%253Aachs%26aulast%3DGianni%26aufirst%3DW.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DGazzaniga%26aufirst%3DP.%26aulast%3DBrama%26aufirst%3DM.%26aulast%3DPietropaolo%26aufirst%3DM.%26aulast%3DVotano%26aufirst%3DS.%26aulast%3DScandurra%26aufirst%3DR.%26atitle%3DRaloxifene%2520modulates%2520interleukin-6%2520and%2520tumor%2520necrosis%2520factor-%25CE%25B1%2520synthesis%2520in%2520vivo%253A%2520results%2520from%2520a%2520pilot%2520clinical%2520study%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab%26date%3D2004%26volume%3D89%26spage%3D6097%26epage%3D6099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ozmen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirmaz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aydin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kafesciler, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guclu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hekimsoy, Z.</span><span> </span><span class="NLM_article-title">Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis</span> <span class="citation_source-journal">Eur. Cytokine Network</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=17400536" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=31-36&author=B.+Ozmenauthor=C.+Kirmazauthor=K.+Aydinauthor=S.+O.+Kafescilerauthor=F.+Gucluauthor=Z.+Hekimsoy&title=Influence+of+the+selective+oestrogen+receptor+modulator+%28raloxifene+hydrochloride%29+on+IL-6%2C+TNF-alpha%2C+TGF-beta1+and+bone+turnover+markers+in+the+treatment+of+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOzmen%26aufirst%3DB.%26aulast%3DKirmaz%26aufirst%3DC.%26aulast%3DAydin%26aufirst%3DK.%26aulast%3DKafesciler%26aufirst%3DS.%2BO.%26aulast%3DGuclu%26aufirst%3DF.%26aulast%3DHekimsoy%26aufirst%3DZ.%26atitle%3DInfluence%2520of%2520the%2520selective%2520oestrogen%2520receptor%2520modulator%2520%2528raloxifene%2520hydrochloride%2529%2520on%2520IL-6%252C%2520TNF-alpha%252C%2520TGF-beta1%2520and%2520bone%2520turnover%2520markers%2520in%2520the%2520treatment%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DEur.%2520Cytokine%2520Network%26date%3D2007%26volume%3D18%26spage%3D31%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Viereck, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaschke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederkleine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siggelkow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emons, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, L. C.</span><span> </span><span class="NLM_article-title">Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">4206</span><span class="NLM_x">–</span> <span class="NLM_lpage">4213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1210%2Fjc.2002-021877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=12970288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=4206-4213&author=V.+Viereckauthor=C.+Grundkerauthor=S.+Blaschkeauthor=B.+Niederkleineauthor=H.+Siggelkowauthor=K.-H.+Froschauthor=D.+Raddatzauthor=G.+Emonsauthor=L.+C.+Hofbauer&title=Raloxifene+concurrently+stimulates+osteoprotegerin+and+inhibits+interleukin-6+production+by+human+trabecular+osteoblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts</span></div><div class="casAuthors">Viereck, Volker; Gruendker, Carsten; Blaschke, Sabine; Niederkleine, Britta; Siggelkow, Heide; Frosch, Karl-Heinz; Raddatz, Dirk; Emons, Guenter; Hofbauer, Lorenz C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4206-4213</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Raloxifene reduces bone loss and prevents vertebral fractures in postmenopausal women.  Its skeletal effects are mediated by estrogen receptors (ER) and their modulation of paracrine osteoblastic factors.  Receptor activator of nuclear factor-κB ligand is essential for osteoclasts and enhances bone resorption, whereas osteoprotegerin (OPG) neutralizes receptor activator of nuclear factor-κB ligand.  Here, we assessed the effects of raloxifene on OPG prodn. in human osteoblasts (hOB).  Raloxifene enhanced gene expression of ER-α and progesterone receptor.  Moreover, raloxifene increased OPG mRNA levels and protein secretion by hOB in a dose- and time-dependent fashion by 2- to 4-fold with a max. effect at 10-7 M and after 72 h (P < 0.001).  Treatment with the ER antagonist ICI 182,780 abrogated the effects of raloxifene on OPG prodn.  Moreover, raloxifene enhanced osteoblastic differentiation markers, type 1 collagen secretion, and alk. phosphatase activity by 3- and 2-fold, resp. (P < 0.001).  In addn., raloxifene inhibited expression of the bone-resorbing cytokine IL-6 by 25-45% (P < 0.001).  In conclusion, our data suggest that raloxifene stimulates OPG prodn. and inhibits IL-6 prodn. by hOB.  Because OPG prodn. increases with osteoblastic maturation, enhancement of OPG prodn. by raloxifene could be related to its stimulatory effects on osteoblastic differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfK7P_so5vqbVg90H21EOLACvtfcHk0liYglRnHGx1zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlagsr4%253D&md5=638d91614906c8a947e1f38d666a0a03</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1210%2Fjc.2002-021877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2002-021877%26sid%3Dliteratum%253Aachs%26aulast%3DViereck%26aufirst%3DV.%26aulast%3DGrundker%26aufirst%3DC.%26aulast%3DBlaschke%26aufirst%3DS.%26aulast%3DNiederkleine%26aufirst%3DB.%26aulast%3DSiggelkow%26aufirst%3DH.%26aulast%3DFrosch%26aufirst%3DK.-H.%26aulast%3DRaddatz%26aufirst%3DD.%26aulast%3DEmons%26aufirst%3DG.%26aulast%3DHofbauer%26aufirst%3DL.%2BC.%26atitle%3DRaloxifene%2520concurrently%2520stimulates%2520osteoprotegerin%2520and%2520inhibits%2520interleukin-6%2520production%2520by%2520human%2520trabecular%2520osteoblasts%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26spage%3D4206%26epage%3D4213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Jochems, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallkopf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerquist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsten, H.</span><span> </span><span class="NLM_article-title">Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3261</span><span class="NLM_x">–</span> <span class="NLM_lpage">3270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1002%2Fart.22873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=17907171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=3261-3270&author=C.+Jochemsauthor=U.+Islanderauthor=A.+Kallkopfauthor=M.+Lagerquistauthor=C.+Ohlssonauthor=H.+Carlsten&title=Role+of+raloxifene+as+a+potent+inhibitor+of+experimental+postmenopausal+polyarthritis+and+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis</span></div><div class="casAuthors">Jochems, Caroline; Islander, Ulrika; Kallkopf, Anna; Lagerquist, Marie; Ohlsson, Claes; Carlsten, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3261-3270</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: In postmenopausal rheumatoid arthritis (RA), both estrogen deficiency and the inflammatory disease contribute to the development of generalized osteoporosis.  Hormone replacement therapy (HRT) with estradiol preserves bone mineral d. (BMD) and ameliorates arthritis, but long-term therapy is no longer an option due to significant side effects.  We therefore used a mouse model of human RA to test the hypothesis that a selective estrogen receptor modulator (SERM), the raloxifene analog LY117018, could be beneficial in the treatment of both arthritis and osteoporosis.  Methods: Female DBA/1 mice were ovariectomized and arthritis was induced with collagen immunization.  Mice received an injection of raloxifene, estradiol, or vehicle control, administered prophylactically or therapeutically, and thereafter the clin. arthritis score was evaluated continuously.  At termination, BMD was analyzed with peripheral quant. computed tomog.  Paws were collected for histol., and sera were analyzed for cytokines and markers of bone and cartilage turnover.  Levels of cytokine mRNA (mRNA) were investigated with real-time polymerase chain reaction.  Results: Treatment with raloxifene dramatically decreased the frequency and severity of arthritis.  Effective preservation of bone and cartilage was seen in raloxifene-exposed mice, as demonstrated by increased BMD and decreased serum levels of cartilage oligomeric matrix protein in the raloxifene-treated mice compared with controls.  Decreased levels of mRNA for both tumor necrosis factor α and RANKL in spleen cells from raloxifene-treated arthritic mice indicated an immunosuppressive action of this SERM.  Conclusion: In a well-established model of postmenopausal RA, the raloxifene analog LY117018 potently inhibits the progression of arthritis and the assocd. development of osteoporosis, both in a prophylactic and in a therapeutic regimen.  Since long-term HRT has been assocd. with significant side effects, raloxifene may be a useful adjuvant treatment for postmenopausal RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGF84a2x-SdLVg90H21EOLACvtfcHk0liYglRnHGx1zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rtLnJ&md5=86f644c62f173056640c413ba95fdbd5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fart.22873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22873%26sid%3Dliteratum%253Aachs%26aulast%3DJochems%26aufirst%3DC.%26aulast%3DIslander%26aufirst%3DU.%26aulast%3DKallkopf%26aufirst%3DA.%26aulast%3DLagerquist%26aufirst%3DM.%26aulast%3DOhlsson%26aufirst%3DC.%26aulast%3DCarlsten%26aufirst%3DH.%26atitle%3DRole%2520of%2520raloxifene%2520as%2520a%2520potent%2520inhibitor%2520of%2520experimental%2520postmenopausal%2520polyarthritis%2520and%2520osteoporosis%26jtitle%3DArthritis%2520Rheum.%26date%3D2007%26volume%3D56%26spage%3D3261%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Edwards, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, E.</span><span> </span><span class="NLM_article-title">The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1287</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1007%2Fs00198-010-1192-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=20229200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotleqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=1287-1293&issue=8&author=C.+J.+Edwardsauthor=E.+Williams&title=The+role+of+interleukin-6+in+rheumatoid+arthritis-associated+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis</span></div><div class="casAuthors">Edwards, C. J.; Williams, E.</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1287-1293</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Introduction Osteoporosis is highly prevalent in patients with rheumatoid arthritis (RA) and is a frequent cause of fractures, disability, reduced quality of life and increased use of healthcare resources.  Discussion Factors assocd. with the development of osteoporosis and fractures in patients with RA include disease activity, inflammation, gender, age, low body mass and glucocorticoid exposure.  Several processes contribute towards the pathol. of RA-assocd. osteoporosis, and increased osteoclast activation and subsequent bone resorption mediated by pro-inflammatory cytokines are thought to play major roles.  Given the key effects of interleukin-6 (IL-6) in both RA and osteoporosis, and its ability to modulate other inflammatory mediators, IL-6 may be an important factor specifically assocd. with osteoporosis in patients with RA.  Conclusion The development of agents that modulate the actions of IL-6 and those of other pro-inflammatory mediators of bone loss may provide alternative osteoporosis management strategies for patients with RA than existing general osteoporosis therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYyuGAMDkCMrVg90H21EOLACvtfcHk0lixBCqPNpVM5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotleqsrY%253D&md5=360e4b2cd93c3e585084a1a0221b3f1a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00198-010-1192-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00198-010-1192-7%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520interleukin-6%2520in%2520rheumatoid%2520arthritis-associated%2520osteoporosis%26jtitle%3DOsteoporosis%2520Int.%26date%3D2010%26volume%3D21%26issue%3D8%26spage%3D1287%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lipsky, P. E.</span><span> </span><span class="NLM_article-title">Interleukin-6 and rheumatic diseases</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=S4&issue=Suppl.+2&author=P.+E.+Lipsky&title=Interleukin-6+and+rheumatic+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26atitle%3DInterleukin-6%2520and%2520rheumatic%2520diseases%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2006%26volume%3D8%26issue%3DSuppl.%25202%26spage%3DS4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 83 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">André Fischer, Martin Smieško, Manuel Sellner, <span class="NLM_string-name hlFld-ContribAuthor">Markus A. Lill</span>. </span><span class="cited-content_cbyCitation_article-title">Decision Making in Structure-Based Drug Discovery: Visual Inspection of Docking Results. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2489-2500. <a href="https://doi.org/10.1021/acs.jmedchem.0c02227" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02227%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDecision%252BMaking%252Bin%252BStructure-Based%252BDrug%252BDiscovery%25253A%252BVisual%252BInspection%252Bof%252BDocking%252BResults%26aulast%3DFischer%26aufirst%3DAndr%25C3%25A9%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23122020%26date%3D22022021%26volume%3D64%26issue%3D5%26spage%3D2489%26epage%3D2500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Haobo Pang, Ye Wang, Fabrice Gallou, <span class="NLM_string-name hlFld-ContribAuthor">Bruce H. Lipshutz</span>. </span><span class="cited-content_cbyCitation_article-title">Fe-Catalyzed Reductive Couplings of Terminal (Hetero)Aryl Alkenes and Alkyl Halides under Aqueous Micellar Conditions. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (43)
                                     , 17117-17124. <a href="https://doi.org/10.1021/jacs.9b04510" title="DOI URL">https://doi.org/10.1021/jacs.9b04510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b04510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b04510%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DFe-Catalyzed%252BReductive%252BCouplings%252Bof%252BTerminal%252B%252528Hetero%252529Aryl%252BAlkenes%252Band%252BAlkyl%252BHalides%252Bunder%252BAqueous%252BMicellar%252BConditions%26aulast%3DPang%26aufirst%3DHaobo%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26042019%26date%3D16102019%26date%3D27092019%26volume%3D141%26issue%3D43%26spage%3D17117%26epage%3D17124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mélaine A.  Kuenemann</span>, <span class="hlFld-ContribAuthor ">Laura M. L.  Bourbon</span>, <span class="hlFld-ContribAuthor ">Céline M.  Labbé</span>, <span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>, and <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>  . </span><span class="cited-content_cbyCitation_article-title">Which Three-Dimensional Characteristics Make Efficient Inhibitors of Protein–Protein Interactions?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (11)
                                     , 3067-3079. <a href="https://doi.org/10.1021/ci500487q" title="DOI URL">https://doi.org/10.1021/ci500487q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500487q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500487q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DWhich%252BThree-Dimensional%252BCharacteristics%252BMake%252BEfficient%252BInhibitors%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteractions%25253F%26aulast%3DKuenemann%26aufirst%3DM%25C3%25A9laine%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D06082014%26date%3D17102014%26date%3D24112014%26date%3D06102014%26volume%3D54%26issue%3D11%26spage%3D3067%26epage%3D3079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabella A.  Guedes</span>, <span class="hlFld-ContribAuthor ">Leon S. C.  Costa</span>, <span class="hlFld-ContribAuthor ">Karina B.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Ana L. M.  Karl</span>, <span class="hlFld-ContribAuthor ">Gregório K.  Rocha</span>, <span class="hlFld-ContribAuthor ">Iury M.  Teixeira</span>, <span class="hlFld-ContribAuthor ">Marcelo M.  Galheigo</span>, <span class="hlFld-ContribAuthor ">Vivian  Medeiros</span>, <span class="hlFld-ContribAuthor ">Eduardo  Krempser</span>, <span class="hlFld-ContribAuthor ">Fábio L.  Custódio</span>, <span class="hlFld-ContribAuthor ">Helio J. C.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Marisa F.  Nicolás</span>, <span class="hlFld-ContribAuthor ">Laurent E.  Dardenne</span>. </span><span class="cited-content_cbyCitation_article-title">Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-84700-0" title="DOI URL">https://doi.org/10.1038/s41598-021-84700-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-84700-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-84700-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDrug%252Bdesign%252Band%252Brepurposing%252Bwith%252BDockThor-VS%252Bweb%252Bserver%252Bfocusing%252Bon%252BSARS-CoV-2%252Btherapeutic%252Btargets%252Band%252Btheir%252Bnon-synonym%252Bvariants%26aulast%3DGuedes%26aufirst%3DIsabella%2BA.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiamin  Zheng</span>, <span class="hlFld-ContribAuthor ">Dongdong  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Yao  Wu</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Xuefei  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128229. <a href="https://doi.org/10.1016/j.bmcl.2021.128229" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128229%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BIII%252529%25253A%252BTargeting%252Bcytokines%252Band%252Bcytokine%252Breceptor%252Bcomplexes%26aulast%3DZheng%26aufirst%3DJiamin%26date%3D2021%26volume%3D48%26spage%3D128229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah  Molehin</span>, <span class="hlFld-ContribAuthor ">Fahmida  Rasha</span>, <span class="hlFld-ContribAuthor ">Rakhshanda Layeequr  Rahman</span>, <span class="hlFld-ContribAuthor ">Kevin  Pruitt</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of aromatase in cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biochemistry</span><span> <strong>2021,</strong> <em>476 </em>
                                    (6)
                                     , 2449-2464. <a href="https://doi.org/10.1007/s11010-021-04099-0" title="DOI URL">https://doi.org/10.1007/s11010-021-04099-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11010-021-04099-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11010-021-04099-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biochemistry%26atitle%3DRegulation%252Bof%252Baromatase%252Bin%252Bcancer%26aulast%3DMolehin%26aufirst%3DDeborah%26date%3D2021%26date%3D2021%26volume%3D476%26issue%3D6%26spage%3D2449%26epage%3D2464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erum  Zafar</span>, <span class="hlFld-ContribAuthor ">Muhammad Faisal  Maqbool</span>, <span class="hlFld-ContribAuthor ">Asia  Iqbal</span>, <span class="hlFld-ContribAuthor ">Amara  Maryam</span>, <span class="hlFld-ContribAuthor ">Hafiz Abdullah  Shakir</span>, <span class="hlFld-ContribAuthor ">Muhammad  Irfan</span>, <span class="hlFld-ContribAuthor ">Muhammad  Khan</span>, <span class="hlFld-ContribAuthor ">Yongming  Li</span>, <span class="hlFld-ContribAuthor ">Tonghui  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review on anticancer mechanism of bazedoxifene. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology and Applied Biochemistry</span><span> <strong>2021,</strong> <em>69 </em><a href="https://doi.org/10.1002/bab.2150" title="DOI URL">https://doi.org/10.1002/bab.2150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bab.2150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbab.2150%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520and%2520Applied%2520Biochemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bon%252Banticancer%252Bmechanism%252Bof%252Bbazedoxifene%26aulast%3DZafar%26aufirst%3DErum%26date%3D2021%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengqi  Huo</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Luo</span>, <span class="hlFld-ContribAuthor ">Junyi  Guo</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>, . </span><span class="cited-content_cbyCitation_article-title">Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2021,</strong> <em>2021 </em>, 1-15. <a href="https://doi.org/10.1155/2021/6699054" title="DOI URL">https://doi.org/10.1155/2021/6699054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/6699054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F6699054%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DAlleviation%252Bof%252BInflammation%252Band%252BOxidative%252BStress%252Bin%252BPressure%252BOverload-Induced%252BCardiac%252BRemodeling%252Band%252BHeart%252BFailure%252Bvia%252BIL-6%25252FSTAT3%252BInhibition%252Bby%252BRaloxifene%26aulast%3DHuo%26aufirst%3DShengqi%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Xiongwen  Chen</span>, <span class="hlFld-ContribAuthor ">Qiaofeng  Jin</span>, <span class="hlFld-ContribAuthor ">Yihan  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhengyang  Han</span>, <span class="hlFld-ContribAuthor ">Dandan  Chen</span>, <span class="hlFld-ContribAuthor ">Yuman  Li</span>, <span class="hlFld-ContribAuthor ">Qing  Lv</span>, <span class="hlFld-ContribAuthor ">Mingxing  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene Regulates Th17 Immune Response to Ameliorate Experimental Autoimmune myocarditis via Inhibition of STAT3 Activation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.613160" title="DOI URL">https://doi.org/10.3389/fphar.2020.613160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.613160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.613160%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DBazedoxifene%252BRegulates%252BTh17%252BImmune%252BResponse%252Bto%252BAmeliorate%252BExperimental%252BAutoimmune%252Bmyocarditis%252Bvia%252BInhibition%252Bof%252BSTAT3%252BActivation%26aulast%3DWang%26aufirst%3DJing%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis  Pozios</span>, <span class="hlFld-ContribAuthor ">Nina N.  Seel</span>, <span class="hlFld-ContribAuthor ">Nina A.  Hering</span>, <span class="hlFld-ContribAuthor ">Lisa  Hartmann</span>, <span class="hlFld-ContribAuthor ">Verena  Liu</span>, <span class="hlFld-ContribAuthor ">Peter  Camaj</span>, <span class="hlFld-ContribAuthor ">Mario H.  Müller</span>, <span class="hlFld-ContribAuthor ">Lucas D.  Lee</span>, <span class="hlFld-ContribAuthor ">Christiane J.  Bruns</span>, <span class="hlFld-ContribAuthor ">Martin E.  Kreis</span>, <span class="hlFld-ContribAuthor ">Hendrik  Seeliger</span>. </span><span class="cited-content_cbyCitation_article-title">Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. </span><span class="cited-content_cbyCitation_journal-name">Cellular Oncology</span><span> <strong>2021,</strong> <em>44 </em>
                                    (1)
                                     , 167-177. <a href="https://doi.org/10.1007/s13402-020-00559-9" title="DOI URL">https://doi.org/10.1007/s13402-020-00559-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13402-020-00559-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13402-020-00559-9%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Oncology%26atitle%3DRaloxifene%252Binhibits%252Bpancreatic%252Badenocarcinoma%252Bgrowth%252Bby%252Binterfering%252Bwith%252BER%2525CE%2525B2%252Band%252BIL-6%25252Fgp130%25252FSTAT3%252Bsignaling%26aulast%3DPozios%26aufirst%3DIoannis%26date%3D2021%26date%3D2020%26volume%3D44%26issue%3D1%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengcheng  Luo</span>, <span class="hlFld-ContribAuthor ">Yina  Wang</span>, <span class="hlFld-ContribAuthor ">Chongqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Junyi  Guo</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Shengqi  Huo</span>, <span class="hlFld-ContribAuthor ">Moran  Wang</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2021,</strong> <em>893 </em>, 173822. <a href="https://doi.org/10.1016/j.ejphar.2020.173822" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.173822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.173822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.173822%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DBazedoxifene%252Bexhibits%252Banti-inflammation%252Band%252Banti-atherosclerotic%252Beffects%252Bvia%252Binhibition%252Bof%252BIL-6%25252FIL-6R%25252FSTAT3%252Bsignaling%26aulast%3DLuo%26aufirst%3DPengcheng%26date%3D2021%26volume%3D893%26spage%3D173822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Daina</span>, <span class="hlFld-ContribAuthor ">Ute F.  Röhrig</span>, <span class="hlFld-ContribAuthor ">Vincent  Zoete</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Drug Design for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 386-401. <a href="https://doi.org/10.1016/B978-0-12-801238-3.11670-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-801238-3.11670-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801238-3.11670-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801238-3.11670-8%26sid%3Dliteratum%253Aachs%26atitle%3DComputer-Aided%252BDrug%252BDesign%252Bfor%252BCancer%252BTherapy%26aulast%3DDaina%26aufirst%3DAntoine%26date%3D2021%26spage%3D386%26epage%3D401%26pub%3DElsevier%26atitle%3DSystems%252BMedicine%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imlimaong  Aier</span>, <span class="hlFld-ContribAuthor ">Pritish Kumar  Varadwaj</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Repositioning: Principles, Resources, and Application of Structure-Based Virtual Screening for the Identification of Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 313-336. <a href="https://doi.org/10.1016/B978-0-12-822312-3.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-822312-3.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-822312-3.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-822312-3.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BRepositioning%25253A%252BPrinciples%25252C%252BResources%25252C%252Band%252BApplication%252Bof%252BStructure-Based%252BVirtual%252BScreening%252Bfor%252Bthe%252BIdentification%252Bof%252BAnticancer%252BAgents%26aulast%3DAier%26aufirst%3DImlimaong%26date%3D2021%26spage%3D313%26epage%3D336%26pub%3DElsevier%26atitle%3DMolecular%252BDocking%252Bfor%252BComputer-Aided%252BDrug%252BDesign%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pathum S.  Thilakasiri</span>, <span class="hlFld-ContribAuthor ">Rhynelle S.  Dmello</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Nero</span>, <span class="hlFld-ContribAuthor ">Michael W.  Parker</span>, <span class="hlFld-ContribAuthor ">Matthias  Ernst</span>, <span class="hlFld-ContribAuthor ">Ashwini L.  Chand</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of drugs as STAT3 inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2021,</strong> <em>68 </em>, 31-46. <a href="https://doi.org/10.1016/j.semcancer.2019.09.022" title="DOI URL">https://doi.org/10.1016/j.semcancer.2019.09.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2019.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2019.09.022%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DRepurposing%252Bof%252Bdrugs%252Bas%252BSTAT3%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DThilakasiri%26aufirst%3DPathum%2BS.%26date%3D2021%26volume%3D68%26spage%3D31%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  Gomez-Gutierrez</span>, <span class="hlFld-ContribAuthor ">Juan J.  Perez</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (1)
                                     , 257. <a href="https://doi.org/10.3390/ijms22010257" title="DOI URL">https://doi.org/10.3390/ijms22010257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22010257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22010257%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252Ba%252BBradykinin%252BB2%252BPartial%252BAgonist%252BProfile%252Bof%252BRaloxifene%252Bin%252Ba%252BDrug%252BRepurposing%252BCampaign%26aulast%3DGomez-Gutierrez%26aufirst%3DPatricia%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D1%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Ávalos-Moreno</span>, <span class="hlFld-ContribAuthor ">Araceli  López-Tejada</span>, <span class="hlFld-ContribAuthor ">Jose L.  Blaya-Cánovas</span>, <span class="hlFld-ContribAuthor ">Francisca E.  Cara-Lupiañez</span>, <span class="hlFld-ContribAuthor ">Adrián  González-González</span>, <span class="hlFld-ContribAuthor ">Jose A.  Lorente</span>, <span class="hlFld-ContribAuthor ">Pedro  Sánchez-Rovira</span>, <span class="hlFld-ContribAuthor ">Sergio  Granados-Principal</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Repurposing for Triple-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Personalized Medicine</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 200. <a href="https://doi.org/10.3390/jpm10040200" title="DOI URL">https://doi.org/10.3390/jpm10040200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jpm10040200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjpm10040200%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Personalized%2520Medicine%26atitle%3DDrug%252BRepurposing%252Bfor%252BTriple-Negative%252BBreast%252BCancer%26aulast%3D%25C3%2581valos-Moreno%26aufirst%3DMarta%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D4%26spage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengcheng  Luo</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Yina  Wang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Shengqi  Huo</span>, <span class="hlFld-ContribAuthor ">Junyi  Guo</span>, <span class="hlFld-ContribAuthor ">Moran  Wang</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE−/− mice. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2020,</strong> <em>261 </em>, 118304. <a href="https://doi.org/10.1016/j.lfs.2020.118304" title="DOI URL">https://doi.org/10.1016/j.lfs.2020.118304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2020.118304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2020.118304%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DRaloxifene%252Binhibits%252BIL-6%25252FSTAT3%252Bsignaling%252Bpathway%252Band%252Bprotects%252Bagainst%252Bhigh-fat-induced%252Batherosclerosis%252Bin%252BApoE%2525E2%252588%252592%25252F%2525E2%252588%252592%252Bmice%26aulast%3DLuo%26aufirst%3DPengcheng%26date%3D2020%26volume%3D261%26spage%3D118304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenmin  Song</span>, <span class="hlFld-ContribAuthor ">Kai  Gao</span>, <span class="hlFld-ContribAuthor ">Panhao  Huang</span>, <span class="hlFld-ContribAuthor ">Zizhao  Tang</span>, <span class="hlFld-ContribAuthor ">Fangqin  Nie</span>, <span class="hlFld-ContribAuthor ">Sujie  Jia</span>, <span class="hlFld-ContribAuthor ">Ren  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene inhibits PDGF-BB induced VSMC phenotypic switch via regulating the autophagy level. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2020,</strong> <em>259 </em>, 118397. <a href="https://doi.org/10.1016/j.lfs.2020.118397" title="DOI URL">https://doi.org/10.1016/j.lfs.2020.118397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2020.118397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2020.118397%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DBazedoxifene%252Binhibits%252BPDGF-BB%252Binduced%252BVSMC%252Bphenotypic%252Bswitch%252Bvia%252Bregulating%252Bthe%252Bautophagy%252Blevel%26aulast%3DSong%26aufirst%3DWenmin%26date%3D2020%26volume%3D259%26spage%3D118397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Coagulopathy in COVID-19: Focus on vascular thrombotic events. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular and Cellular Cardiology</span><span> <strong>2020,</strong> <em>146 </em>, 32-40. <a href="https://doi.org/10.1016/j.yjmcc.2020.07.003" title="DOI URL">https://doi.org/10.1016/j.yjmcc.2020.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yjmcc.2020.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yjmcc.2020.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520and%2520Cellular%2520Cardiology%26atitle%3DCoagulopathy%252Bin%252BCOVID-19%25253A%252BFocus%252Bon%252Bvascular%252Bthrombotic%252Bevents%26aulast%3DShi%26aufirst%3DWei%26date%3D2020%26volume%3D146%26spage%3D32%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongmei  Song</span>, <span class="hlFld-ContribAuthor ">Wenying  Yu</span>, <span class="hlFld-ContribAuthor ">Yuhao  Ren</span>, <span class="hlFld-ContribAuthor ">Jiawen  Zhu</span>, <span class="hlFld-ContribAuthor ">Chengying  Wan</span>, <span class="hlFld-ContribAuthor ">Guiping  Cai</span>, <span class="hlFld-ContribAuthor ">Jianpeng  Guo</span>, <span class="hlFld-ContribAuthor ">Wenda  Zhang</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of bazedoxifene analogues targeting glycoprotein 130. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112375. <a href="https://doi.org/10.1016/j.ejmech.2020.112375" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112375%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbazedoxifene%252Banalogues%252Btargeting%252Bglycoprotein%252B130%26aulast%3DSong%26aufirst%3DDongmei%26date%3D2020%26volume%3D199%26spage%3D112375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riley D.  Metcalfe</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Putoczki</span>, <span class="hlFld-ContribAuthor ">Michael D. W.  Griffin</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.01424" title="DOI URL">https://doi.org/10.3389/fimmu.2020.01424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.01424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.01424%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DStructural%252BUnderstanding%252Bof%252BInterleukin%252B6%252BFamily%252BCytokine%252BSignaling%252Band%252BTargeted%252BTherapies%25253A%252BFocus%252Bon%252BInterleukin%252B11%26aulast%3DMetcalfe%26aufirst%3DRiley%2BD.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Sharma</span>, <span class="hlFld-ContribAuthor ">Osvaldo  Yañez</span>, <span class="hlFld-ContribAuthor ">César  Zúñiga</span>, <span class="hlFld-ContribAuthor ">Ashish  Kumar</span>, <span class="hlFld-ContribAuthor ">Gurpinder  Singh</span>, <span class="hlFld-ContribAuthor ">Plinio  Cantero-López</span>. </span><span class="cited-content_cbyCitation_article-title">Protein-surfactant interactions: A multitechnique approach on the effect of Co-solvents over bovine serum albumin (BSA)-cetyl pyridinium chloride (CPC) system. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2020,</strong> <em>747 </em>, 137349. <a href="https://doi.org/10.1016/j.cplett.2020.137349" title="DOI URL">https://doi.org/10.1016/j.cplett.2020.137349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2020.137349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2020.137349%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3DProtein-surfactant%252Binteractions%25253A%252BA%252Bmultitechnique%252Bapproach%252Bon%252Bthe%252Beffect%252Bof%252BCo-solvents%252Bover%252Bbovine%252Bserum%252Balbumin%252B%252528BSA%252529-cetyl%252Bpyridinium%252Bchloride%252B%252528CPC%252529%252Bsystem%26aulast%3DSharma%26aufirst%3DVivek%26date%3D2020%26volume%3D747%26spage%3D137349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Luo</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Junyi  Guo</span>, <span class="hlFld-ContribAuthor ">Maocai  Zhai</span>, <span class="hlFld-ContribAuthor ">Jingwen  Tao</span>, <span class="hlFld-ContribAuthor ">Shengqi  Huo</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E–Knockout Mice. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00392" title="DOI URL">https://doi.org/10.3389/fphar.2020.00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00392%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DBazedoxifene%252BAttenuates%252BAbdominal%252BAortic%252BAneurysm%252BFormation%252Bvia%252BDownregulation%252Bof%252BInterleukin-6%25252FGlycoprotein%252B130%25252FSignal%252BTransducer%252Band%252BActivator%252Bof%252BTranscription%252B3%252BSignaling%252BPathway%252Bin%252BApolipoprotein%252BE%2525E2%252580%252593Knockout%252BMice%26aulast%3DYan%26aufirst%3DDan%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Luo</span>, <span class="hlFld-ContribAuthor ">Maocai  Zhai</span>, <span class="hlFld-ContribAuthor ">Jingwen  Tao</span>, <span class="hlFld-ContribAuthor ">Shengqi  Huo</span>, <span class="hlFld-ContribAuthor ">Junyi  Guo</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Interleukin‐6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2020,</strong> <em>24 </em>
                                    (8)
                                     , 4748-4761. <a href="https://doi.org/10.1111/jcmm.15147" title="DOI URL">https://doi.org/10.1111/jcmm.15147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.15147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.15147%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DInhibition%252Bof%252BInterleukin%2525E2%252580%2525906%25252Fglycoprotein%252B130%252Bsignalling%252Bby%252BBazedoxifene%252Bameliorates%252Bcardiac%252Bremodelling%252Bin%252Bpressure%252Boverload%252Bmice%26aulast%3DShi%26aufirst%3DWei%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D8%26spage%3D4748%26epage%3D4761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sukhvir  Kaur</span>, <span class="hlFld-ContribAuthor ">Yogita  Bansal</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Gulshan  Bansal</span>. </span><span class="cited-content_cbyCitation_article-title">A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (5)
                                     , 115327. <a href="https://doi.org/10.1016/j.bmc.2020.115327" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115327%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bpanoramic%252Breview%252Bof%252BIL-6%25253A%252BStructure%25252C%252Bpathophysiological%252Broles%252Band%252Binhibitors%26aulast%3DKaur%26aufirst%3DSukhvir%26date%3D2020%26volume%3D28%26issue%3D5%26spage%3D115327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tolu  Omokehinde</span>, <span class="hlFld-ContribAuthor ">Rachelle W.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">GP130 Cytokines in Breast Cancer and Bone. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 326. <a href="https://doi.org/10.3390/cancers12020326" title="DOI URL">https://doi.org/10.3390/cancers12020326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12020326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12020326%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DGP130%252BCytokines%252Bin%252BBreast%252BCancer%252Band%252BBone%26aulast%3DOmokehinde%26aufirst%3DTolu%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Sharma</span>, <span class="hlFld-ContribAuthor ">Osvaldo  Yañez</span>, <span class="hlFld-ContribAuthor ">Melissa  Alegría-Arcos</span>, <span class="hlFld-ContribAuthor ">Ashish  Kumar</span>, <span class="hlFld-ContribAuthor ">Ramesh C.  Thakur</span>, <span class="hlFld-ContribAuthor ">Plinio  Cantero-López</span>. </span><span class="cited-content_cbyCitation_article-title">A physicochemical and conformational study of co-solvent effect on the molecular interactions between similarly charged protein surfactant (BSA-SDBS) system. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Chemical Thermodynamics</span><span> <strong>2020,</strong> <em>142 </em>, 106022. <a href="https://doi.org/10.1016/j.jct.2019.106022" title="DOI URL">https://doi.org/10.1016/j.jct.2019.106022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jct.2019.106022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jct.2019.106022%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Chemical%2520Thermodynamics%26atitle%3DA%252Bphysicochemical%252Band%252Bconformational%252Bstudy%252Bof%252Bco-solvent%252Beffect%252Bon%252Bthe%252Bmolecular%252Binteractions%252Bbetween%252Bsimilarly%252Bcharged%252Bprotein%252Bsurfactant%252B%252528BSA-SDBS%252529%252Bsystem%26aulast%3DSharma%26aufirst%3DVivek%26date%3D2020%26volume%3D142%26spage%3D106022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Larisa  Đurić</span>, <span class="hlFld-ContribAuthor ">Maja  Milanović</span>, <span class="hlFld-ContribAuthor ">Nataša  Milošević</span>, <span class="hlFld-ContribAuthor ">Nataša  Milić</span>. </span><span class="cited-content_cbyCitation_article-title">New pharmaceuticals: The importance of serendipity. </span><span class="cited-content_cbyCitation_journal-name">Medicinski casopis</span><span> <strong>2020,</strong> <em>54 </em>
                                    (4)
                                     , 143-148. <a href="https://doi.org/10.5937/mckg54-28546" title="DOI URL">https://doi.org/10.5937/mckg54-28546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5937/mckg54-28546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5937%2Fmckg54-28546%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinski%2520casopis%26atitle%3DNew%252Bpharmaceuticals%25253A%252BThe%252Bimportance%252Bof%252Bserendipity%26aulast%3D%25C4%2590uri%25C4%2587%26aufirst%3DLarisa%26date%3D2020%26volume%3D54%26issue%3D4%26spage%3D143%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Wei</span>, <span class="hlFld-ContribAuthor ">Ling  Ma</span>, <span class="hlFld-ContribAuthor ">Yi-Hui  Lai</span>, <span class="hlFld-ContribAuthor ">Ruijie  Zhang</span>, <span class="hlFld-ContribAuthor ">Huameng  Li</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1072-8" title="DOI URL">https://doi.org/10.1186/s13046-019-1072-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1072-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1072-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DBazedoxifene%252Bas%252Ba%252Bnovel%252BGP130%252Binhibitor%252Bfor%252BColon%252BCancer%252Btherapy%26aulast%3DWei%26aufirst%3DJia%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judith  Bossen</span>, <span class="hlFld-ContribAuthor ">Karin  Uliczka</span>, <span class="hlFld-ContribAuthor ">Line  Steen</span>, <span class="hlFld-ContribAuthor ">Roxana  Pfefferkorn</span>, <span class="hlFld-ContribAuthor ">Mandy Mong-Quyen  Mai</span>, <span class="hlFld-ContribAuthor ">Lia  Burkhardt</span>, <span class="hlFld-ContribAuthor ">Michael  Spohn</span>, <span class="hlFld-ContribAuthor ">Iris  Bruchhaus</span>, <span class="hlFld-ContribAuthor ">Christine  Fink</span>, <span class="hlFld-ContribAuthor ">Holger  Heine</span>, <span class="hlFld-ContribAuthor ">Thomas  Roeder</span>. </span><span class="cited-content_cbyCitation_article-title">An EGFR-Induced
              Drosophila
              Lung Tumor Model Identifies Alternative Combination Treatments. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (9)
                                     , 1659-1668. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0168" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0168%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DAn%252BEGFR-Induced%252BDrosophila%252BLung%252BTumor%252BModel%252BIdentifies%252BAlternative%252BCombination%252BTreatments%26aulast%3DBossen%26aufirst%3DJudith%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D9%26spage%3D1659%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalie  Lagarde</span>, <span class="hlFld-ContribAuthor ">Elodie  Goldwaser</span>, <span class="hlFld-ContribAuthor ">Tania  Pencheva</span>, <span class="hlFld-ContribAuthor ">Dessislava  Jereva</span>, <span class="hlFld-ContribAuthor ">Ilza  Pajeva</span>, <span class="hlFld-ContribAuthor ">Julien  Rey</span>, <span class="hlFld-ContribAuthor ">Pierre  Tuffery</span>, <span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>, <span class="hlFld-ContribAuthor ">Maria A.  Miteva</span>. </span><span class="cited-content_cbyCitation_article-title">A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (18)
                                     , 4648. <a href="https://doi.org/10.3390/ijms20184648" title="DOI URL">https://doi.org/10.3390/ijms20184648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20184648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20184648%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DA%252BFree%252BWeb-Based%252BProtocol%252Bto%252BAssist%252BStructure-Based%252BVirtual%252BScreening%252BExperiments%26aulast%3DLagarde%26aufirst%3DNathalie%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D18%26spage%3D4648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Shi</span>, <span class="hlFld-ContribAuthor ">Sean  Hunter</span>, <span class="hlFld-ContribAuthor ">Tony  Hunter</span>. </span><span class="cited-content_cbyCitation_article-title">Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (8)
                                     , 1337-1340. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0605" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0605%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DStem%252BCell%252BFactor%252BLIFted%252Bas%252Ba%252BPromising%252BClinical%252BTarget%252Bfor%252BCancer%252BTherapy%26aulast%3DShi%26aufirst%3DYu%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D8%26spage%3D1337%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jilai  Tian</span>, <span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Shengling  Fu</span>, <span class="hlFld-ContribAuthor ">Ruijie  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Pan</span>, <span class="hlFld-ContribAuthor ">Yang  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaojuan  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Xiao</span>, <span class="hlFld-ContribAuthor ">Huey-Jen  Lin</span>, <span class="hlFld-ContribAuthor ">Hui-Wen  Lo</span>, <span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2019,</strong> <em>175 </em>
                                    (3)
                                     , 553-566. <a href="https://doi.org/10.1007/s10549-019-05183-2" title="DOI URL">https://doi.org/10.1007/s10549-019-05183-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-019-05183-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-019-05183-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DBazedoxifene%252Bis%252Ba%252Bnovel%252BIL-6%25252FGP130%252Binhibitor%252Bfor%252Btreating%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DTian%26aufirst%3DJilai%26date%3D2019%26date%3D2019%26volume%3D175%26issue%3D3%26spage%3D553%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Jilai  Tian</span>, <span class="hlFld-ContribAuthor ">Gloria H.  Su</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Current Cancer Drug Targets</span><span> <strong>2019,</strong> <em>19 </em>
                                    (5)
                                     , 417-427. <a href="https://doi.org/10.2174/1568009618666180430123939" title="DOI URL">https://doi.org/10.2174/1568009618666180430123939</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568009618666180430123939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568009618666180430123939%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Cancer%2520Drug%2520Targets%26atitle%3DBlocking%252BIL-6%25252FGP130%252BSignaling%252BInhibits%252BCell%252BViability%25252FProliferation%25252C%252BGlycolysis%25252C%252Band%252BColony%252BForming%252BActivity%252Bin%252BHuman%252BPancreatic%252BCancer%252BCells%26aulast%3DChen%26aufirst%3DXiang%26date%3D2019%26volume%3D19%26issue%3D5%26spage%3D417%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengling  Fu</span>, <span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Hui-Wen  Lo</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2019,</strong> <em>448 </em>, 11-19. <a href="https://doi.org/10.1016/j.canlet.2019.01.026" title="DOI URL">https://doi.org/10.1016/j.canlet.2019.01.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2019.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2019.01.026%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DCombined%252Bbazedoxifene%252Band%252Bpaclitaxel%252Btreatments%252Binhibit%252Bcell%252Bviability%25252C%252Bcell%252Bmigration%25252C%252Bcolony%252Bformation%25252C%252Band%252Btumor%252Bgrowth%252Band%252Binduce%252Bapoptosis%252Bin%252Bbreast%252Bcancer%26aulast%3DFu%26aufirst%3DShengling%26date%3D2019%26volume%3D448%26spage%3D11%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pathum  Thilakasiri</span>, <span class="hlFld-ContribAuthor ">Jennifer  Huynh</span>, <span class="hlFld-ContribAuthor ">Ashleigh R  Poh</span>, <span class="hlFld-ContribAuthor ">Chin Wee  Tan</span>, <span class="hlFld-ContribAuthor ">Tracy L  Nero</span>, <span class="hlFld-ContribAuthor ">Kelly  Tran</span>, <span class="hlFld-ContribAuthor ">Adam C  Parslow</span>, <span class="hlFld-ContribAuthor ">Shoukat  Afshar‐Sterle</span>, <span class="hlFld-ContribAuthor ">David  Baloyan</span>, <span class="hlFld-ContribAuthor ">Natalie J  Hannan</span>, <span class="hlFld-ContribAuthor ">Michael  Buchert</span>, <span class="hlFld-ContribAuthor ">Andrew Mark  Scott</span>, <span class="hlFld-ContribAuthor ">Michael DW  Griffin</span>, <span class="hlFld-ContribAuthor ">Frederic  Hollande</span>, <span class="hlFld-ContribAuthor ">Michael W  Parker</span>, <span class="hlFld-ContribAuthor ">Tracy L  Putoczki</span>, <span class="hlFld-ContribAuthor ">Matthias  Ernst</span>, <span class="hlFld-ContribAuthor ">Ashwini L  Chand</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing the selective estrogen receptor modulator
              bazedoxifene
              to suppress gastrointestinal cancer growth. </span><span class="cited-content_cbyCitation_journal-name">EMBO Molecular Medicine</span><span> <strong>2019,</strong> <em>11 </em>
                                    (4)
                                     <a href="https://doi.org/10.15252/emmm.201809539" title="DOI URL">https://doi.org/10.15252/emmm.201809539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/emmm.201809539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Femmm.201809539%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520Molecular%2520Medicine%26atitle%3DRepurposing%252Bthe%252Bselective%252Bestrogen%252Breceptor%252Bmodulator%252Bbazedoxifene%252Bto%252Bsuppress%252Bgastrointestinal%252Bcancer%252Bgrowth%26aulast%3DThilakasiri%26aufirst%3DPathum%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan D.  Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Is Estrogen the Answer for Osteosarcoma?. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2019,</strong> <em>79 </em>
                                    (6)
                                     , 1034-1035. <a href="https://doi.org/10.1158/0008-5472.CAN-19-0209" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-19-0209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-19-0209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-19-0209%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DIs%252BEstrogen%252Bthe%252BAnswer%252Bfor%252BOsteosarcoma%25253F%26aulast%3DRoberts%26aufirst%3DRyan%2BD.%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D6%26spage%3D1034%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sayada Reemsha  Kazmi</span>, <span class="hlFld-ContribAuthor ">Ren  Jun</span>, <span class="hlFld-ContribAuthor ">Myeong-Sang  Yu</span>, <span class="hlFld-ContribAuthor ">Chanjin  Jung</span>, <span class="hlFld-ContribAuthor ">Dokyun  Na</span>. </span><span class="cited-content_cbyCitation_article-title">In silico approaches and tools for the prediction of drug metabolism and fate: A review. </span><span class="cited-content_cbyCitation_journal-name">Computers in Biology and Medicine</span><span> <strong>2019,</strong> <em>106 </em>, 54-64. <a href="https://doi.org/10.1016/j.compbiomed.2019.01.008" title="DOI URL">https://doi.org/10.1016/j.compbiomed.2019.01.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiomed.2019.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiomed.2019.01.008%26sid%3Dliteratum%253Aachs%26jtitle%3DComputers%2520in%2520Biology%2520and%2520Medicine%26atitle%3DIn%252Bsilico%252Bapproaches%252Band%252Btools%252Bfor%252Bthe%252Bprediction%252Bof%252Bdrug%252Bmetabolism%252Band%252Bfate%25253A%252BA%252Breview%26aulast%3DKazmi%26aufirst%3DSayada%2BReemsha%26date%3D2019%26volume%3D106%26spage%3D54%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Yina  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Chongqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Shengqi  Huo</span>, <span class="hlFld-ContribAuthor ">Jialin  Duan</span>, <span class="hlFld-ContribAuthor ">Jingwen  Tao</span>, <span class="hlFld-ContribAuthor ">Maocai  Zhai</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Luo</span>, <span class="hlFld-ContribAuthor ">Junyi  Guo</span>, <span class="hlFld-ContribAuthor ">Lei  Tian</span>, <span class="hlFld-ContribAuthor ">Lulu  Mageta</span>, <span class="hlFld-ContribAuthor ">David  Jou</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2019,</strong> <em>110 </em>
                                    (3)
                                     , 950-961. <a href="https://doi.org/10.1111/cas.13940" title="DOI URL">https://doi.org/10.1111/cas.13940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.13940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.13940%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DBazedoxifene%252Bexhibits%252Bgrowth%252Bsuppressive%252Bactivity%252Bby%252Btargeting%252Binterleukin-6%25252Fglycoprotein%252B130%25252Fsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252Bsignaling%252Bin%252Bhepatocellular%252Bcarcinoma%26aulast%3DMa%26aufirst%3DHaiyan%26date%3D2019%26date%3D2019%26volume%3D110%26issue%3D3%26spage%3D950%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aditi  Gangopadhyay</span>, <span class="hlFld-ContribAuthor ">Hirak Jyoti  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Abhijit  Datta</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Docking and Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 889-922. <a href="https://doi.org/10.4018/978-1-5225-8903-7.ch035" title="DOI URL">https://doi.org/10.4018/978-1-5225-8903-7.ch035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4018/978-1-5225-8903-7.ch035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4018%2F978-1-5225-8903-7.ch035%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%252BDocking%252Band%252BDrug%252BDesign%26aulast%3DGangopadhyay%26aufirst%3DAditi%26date%3D2019%26spage%3D889%26epage%3D922%26pub%3DIGI%2520Global%26atitle%3DBiotechnology%26aulast%3DManagement%2BAssociation%26aufirst%3DInformation%2BResources%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali  Masjedi</span>, <span class="hlFld-ContribAuthor ">Vida  Hashemi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Hojjat-Farsangi</span>, <span class="hlFld-ContribAuthor ">Ghasem  Ghalamfarsa</span>, <span class="hlFld-ContribAuthor ">Gholamreza  Azizi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Yousefi</span>, <span class="hlFld-ContribAuthor ">Farhad  Jadidi-Niaragh</span>. </span><span class="cited-content_cbyCitation_article-title">The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>108 </em>, 1415-1424. <a href="https://doi.org/10.1016/j.biopha.2018.09.177" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.09.177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.09.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.09.177%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DThe%252Bsignificant%252Brole%252Bof%252Binterleukin-6%252Band%252Bits%252Bsignaling%252Bpathway%252Bin%252Bthe%252Bimmunopathogenesis%252Band%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DMasjedi%26aufirst%3DAli%26date%3D2018%26volume%3D108%26spage%3D1415%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sameeksha  Tiwari</span>, <span class="hlFld-ContribAuthor ">Manika  Awasthi</span>, <span class="hlFld-ContribAuthor ">Swati  Singh</span>, <span class="hlFld-ContribAuthor ">Veda P.  Pandey</span>, <span class="hlFld-ContribAuthor ">Upendra N.  Dwivedi</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of interaction of mutant TP53 and wild type BRCA1 by alkaloids: a computational approach towards targeting protein-protein interaction as a futuristic therapeutic intervention strategy for breast cancer impediment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (13)
                                     , 3376-3387. <a href="https://doi.org/10.1080/07391102.2017.1388286" title="DOI URL">https://doi.org/10.1080/07391102.2017.1388286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1388286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1388286%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DModulation%252Bof%252Binteraction%252Bof%252Bmutant%252BTP53%252Band%252Bwild%252Btype%252BBRCA1%252Bby%252Balkaloids%25253A%252Ba%252Bcomputational%252Bapproach%252Btowards%252Btargeting%252Bprotein-protein%252Binteraction%252Bas%252Ba%252Bfuturistic%252Btherapeutic%252Bintervention%252Bstrategy%252Bfor%252Bbreast%252Bcancer%252Bimpediment%26aulast%3DTiwari%26aufirst%3DSameeksha%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D13%26spage%3D3376%26epage%3D3387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalie  Lagarde</span>, <span class="hlFld-ContribAuthor ">Julien  Rey</span>, <span class="hlFld-ContribAuthor ">Aram  Gyulkhandanyan</span>, <span class="hlFld-ContribAuthor ">Pierre  Tufféry</span>, <span class="hlFld-ContribAuthor ">Maria A.  Miteva</span>, <span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>. </span><span class="cited-content_cbyCitation_article-title">Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (64)
                                     , 32346-32361. <a href="https://doi.org/10.18632/oncotarget.25966" title="DOI URL">https://doi.org/10.18632/oncotarget.25966</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.25966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.25966%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DOnline%252Bstructure-based%252Bscreening%252Bof%252Bpurchasable%252Bapproved%252Bdrugs%252Band%252Bnatural%252Bcompounds%25253A%252Bretrospective%252Bexamples%252Bof%252Bdrug%252Brepositioning%252Bon%252Bcancer%252Btargets%26aulast%3DLagarde%26aufirst%3DNathalie%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D64%26spage%3D32346%26epage%3D32361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yicheng  Mei</span>, <span class="hlFld-ContribAuthor ">Baowei  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Rational application of drug promiscuity in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (15)
                                     , 1835-1851. <a href="https://doi.org/10.4155/fmc-2018-0018" title="DOI URL">https://doi.org/10.4155/fmc-2018-0018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0018%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bapplication%252Bof%252Bdrug%252Bpromiscuity%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMei%26aufirst%3DYicheng%26date%3D2018%26volume%3D10%26issue%3D15%26spage%3D1835%26epage%3D1851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiktoria  Jedwabny</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Edyta  Dyguda-Kazimierowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical Model of EphA2-Ephrin A1 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1688. <a href="https://doi.org/10.3390/molecules23071688" title="DOI URL">https://doi.org/10.3390/molecules23071688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071688%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTheoretical%252BModel%252Bof%252BEphA2-Ephrin%252BA1%252BInhibition%26aulast%3DJedwabny%26aufirst%3DWiktoria%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanhong  Li</span>, <span class="hlFld-ContribAuthor ">Jilai  Tian</span>, <span class="hlFld-ContribAuthor ">Hongming  Zhang</span>, <span class="hlFld-ContribAuthor ">Shoubing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiyong  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiapeng  Yang</span>, <span class="hlFld-ContribAuthor ">Zhigang  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenling  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer. </span><span class="cited-content_cbyCitation_journal-name">Apoptosis</span><span> <strong>2018,</strong> <em>23 </em>
                                    (5-6)
                                     , 356-374. <a href="https://doi.org/10.1007/s10495-018-1460-0" title="DOI URL">https://doi.org/10.1007/s10495-018-1460-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10495-018-1460-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10495-018-1460-0%26sid%3Dliteratum%253Aachs%26jtitle%3DApoptosis%26atitle%3DDown-regulating%252BIL-6%25252FGP130%252Btargets%252Bimproved%252Bthe%252Banti-tumor%252Beffects%252Bof%252B5-fluorouracil%252Bin%252Bcolon%252Bcancer%26aulast%3DLi%26aufirst%3DSanhong%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D5-6%26spage%3D356%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul K.  Maurya</span>, <span class="hlFld-ContribAuthor ">Om P. S.  Patel</span>, <span class="hlFld-ContribAuthor ">Devireddy  Anand</span>, <span class="hlFld-ContribAuthor ">Prem P.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate selective synthesis of indole, tetrahydroquinoline and quinoline derivatives
              via
              intramolecular addition of hydrazones and imines. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2018,</strong> <em>5 </em>
                                    (7)
                                     , 1170-1175. <a href="https://doi.org/10.1039/C7QO01115F" title="DOI URL">https://doi.org/10.1039/C7QO01115F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO01115F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO01115F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSubstrate%252Bselective%252Bsynthesis%252Bof%252Bindole%25252C%252Btetrahydroquinoline%252Band%252Bquinoline%252Bderivatives%252Bvia%252Bintramolecular%252Baddition%252Bof%252Bhydrazones%252Band%252Bimines%26aulast%3DMaurya%26aufirst%3DRahul%2BK.%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D7%26spage%3D1170%26epage%3D1175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aditi  Gangopadhyay</span>, <span class="hlFld-ContribAuthor ">Hirak Jyoti  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Abhijit  Datta</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Docking and Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 207-241. <a href="https://doi.org/10.4018/978-1-5225-2607-0.ch009" title="DOI URL">https://doi.org/10.4018/978-1-5225-2607-0.ch009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4018/978-1-5225-2607-0.ch009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4018%2F978-1-5225-2607-0.ch009%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%252BDocking%252Band%252BDrug%252BDesign%26aulast%3DGangopadhyay%26aufirst%3DAditi%26date%3D2018%26spage%3D207%26epage%3D241%26pub%3DIGI%2520Global%26atitle%3DApplying%252BBig%252BData%252BAnalytics%252Bin%252BBioinformatics%252Band%252BMedicine%26aulast%3DLytras%26aufirst%3DMiltiadis%2BD.%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sitanshu S.  Singh</span>, <span class="hlFld-ContribAuthor ">Seetharama D.  Jois</span>. </span><span class="cited-content_cbyCitation_article-title">Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 1-59. <a href="https://doi.org/10.1016/bs.apcsb.2017.08.003" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2017.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2017.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2017.08.003%26sid%3Dliteratum%253Aachs%26atitle%3DHomo-%252Band%252BHeterodimerization%252Bof%252BProteins%252Bin%252BCell%252BSignaling%25253A%252BInhibition%252Band%252BDrug%252BDesign%26aulast%3DSingh%26aufirst%3DSitanshu%2BS.%26date%3D2018%26spage%3D1%26epage%3D59%26pub%3DElsevier%26atitle%3DProtein-Protein%252BInteractions%252Bin%252BHuman%252BDisease%25252C%252BPart%252BB%26date%3D2018%26volume%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Woong-Hee  Shin</span>, <span class="hlFld-ContribAuthor ">Charles W.  Christoffer</span>, <span class="hlFld-ContribAuthor ">Daisuke  Kihara</span>. </span><span class="cited-content_cbyCitation_article-title">In silico structure-based approaches to discover protein-protein interaction-targeting drugs. </span><span class="cited-content_cbyCitation_journal-name">Methods</span><span> <strong>2017,</strong> <em>131 </em>, 22-32. <a href="https://doi.org/10.1016/j.ymeth.2017.08.006" title="DOI URL">https://doi.org/10.1016/j.ymeth.2017.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymeth.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymeth.2017.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DMethods%26atitle%3DIn%252Bsilico%252Bstructure-based%252Bapproaches%252Bto%252Bdiscover%252Bprotein-protein%252Binteraction-targeting%252Bdrugs%26aulast%3DShin%26aufirst%3DWoong-Hee%26date%3D2017%26volume%3D131%26spage%3D22%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Jia  Wei</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Christopher  Pierson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Finlay</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Oncology</span><span> <strong>2017,</strong> <em> </em><a href="https://doi.org/10.3892/ijo.2017.4211" title="DOI URL">https://doi.org/10.3892/ijo.2017.4211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijo.2017.4211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijo.2017.4211%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Oncology%26atitle%3DBlocking%252Binterleukin-6%252Bsignaling%252Binhibits%252Bcell%252Bviability%25252Fproliferation%25252C%252Bglycolysis%25252C%252Band%252Bcolony%252Bforming%252Bactivity%252Bof%252Bhuman%252Bmedulloblastoma%252Bcells%26aulast%3DChen%26aufirst%3DXiang%26date%3D2017%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Xu</span>, <span class="hlFld-ContribAuthor ">Khuchtumur  Bum-Erdene</span>, <span class="hlFld-ContribAuthor ">Yubing  Si</span>, <span class="hlFld-ContribAuthor ">Donghui  Zhou</span>, <span class="hlFld-ContribAuthor ">Mona K.  Ghozayel</span>, <span class="hlFld-ContribAuthor ">Samy O.  Meroueh</span>. </span><span class="cited-content_cbyCitation_article-title">Mimicking Intermolecular Interactions of Tight Protein-Protein Complexes for Small-Molecule Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (21)
                                     , 1794-1809. <a href="https://doi.org/10.1002/cmdc.201700572" title="DOI URL">https://doi.org/10.1002/cmdc.201700572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700572%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMimicking%252BIntermolecular%252BInteractions%252Bof%252BTight%252BProtein-Protein%252BComplexes%252Bfor%252BSmall-Molecule%252BAntagonists%26aulast%3DXu%26aufirst%3DDavid%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D21%26spage%3D1794%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arti  Yadav</span>, <span class="hlFld-ContribAuthor ">Bhavna  Kumar</span>, <span class="hlFld-ContribAuthor ">Theodoros N.  Teknos</span>, <span class="hlFld-ContribAuthor ">Pawan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (40)
                                     , 66912-66924. <a href="https://doi.org/10.18632/oncotarget.11464" title="DOI URL">https://doi.org/10.18632/oncotarget.11464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.11464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.11464%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DBazedoxifene%252Benhances%252Bthe%252Banti-tumor%252Beffects%252Bof%252Bcisplatin%252Band%252Bradiation%252Btreatment%252Bby%252Bblocking%252BIL-6%252Bsignaling%252Bin%252Bhead%252Band%252Bneck%252Bcancer%26aulast%3DYadav%26aufirst%3DArti%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D40%26spage%3D66912%26epage%3D66924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Chongqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Miaomiao  Xiao</span>, <span class="hlFld-ContribAuthor ">Yina  Wang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Hua  Qin</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lv</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2017,</strong> <em>491 </em>
                                    (1)
                                     , 159-165. <a href="https://doi.org/10.1016/j.bbrc.2017.07.067" title="DOI URL">https://doi.org/10.1016/j.bbrc.2017.07.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2017.07.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2017.07.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DInhibition%252Bof%252BIL-6%25252FSTAT3%252Bsignaling%252Bin%252Bhuman%252Bcancer%252Bcells%252Busing%252BEvista%26aulast%3DShi%26aufirst%3DWei%26date%3D2017%26volume%3D491%26issue%3D1%26spage%3D159%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Xiao</span>, <span class="hlFld-ContribAuthor ">Hemant Kumar  Bid</span>, <span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaojuan  Wu</span>, <span class="hlFld-ContribAuthor ">Jia  Wei</span>, <span class="hlFld-ContribAuthor ">Yang  Bian</span>, <span class="hlFld-ContribAuthor ">Chengguang  Zhao</span>, <span class="hlFld-ContribAuthor ">Huameng  Li</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, . </span><span class="cited-content_cbyCitation_article-title">Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2017,</strong> <em>12 </em>
                                    (7)
                                     , e0180297. <a href="https://doi.org/10.1371/journal.pone.0180297" title="DOI URL">https://doi.org/10.1371/journal.pone.0180297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0180297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0180297%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DRepositioning%252BBazedoxifene%252Bas%252Ba%252Bnovel%252BIL-6%25252FGP130%252Bsignaling%252Bantagonist%252Bfor%252Bhuman%252Brhabdomyosarcoma%252Btherapy%26aulast%3DXiao%26aufirst%3DHui%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D7%26spage%3De0180297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malabika  Sen</span>, <span class="hlFld-ContribAuthor ">Paul A.  Johnston</span>, <span class="hlFld-ContribAuthor ">Netanya I.  Pollock</span>, <span class="hlFld-ContribAuthor ">Kara  DeGrave</span>, <span class="hlFld-ContribAuthor ">Sonali C.  Joyce</span>, <span class="hlFld-ContribAuthor ">Maria L.  Freilino</span>, <span class="hlFld-ContribAuthor ">Yun  Hua</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Camarco</span>, <span class="hlFld-ContribAuthor ">David A.  Close</span>, <span class="hlFld-ContribAuthor ">Donna M.  Huryn</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Grandis</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Biology</span><span> <strong>2017,</strong> <em>10 </em>
                                    (3)
                                     , 129-141. <a href="https://doi.org/10.1007/s12154-017-0169-9" title="DOI URL">https://doi.org/10.1007/s12154-017-0169-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12154-017-0169-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12154-017-0169-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Biology%26atitle%3DMechanism%252Bof%252Baction%252Bof%252Bselective%252Binhibitors%252Bof%252BIL-6%252Binduced%252BSTAT3%252Bpathway%252Bin%252Bhead%252Band%252Bneck%252Bcancer%252Bcell%252Blines%26aulast%3DSen%26aufirst%3DMalabika%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D3%26spage%3D129%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darong  Kim</span>, <span class="hlFld-ContribAuthor ">Hee Yeon  Won</span>, <span class="hlFld-ContribAuthor ">Eun Sook  Hwang</span>, <span class="hlFld-ContribAuthor ">Young-Kook  Kim</span>, <span class="hlFld-ContribAuthor ">Hea-Young Park  Choo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of benzoxazole derivatives as interleukin-6 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (12)
                                     , 3127-3134. <a href="https://doi.org/10.1016/j.bmc.2017.03.072" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bbenzoxazole%252Bderivatives%252Bas%252Binterleukin-6%252Bantagonists%26aulast%3DKim%26aufirst%3DDarong%26date%3D2017%26volume%3D25%26issue%3D12%26spage%3D3127%26epage%3D3134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yina  Wang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Ma</span>, <span class="hlFld-ContribAuthor ">Chongqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">David  Jou</span>, <span class="hlFld-ContribAuthor ">Huameng  Li</span>, <span class="hlFld-ContribAuthor ">Cuntai  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiagao  Lü</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (20)
                                     , 33683-33693. <a href="https://doi.org/10.18632/oncotarget.16898" title="DOI URL">https://doi.org/10.18632/oncotarget.16898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.16898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.16898%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DGrowth-suppressive%252Bactivity%252Bof%252Braloxifene%252Bon%252Bliver%252Bcancer%252Bcells%252Bby%252Btargeting%252BIL-6%25252FGP130%252Bsignaling%26aulast%3DWang%26aufirst%3DYina%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D20%26spage%3D33683%26epage%3D33693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Lagorce</span>, <span class="hlFld-ContribAuthor ">Dominique  Douguet</span>, <span class="hlFld-ContribAuthor ">Maria A.  Miteva</span>, <span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>. </span><span class="cited-content_cbyCitation_article-title">Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep46277" title="DOI URL">https://doi.org/10.1038/srep46277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep46277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep46277%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DComputational%252Banalysis%252Bof%252Bcalculated%252Bphysicochemical%252Band%252BADMET%252Bproperties%252Bof%252Bprotein-protein%252Binteraction%252Binhibitors%26aulast%3DLagorce%26aufirst%3DDavid%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.R.  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–Protein Interaction Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 154-201. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12392-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12392-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12392-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12392-3%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%252Bin%252BCancer%26aulast%3DHardcastle%26aufirst%3DI.R.%26date%3D2017%26spage%3D154%26epage%3D201%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hannes P. L.  Gemoets</span>, <span class="hlFld-ContribAuthor ">Indrek  Kalvet</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Nyuchev</span>, <span class="hlFld-ContribAuthor ">Nico  Erdmann</span>, <span class="hlFld-ContribAuthor ">Volker  Hessel</span>, <span class="hlFld-ContribAuthor ">Franziska  Schoenebeck</span>, <span class="hlFld-ContribAuthor ">Timothy  Noël</span>. </span><span class="cited-content_cbyCitation_article-title">Mild and selective base-free C–H arylation of heteroarenes: experiment and computation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 1046-1055. <a href="https://doi.org/10.1039/C6SC02595A" title="DOI URL">https://doi.org/10.1039/C6SC02595A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6SC02595A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6SC02595A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DMild%252Band%252Bselective%252Bbase-free%252BC%2525E2%252580%252593H%252Barylation%252Bof%252Bheteroarenes%25253A%252Bexperiment%252Band%252Bcomputation%26aulast%3DGemoets%26aufirst%3DHannes%2BP.%2BL.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D1046%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiktoria  Jedwabny</span>, <span class="hlFld-ContribAuthor ">Szymon  Kłossowski</span>, <span class="hlFld-ContribAuthor ">Trupta  Purohit</span>, <span class="hlFld-ContribAuthor ">Tomasz  Cierpicki</span>, <span class="hlFld-ContribAuthor ">Jolanta  Grembecka</span>, <span class="hlFld-ContribAuthor ">Edyta  Dyguda-Kazimierowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical models of inhibitory activity for inhibitors of protein–protein interactions: targeting menin–mixed lineage leukemia with small molecules. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 2216-2227. <a href="https://doi.org/10.1039/C7MD00170C" title="DOI URL">https://doi.org/10.1039/C7MD00170C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00170C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00170C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DTheoretical%252Bmodels%252Bof%252Binhibitory%252Bactivity%252Bfor%252Binhibitors%252Bof%252Bprotein%2525E2%252580%252593protein%252Binteractions%25253A%252Btargeting%252Bmenin%2525E2%252580%252593mixed%252Blineage%252Bleukemia%252Bwith%252Bsmall%252Bmolecules%26aulast%3DJedwabny%26aufirst%3DWiktoria%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D12%26spage%3D2216%26epage%3D2227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Yajie  Xie</span>, <span class="hlFld-ContribAuthor ">Lianpeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Yujin  Li</span>, <span class="hlFld-ContribAuthor ">Hongwei  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of benzothiophene and indole derivatives through metal-free propargyl–allene rearrangement and allyl migration. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>13 </em>, 1866-1870. <a href="https://doi.org/10.3762/bjoc.13.181" title="DOI URL">https://doi.org/10.3762/bjoc.13.181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.13.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.13.181%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bbenzothiophene%252Band%252Bindole%252Bderivatives%252Bthrough%252Bmetal-free%252Bpropargyl%2525E2%252580%252593allene%252Brearrangement%252Band%252Ballyl%252Bmigration%26aulast%3DYao%26aufirst%3DJinzhong%26date%3D2017%26date%3D2017%26volume%3D13%26spage%3D1866%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojuan  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Cao</span>, <span class="hlFld-ContribAuthor ">Hui  Xiao</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2016,</strong> <em>15 </em>
                                    (11)
                                     , 2609-2619. <a href="https://doi.org/10.1158/1535-7163.MCT-15-0921" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-15-0921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-15-0921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-15-0921%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DBazedoxifene%252Bas%252Ba%252BNovel%252BGP130%252BInhibitor%252Bfor%252BPancreatic%252BCancer%252BTherapy%26aulast%3DWu%26aufirst%3DXiaojuan%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D11%26spage%3D2609%26epage%3D2619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhichao  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Fang</span>, <span class="hlFld-ContribAuthor ">William  Slikker</span>, <span class="hlFld-ContribAuthor ">Weida  Tong</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2016,</strong> <em>37 </em>
                                    (10)
                                     , 843-857. <a href="https://doi.org/10.1016/j.tips.2016.06.010" title="DOI URL">https://doi.org/10.1016/j.tips.2016.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2016.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2016.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DPotential%252BReuse%252Bof%252BOncology%252BDrugs%252Bin%252Bthe%252BTreatment%252Bof%252BRare%252BDiseases%26aulast%3DLiu%26aufirst%3DZhichao%26date%3D2016%26volume%3D37%26issue%3D10%26spage%3D843%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjing  Liu</span>, <span class="hlFld-ContribAuthor ">Zhaohui  Xiong</span>, <span class="hlFld-ContribAuthor ">Andrea  Beasley</span>, <span class="hlFld-ContribAuthor ">Thomas  D'Amico</span>, <span class="hlFld-ContribAuthor ">Xiaoxin Luke  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Personalized and targeted therapy of esophageal squamous cell carcinoma: an update. </span><span class="cited-content_cbyCitation_journal-name">Annals of the New York Academy of Sciences</span><span> <strong>2016,</strong> <em>1381 </em>
                                    (1)
                                     , 66-73. <a href="https://doi.org/10.1111/nyas.13144" title="DOI URL">https://doi.org/10.1111/nyas.13144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nyas.13144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnyas.13144%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520New%2520York%2520Academy%2520of%2520Sciences%26atitle%3DPersonalized%252Band%252Btargeted%252Btherapy%252Bof%252Besophageal%252Bsquamous%252Bcell%252Bcarcinoma%25253A%252Ban%252Bupdate%26aulast%3DLiu%26aufirst%3DYongjing%26date%3D2016%26date%3D2016%26volume%3D1381%26issue%3D1%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rini  Jacob</span>, <span class="hlFld-ContribAuthor ">Anbalagan  Moorthy</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting secret handshakes of biological processes for novel drug development. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (2)
                                     , 132-140. <a href="https://doi.org/10.1007/s11515-016-1394-2" title="DOI URL">https://doi.org/10.1007/s11515-016-1394-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11515-016-1394-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11515-016-1394-2%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Biology%26atitle%3DTargeting%252Bsecret%252Bhandshakes%252Bof%252Bbiological%252Bprocesses%252Bfor%252Bnovel%252Bdrug%252Bdevelopment%26aulast%3DJacob%26aufirst%3DRini%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D2%26spage%3D132%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S S  Tarighat</span>, <span class="hlFld-ContribAuthor ">R  Santhanam</span>, <span class="hlFld-ContribAuthor ">D  Frankhouser</span>, <span class="hlFld-ContribAuthor ">H S  Radomska</span>, <span class="hlFld-ContribAuthor ">H  Lai</span>, <span class="hlFld-ContribAuthor ">M  Anghelina</span>, <span class="hlFld-ContribAuthor ">H  Wang</span>, <span class="hlFld-ContribAuthor ">X  Huang</span>, <span class="hlFld-ContribAuthor ">L  Alinari</span>, <span class="hlFld-ContribAuthor ">A  Walker</span>, <span class="hlFld-ContribAuthor ">M A  Caligiuri</span>, <span class="hlFld-ContribAuthor ">C M  Croce</span>, <span class="hlFld-ContribAuthor ">L  Li</span>, <span class="hlFld-ContribAuthor ">R  Garzon</span>, <span class="hlFld-ContribAuthor ">C  Li</span>, <span class="hlFld-ContribAuthor ">R A  Baiocchi</span>, <span class="hlFld-ContribAuthor ">G  Marcucci</span>. </span><span class="cited-content_cbyCitation_article-title">The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2016,</strong> <em>30 </em>
                                    (4)
                                     , 789-799. <a href="https://doi.org/10.1038/leu.2015.308" title="DOI URL">https://doi.org/10.1038/leu.2015.308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/leu.2015.308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fleu.2015.308%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DThe%252Bdual%252Bepigenetic%252Brole%252Bof%252BPRMT5%252Bin%252Bacute%252Bmyeloid%252Bleukemia%25253A%252Bgene%252Bactivation%252Band%252Brepression%252Bvia%252Bhistone%252Barginine%252Bmethylation%26aulast%3DTarighat%26aufirst%3DS%2BS%26date%3D2016%26date%3D2015%26volume%3D30%26issue%3D4%26spage%3D789%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tae-Hwe  Heo</span>, <span class="hlFld-ContribAuthor ">Joseph  Wahler</span>, <span class="hlFld-ContribAuthor ">Nanjoo  Suh</span>. </span><span class="cited-content_cbyCitation_article-title">Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (13)
                                     , 15460-15473. <a href="https://doi.org/10.18632/oncotarget.7102" title="DOI URL">https://doi.org/10.18632/oncotarget.7102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.7102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.7102%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DPotential%252Btherapeutic%252Bimplications%252Bof%252BIL-6%25252FIL-6R%25252Fgp130-targeting%252Bagents%252Bin%252Bbreast%252Bcancer%26aulast%3DHeo%26aufirst%3DTae-Hwe%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D13%26spage%3D15460%26epage%3D15473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarbjit  Singh</span>, <span class="hlFld-ContribAuthor ">Veeraswamy  Gajulapati</span>, <span class="hlFld-ContribAuthor ">Kondaji  Gajulapati</span>, <span class="hlFld-ContribAuthor ">Ja-Il  Goo</span>, <span class="hlFld-ContribAuthor ">Yeon-Hwa  Park</span>, <span class="hlFld-ContribAuthor ">Hwa Young  Jung</span>, <span class="hlFld-ContribAuthor ">Sung Yoon  Lee</span>, <span class="hlFld-ContribAuthor ">Jung Ho  Choi</span>, <span class="hlFld-ContribAuthor ">Young Kook  Kim</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>, <span class="hlFld-ContribAuthor ">Tae-Hwe  Heo</span>, <span class="hlFld-ContribAuthor ">Yongseok  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (4)
                                     , 1282-1286. <a href="https://doi.org/10.1016/j.bmcl.2016.01.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationship%252Bstudy%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Boxazolidinone%252Bderivatives%252Bas%252BIL-6%252Bsignaling%252Bblockers%26aulast%3DSingh%26aufirst%3DSarbjit%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D1282%26epage%3D1286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengguang  Zhao</span>, <span class="hlFld-ContribAuthor ">Huameng  Li</span>, <span class="hlFld-ContribAuthor ">Huey-Jen  Lin</span>, <span class="hlFld-ContribAuthor ">Shulin  Yang</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>, <span class="hlFld-ContribAuthor ">Guang  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2016,</strong> <em>37 </em>
                                    (1)
                                     , 47-61. <a href="https://doi.org/10.1016/j.tips.2015.10.001" title="DOI URL">https://doi.org/10.1016/j.tips.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2015.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DFeedback%252BActivation%252Bof%252BSTAT3%252Bas%252Ba%252BCancer%252BDrug-Resistance%252BMechanism%26aulast%3DZhao%26aufirst%3DChengguang%26date%3D2016%26volume%3D37%26issue%3D1%26spage%3D47%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Bartolowits</span>, <span class="hlFld-ContribAuthor ">V. Jo  Davisson</span>. </span><span class="cited-content_cbyCitation_article-title">Considerations of Protein Subpockets in Fragment-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>87 </em>
                                    (1)
                                     , 5-20. <a href="https://doi.org/10.1111/cbdd.12631" title="DOI URL">https://doi.org/10.1111/cbdd.12631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12631%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DConsiderations%252Bof%252BProtein%252BSubpockets%252Bin%252BFragment-Based%252BDrug%252BDesign%26aulast%3DBartolowits%26aufirst%3DMatthew%26date%3D2016%26date%3D2015%26volume%3D87%26issue%3D1%26spage%3D5%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Johnston</span>, <span class="hlFld-ContribAuthor ">Malabika  Sen</span>, <span class="hlFld-ContribAuthor ">Yun  Hua</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Camarco</span>, <span class="hlFld-ContribAuthor ">Tong Ying  Shun</span>, <span class="hlFld-ContribAuthor ">John S.  Lazo</span>, <span class="hlFld-ContribAuthor ">Gabriela Mustata  Wilson</span>, <span class="hlFld-ContribAuthor ">Lynn O.  Resnick</span>, <span class="hlFld-ContribAuthor ">Matthew G.  LaPorte</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Donna M.  Huryn</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Grandis</span>. </span><span class="cited-content_cbyCitation_article-title">HCS Campaign to Identify Selective Inhibitors of IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2015,</strong> <em>13 </em>
                                    (7)
                                     , 356-376. <a href="https://doi.org/10.1089/adt.2015.663" title="DOI URL">https://doi.org/10.1089/adt.2015.663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2015.663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2015.663%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DHCS%252BCampaign%252Bto%252BIdentify%252BSelective%252BInhibitors%252Bof%252BIL-6-Induced%252BSTAT3%252BPathway%252BActivation%252Bin%252BHead%252Band%252BNeck%252BCancer%252BCell%252BLines%26aulast%3DJohnston%26aufirst%3DPaul%2BA.%26date%3D2015%26volume%3D13%26issue%3D7%26spage%3D356%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  Villoutreix</span>, <span class="hlFld-ContribAuthor ">Melaine  Kuenemann</span>, <span class="hlFld-ContribAuthor ">David  Lagorce</span>, <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>, <span class="hlFld-ContribAuthor ">Maria  Miteva</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Approaches Assisting the Rational Design of Low Molecular Weight Protein–Protein Interaction Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 441-482. <a href="https://doi.org/10.1201/b18799-21" title="DOI URL">https://doi.org/10.1201/b18799-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/b18799-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2Fb18799-21%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252BSilico%252BApproaches%252BAssisting%252Bthe%252BRational%252BDesign%252Bof%252BLow%252BMolecular%252BWeight%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BModulators%26aulast%3DVilloutreix%26aufirst%3DBruno%26date%3D2015%26date%3D2015%26spage%3D441%26epage%3D482%26pub%3DCRC%2520Press%26atitle%3DIn%252BSilico%252BDrug%252BDiscovery%252Band%252BDesign%26aulast%3DCavasotto%26aufirst%3DClaudio%26date%3D2015%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-You  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the potential of global protein–protein docking: an overview and critical assessment of current programs for automatic ab initio docking. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (8)
                                     , 969-977. <a href="https://doi.org/10.1016/j.drudis.2015.03.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.03.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.03.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DExploring%252Bthe%252Bpotential%252Bof%252Bglobal%252Bprotein%2525E2%252580%252593protein%252Bdocking%25253A%252Ban%252Boverview%252Band%252Bcritical%252Bassessment%252Bof%252Bcurrent%252Bprograms%252Bfor%252Bautomatic%252Bab%252Binitio%252Bdocking%26aulast%3DHuang%26aufirst%3DSheng-You%26date%3D2015%26volume%3D20%26issue%3D8%26spage%3D969%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elias Silva  dos Santos</span>, <span class="hlFld-ContribAuthor ">Leila Cristiane Virgens  de Souza</span>, <span class="hlFld-ContribAuthor ">Patrícia Nascimento  de Assis</span>, <span class="hlFld-ContribAuthor ">Paulo Fernando  de Almeida</span>, <span class="hlFld-ContribAuthor ">Elias  Ramos-de-Souza</span>. </span><span class="cited-content_cbyCitation_article-title">Souring control in fluid samples of oil industry using a multiple ligand simultaneous docking (MLSD) strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2015,</strong> <em>33 </em>
                                    (6)
                                     , 1176-1184. <a href="https://doi.org/10.1080/07391102.2014.937461" title="DOI URL">https://doi.org/10.1080/07391102.2014.937461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2014.937461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2014.937461%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DSouring%252Bcontrol%252Bin%252Bfluid%252Bsamples%252Bof%252Boil%252Bindustry%252Busing%252Ba%252Bmultiple%252Bligand%252Bsimultaneous%252Bdocking%252B%252528MLSD%252529%252Bstrategy%26aulast%3Ddos%2BSantos%26aufirst%3DElias%2BSilva%26date%3D2015%26date%3D2014%26volume%3D33%26issue%3D6%26spage%3D1176%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melody Y.  Pai</span>, <span class="hlFld-ContribAuthor ">Brett  Lomenick</span>, <span class="hlFld-ContribAuthor ">Heejun  Hwang</span>, <span class="hlFld-ContribAuthor ">Robert  Schiestl</span>, <span class="hlFld-ContribAuthor ">William  McBride</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Loo</span>, <span class="hlFld-ContribAuthor ">Jing  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Affinity Responsive Target Stability (DARTS) for Small-Molecule Target Identification. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 287-298. <a href="https://doi.org/10.1007/978-1-4939-2269-7_22" title="DOI URL">https://doi.org/10.1007/978-1-4939-2269-7_22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2269-7_22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2269-7_22%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BAffinity%252BResponsive%252BTarget%252BStability%252B%252528DARTS%252529%252Bfor%252BSmall-Molecule%252BTarget%252BIdentification%26aulast%3DPai%26aufirst%3DMelody%2BY.%26date%3D2015%26date%3D2014%26spage%3D287%26epage%3D298%26pub%3DSpringer%2520New%2520York%26atitle%3DChemical%252BBiology%26aulast%3DHempel%26aufirst%3DJonathan%2BE.%26date%3D2015%26volume%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jill M.  Tham</span>, <span class="hlFld-ContribAuthor ">Sofie C.  Van Huffel</span>, <span class="hlFld-ContribAuthor ">Wanjin  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding of Complex Protein Interactions with Respect to Anchorage Independence. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 205-225. <a href="https://doi.org/10.1007/978-1-4939-2309-0_16" title="DOI URL">https://doi.org/10.1007/978-1-4939-2309-0_16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2309-0_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2309-0_16%26sid%3Dliteratum%253Aachs%26atitle%3DUnderstanding%252Bof%252BComplex%252BProtein%252BInteractions%252Bwith%252BRespect%252Bto%252BAnchorage%252BIndependence%26aulast%3DTham%26aufirst%3DJill%2BM.%26date%3D2015%26date%3D2014%26spage%3D205%26epage%3D225%26pub%3DSpringer%2520New%2520York%26atitle%3DMembrane%252BTrafficking%26aulast%3DTang%26aufirst%3DBor%2BLuen%26date%3D2015%26volume%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Didier  Rognan</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of protein–protein interaction inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     , 51-60. <a href="https://doi.org/10.1039/C4MD00328D" title="DOI URL">https://doi.org/10.1039/C4MD00328D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00328D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00328D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRational%252Bdesign%252Bof%252Bprotein%2525E2%252580%252593protein%252Binteraction%252Binhibitors%26aulast%3DRognan%26aufirst%3DDidier%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3D51%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2015,</strong> <em>44 </em>
                                    (22)
                                     , 8238-8259. <a href="https://doi.org/10.1039/C5CS00252D" title="DOI URL">https://doi.org/10.1039/C5CS00252D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CS00252D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CS00252D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DState-of-the-art%252Bstrategies%252Bfor%252Btargeting%252Bprotein%2525E2%252580%252593protein%252Binteractions%252Bby%252Bsmall-molecule%252Binhibitors%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2015%26date%3D2015%26volume%3D44%26issue%3D22%26spage%3D8238%26epage%3D8259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Chun Jim  Hsu</span>, <span class="hlFld-ContribAuthor ">Carol Lynn  Nilsson</span>, <span class="hlFld-ContribAuthor ">Fernanda  Laezza</span>. </span><span class="cited-content_cbyCitation_article-title">Role of the Axonal Initial Segment in Psychiatric Disorders: Function, Dysfunction, and Intervention. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2014,</strong> <em>5 </em><a href="https://doi.org/10.3389/fpsyt.2014.00109" title="DOI URL">https://doi.org/10.3389/fpsyt.2014.00109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2014.00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2014.00109%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DRole%252Bof%252Bthe%252BAxonal%252BInitial%252BSegment%252Bin%252BPsychiatric%252BDisorders%25253A%252BFunction%25252C%252BDysfunction%25252C%252Band%252BIntervention%26aulast%3DHsu%26aufirst%3DWei-Chun%2BJim%26date%3D2014%26date%3D2014%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>, <span class="hlFld-ContribAuthor ">Melaine A.  Kuenemann</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Poyet</span>, <span class="hlFld-ContribAuthor ">Heriberto  Bruzzoni-Giovanelli</span>, <span class="hlFld-ContribAuthor ">Céline  Labbé</span>, <span class="hlFld-ContribAuthor ">David  Lagorce</span>, <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>, <span class="hlFld-ContribAuthor ">Maria A.  Miteva</span>. </span><span class="cited-content_cbyCitation_article-title">Drug-Like ProteinProtein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2014,</strong> <em>33 </em>
                                    (6-7)
                                     , 414-437. <a href="https://doi.org/10.1002/minf.201400040" title="DOI URL">https://doi.org/10.1002/minf.201400040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201400040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201400040%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DDrug-Like%252BProtein%2525EF%2525A3%2525BFProtein%252BInteraction%252BModulators%25253A%252BChallenges%252Band%252BOpportunities%252Bfor%252BDrug%252BDiscovery%252Band%252BChemical%252BBiology%26aulast%3DVilloutreix%26aufirst%3DBruno%2BO.%26date%3D2014%26date%3D2014%26volume%3D33%26issue%3D6-7%26spage%3D414%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IL-6/GP130/STAT3 signal transduction. IL-6 first binds to IL-6Rα to form the binary complex through site I interactions. The IL-6/IL-6Rα complex then binds to D2 and D3 domains of GP130 through site II interactions and forms trimeric complex IL-6/IL-6Rα/GP130. The subsequent site III reciprocal interaction of IL-6 of one trimer with the D1 domain of GP130 of the other trimer leads to homodimerization of the heterotrimer into heterohexamer complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1P9M">1P9M</a>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> MDL-A binds to the GP130 D1 domain and inhibits hexameric complex formation by disrupting interactions between IL-6 and the GP130 D1 domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeling of binding hot spots at the IL-6/GP130 D1 domain interface. (A) D1 domain is represented as electrostatic potential surface (red, negatively charged; blue, positively charged; white, hydrophobic). IL-6 is in ribbon representation. The two larger yellow eclipses indicate the two main binding “hot spots”, Leu57 binding site and Trp157 binding site, between IL-6 and GP130. (B) Binding modeling of MDL-A to the GP130 D1 domain. D1 domain is in ribbon representation, and MDL-A is in thick ball-and-stick rendering. Hydrogen bonds are shown as red dotted lines. MDL-A disrupts both binding spots of the GP130 D1 domain. MDL-A forms three hydrogen bonds with Asn92, Cys6, and the carbonyl backbone of Val93 residues of GP130. The modeling indicates that the long butyl tail of MDL-A displaces Leu57 (thin red line), and the indoline moiety partially disrupts Trp157 (thin red line) of the helix D of IL-6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Feature fragments from Trp157 and Leu57 residues of IL-6, inhibitor MDL-A, and its analogues to mimic the hot spot residues of IL-6. (B) Structures of drug scaffolds identified for the binding hot spots of GP130.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking modeling of the best drug scaffolds, the virtual templates, and drug candidates to GP130. (A) In top hits of fragment sets S1 (red) and S2 (green color), fragment fb1 (phenylpiperdinyl) occupied the Leu57 hot spot while f2 (2-phenylindole) and f5 (2-phenyl-1-benzothiophene) bound to the Trp157 binding site of GP130 with binding energies of −9.4 and −9.5 kcal/mol, respectively. (B) Tethering fragments in hits S1 and S2 gave virtual template compounds T1 (red) and T2 (green), respectively. Docking free energies and binding modes of template compounds T1 (−9.1 kcal/mol) and T2 (−9.3 kcal/mol) are close to the corresponding fragments in hits S1 and S2. (C) Drug raloxifene was identified as a novel inhibitor of GP130 D1 by similarity searching for T2 in DrugBank. Docking of raloxifene (thick gray ball-and-stick) to GP130 D1 showed that piperidinyl and 1-benzothiophene moieties mimic the native Leu57 and Trp157 (in white lines) of IL-6 in the hot spots, respectively. (D) Docking of drug candidate bazedoxifene (thick gray ball-and-stick) to GP130 D1 domain. The indole moiety and seven-membered ring azepanyl of bazedoxifene almost overlap with the native Trp157 and Leu57 residues (white lines) of IL-6, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Modeling of binding interactions of raloxifene with the key residues in the active site in the GP130 D1 domain. Raloxifene is in thick ball-and-stick representation. Native residues Leu57 and Trp157 of IL-6 are thin red lines. Residues of GP130 are labeled in blue color. Asn92 and Cys6 form hydrogen bonds (green dotted lines) with raloxifene.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. DARTS assay to estimate raloxifene and bazedoxifene binding to target GP130. In RH30 sarcoma cell lysates, the proteolysis of GP130 by pronase is decreased by the treatment of raloxifene (Evista) or bazedoxifene (100 and 1000 μM). The results suggest that the direct binding of raloxifene or bazedoxifene to GP130 stabilizes the structure of GP130 and therefore protects it from proteolytic digestion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Selective inhibition of the IL-6 induced P-STAT3 by raloxifene (Evista) and bazedoxifene. (A) In human pancreatic cancer cells (PANC-1, ER negative) with treatment of IL-6 and raloxifene (25 μM), the downstream STAT3 phosphorylation (P-STAT3 at Y705) stimulated by IL-6 was significantly inhibited. In contrast, the P-STAT3 induced by LIF or P-STAT1 induced by IFN-γ was not suppressed. (B) Bazedoxifene (25 μM) selectively inhibited P-STAT3 induced by IL-6 but not P-STAT3 induced by LIF or P-STAT1 induced by IFN-γ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/medium/jm-2013-01144z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of raloxifene and bazedoxifene on constitutive STAT3 activity level in SUM159 cancer cells. (A) In human breast cancer cells (SUM159, ER negative) expressing IL-6 and GP130, raloxifene (15–50 μM) down-regulated the constitutive STAT3 phosphorylation (P-STAT3) activity level. (B) Bazedoxifene (10–30 μM) inhibited the constitutive P-STAT3 activity levels induced by the expressed IL-6 and GP130.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401144z/production/images/large/jm-2013-01144z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401144z&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span> </span><span class="NLM_article-title">Interleukin-6 and its receptor: a paradigm for cytokines</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=593-597&author=T.+Kishimotoauthor=S.+Akiraauthor=T.+Taga&title=Interleukin-6+and+its+receptor%3A+a+paradigm+for+cytokines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DInterleukin-6%2520and%2520its%2520receptor%253A%2520a%2520paradigm%2520for%2520cytokines%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D593%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span> </span><span class="NLM_article-title">IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">1808</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1993&pages=1808-1810&author=M.+Murakamiauthor=M.+Hibiauthor=N.+Nakagawaauthor=T.+Nakagawaauthor=K.+Yasukawaauthor=K.+Yamanishiauthor=T.+Tagaauthor=T.+Kishimoto&title=IL-6-induced+homodimerization+of+gp130+and+associated+activation+of+a+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DHibi%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DN.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DYamanishi%26aufirst%3DK.%26aulast%3DTaga%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DIL-6-induced%2520homodimerization%2520of%2520gp130%2520and%2520associated%2520activation%2520of%2520a%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D1993%26volume%3D260%26spage%3D1808%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Boulanger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brevnova, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">2101</span><span class="NLM_x">–</span> <span class="NLM_lpage">2104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=2101-2104&author=M.+J.+Boulangerauthor=D.+C.+Chowauthor=E.+E.+Brevnovaauthor=K.+C.+Garcia&title=Hexameric+structure+and+assembly+of+the+interleukin-6%2FIL-6+alpha-receptor%2Fgp130+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoulanger%26aufirst%3DM.%2BJ.%26aulast%3DChow%26aufirst%3DD.%2BC.%26aulast%3DBrevnova%26aufirst%3DE.%2BE.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DHexameric%2520structure%2520and%2520assembly%2520of%2520the%2520interleukin-6%252FIL-6%2520alpha-receptor%252Fgp130%2520complex%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D2101%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">Cytokine receptor signaling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=591-594&author=J.+N.+Ihle&title=Cytokine+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DCytokine%2520receptor%2520signaling%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D591%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Darnell, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">STATs and gene regulation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1630-1635&author=J.+E.+Darnell&title=STATs+and+gene+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26atitle%3DSTATs%2520and%2520gene%2520regulation%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1630%26epage%3D1635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of Stat3 signaling pathway</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.2174%2F156800907780006922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=17305481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=91-107&author=J.+Dengauthor=F.+Grandeauthor=N.+Neamati&title=Small+molecule+inhibitors+of+Stat3+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of Stat3 signaling pathway</span></div><div class="casAuthors">Deng, Jinxia; Grande, Fedora; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-107</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Constitutive activation of the Signal Transducers and Activators of Transcription 3 (Stat3) meditated signaling pathway is very important for cell growth and survival.  Compelling evidence from mechanistic studies with antisense, RNA interference (RNAi), peptides, and small mol. inhibitors indicate that blocking Stat3 signaling can lead to successful suppression of tumor cell growth and apoptosis.  Thus, Stat3 is an attractive mol. target for the development of novel cancer therapeutics.  In this article, we present the 1st comprehensive review focusing on small mol. inhibitors that effectively block the Stat3 signaling pathway.  These inhibitors, from a structural point of view, are divided into 5 classes of compds.  They include (1) natural products and derivs., such as curcumin, resveratrol and others, (2) tyrphostins, (3) platinum-contg. complexes, (4) peptidomimetics, and (5) azaspiranes.  Some compds. may have multiple targets including Stat3 protein, therefore these compds. need further optimization and validation.  The purpose of this review is to provide a resource for researchers interested in Stat3 targeted small mols. which will be beneficial for database development and template design for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFbtKVwWNFBLVg90H21EOLACvtfcHk0lgn8wI_5_n9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOgtrs%253D&md5=b5cfd418452ffc185f585577bb170cbb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F156800907780006922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907780006922%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520Stat3%2520signaling%2520pathway%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D91%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rho, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunazuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, S.</span><span> </span><span class="NLM_article-title">Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">14728</span><span class="NLM_x">–</span> <span class="NLM_lpage">14733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=14728-14733&author=M.+Hayashiauthor=M.+C.+Rhoauthor=A.+Enomotoauthor=A.+Fukamiauthor=Y.+P.+Kimauthor=Y.+Kikuchiauthor=T.+Sunazukaauthor=T.+Hiroseauthor=K.+Komiyamaauthor=S.+Omura&title=Suppression+of+bone+resorption+by+madindoline+A%2C+a+novel+nonpeptide+antagonist+to+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DRho%26aufirst%3DM.%2BC.%26aulast%3DEnomoto%26aufirst%3DA.%26aulast%3DFukami%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DY.%2BP.%26aulast%3DKikuchi%26aufirst%3DY.%26aulast%3DSunazuka%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DKomiyama%26aufirst%3DK.%26aulast%3DOmura%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520bone%2520resorption%2520by%2520madindoline%2520A%252C%2520a%2520novel%2520nonpeptide%2520antagonist%2520to%2520gp130%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D14728%26epage%3D14733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Saleh, A. Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenman, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vranken, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolewski, J. J.</span><span> </span><span class="NLM_article-title">Binding of madindoline A to the extracellular domain of gp130</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">10822</span><span class="NLM_x">–</span> <span class="NLM_lpage">10827</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi050439%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10822-10827&author=A.+Z.+M.+Salehauthor=K.+L.+Greenmanauthor=S.+Billingsauthor=D.+L.+Van+Vrankenauthor=J.+J.+Krolewski&title=Binding+of+madindoline+A+to+the+extracellular+domain+of+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi050439%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050439%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSaleh%26aufirst%3DA.%2BZ.%2BM.%26aulast%3DGreenman%26aufirst%3DK.%2BL.%26aulast%3DBillings%26aufirst%3DS.%26aulast%3DVan%2BVranken%26aufirst%3DD.%2BL.%26aulast%3DKrolewski%26aufirst%3DJ.%2BJ.%26atitle%3DBinding%2520of%2520madindoline%2520A%2520to%2520the%2520extracellular%2520domain%2520of%2520gp130%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10822%26epage%3D10827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kumari, V.</span> Ph.D. Dissertation, The Ohio State University,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>unpublished data.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kumari%2C+V.+Ph.D.+Dissertation%2C+The+Ohio+State+University%2C+2011%3B+unpublished+data."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DV.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein–protein interfaces</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein%E2%80%93protein+interfaces"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein%25E2%2580%2593protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">White, A. W.; Westwell, A. D.; Brahemi, G.</span><span> </span><span class="NLM_article-title">Protein–protein interactions as targets for small-molecule therapeutics in cancer</span>.  <span class="citation_source-journal">Expert Rev. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e8</span>, DOI: <span class="refDoi"> DOI: 10.1017/S1462399408000641</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1017%2FS1462399408000641" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=e8&author=A.+W.+White&author=A.+D.+Westwell&author=G.+Brahemi&title=Protein%E2%80%93protein+interactions+as+targets+for+small-molecule+therapeutics+in+cancer&doi=10.1017%2FS1462399408000641"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1017%2FS1462399408000641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399408000641%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BW.%26atitle%3DProtein%25E2%2580%2593protein%2520interactions%2520as%2520targets%2520for%2520small-molecule%2520therapeutics%2520in%2520cancer%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2008%26volume%3D10%26spage%3De8%26doi%3D10.1017%2FS1462399408000641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bienstock, R. J.</span><span> </span><span class="NLM_article-title">Computational drug design targeting protein–protein interactions</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.2174%2F138161212799436449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=22316151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1240-1254&author=R.+J.+Bienstock&title=Computational+drug+design+targeting+protein%E2%80%93protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Computational drug design targeting protein-protein interactions</span></div><div class="casAuthors">Bienstock, Rachelle J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1240-1254</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Novel discoveries in mol. disease pathways within the cell, combined with increasing information regarding protein binding partners has lead to a new approach in drug discovery.  There is interest in designing drugs to modulate protein-protein interactions as opposed to solely targeting the catalytic active site within a single enzyme or protein.  There are many challenges in this new approach to drug discovery, particularly since the protein-protein interface has a larger surface area, can comprise a discontinuous epitope, and is more amorphous and less well defined than the typical drug design target, a small contained enzyme-binding pocket.  Computational methods to predict modes of protein-protein interaction, as well as protein interface hot spots, have garnered significant interest, in order to facilitate the development of drugs to successfully disrupt and inhibit protein-protein interactions.  This review summarizes some current methods available for computational protein-protein docking, as well as tabulating some examples of the successful design of antagonists and small mol. inhibitors for protein-protein interactions.  Several of these drugs are now beginning to appear in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrecmci1x1FD7Vg90H21EOLACvtfcHk0ljJgcz9eQ270w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbo%253D&md5=55b00723ce8b41d3098805f8088ac1a4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161212799436449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436449%26sid%3Dliteratum%253Aachs%26aulast%3DBienstock%26aufirst%3DR.%2BJ.%26atitle%3DComputational%2520drug%2520design%2520targeting%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1240%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Multiple ligand simultaneous docking (MLSD): orchestrated dancing of ligands in binding sites of protein</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2014</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=2014-2022&author=H.+Liauthor=C.+Li&title=Multiple+ligand+simultaneous+docking+%28MLSD%29%3A+orchestrated+dancing+of+ligands+in+binding+sites+of+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DMultiple%2520ligand%2520simultaneous%2520docking%2520%2528MLSD%2529%253A%2520orchestrated%2520dancing%2520of%2520ligands%2520in%2520binding%2520sites%2520of%2520protein%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D2014%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of STAT3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5592</span><span class="NLM_x">–</span> <span class="NLM_lpage">5596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101330h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5592-5596&author=H.+Liauthor=A.+Liuauthor=Z.+Zhaoauthor=Y.+Xuauthor=J.+Linauthor=D.+Jouauthor=C.+Li&title=Fragment-based+drug+design+and+drug+repositioning+using+multiple+ligand+simultaneous+docking+%28MLSD%29%3A+identifying+celecoxib+and+template+compounds+as+novel+inhibitors+of+STAT3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm101330h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101330h%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DJou%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DFragment-based%2520drug%2520design%2520and%2520drug%2520repositioning%2520using%2520multiple%2520ligand%2520simultaneous%2520docking%2520%2528MLSD%2529%253A%2520identifying%2520celecoxib%2520and%2520template%2520compounds%2520as%2520novel%2520inhibitors%2520of%2520STAT3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5592%26epage%3D5596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jevnikar, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, J. A.</span><span> </span><span class="NLM_article-title">Antiestrogens. 2. Structure–activity studies in a series of 3-aroyl-2-arylbenzo[<i>b</i>]thiophene derivatives leading to (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00374a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=1057-1066&issue=8&author=C.+D.+Jonesauthor=M.+G.+Jevnikarauthor=A.+J.+Pikeauthor=M.+K.+Petersauthor=L.+J.+Blackauthor=A.+R.+Thompsonauthor=J.+F.+Falconeauthor=J.+A.+Clemens&title=Antiestrogens.+2.+Structure%E2%80%93activity+studies+in+a+series+of+3-aroyl-2-arylbenzo%5Bb%5Dthiophene+derivatives+leading+to+%28LY+156758%29%2C+a+remarkably+effective+estrogen+antagonist+with+only+minimal+intrinsic+estrogenicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00374a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00374a021%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DJevnikar%26aufirst%3DM.%2BG.%26aulast%3DPike%26aufirst%3DA.%2BJ.%26aulast%3DPeters%26aufirst%3DM.%2BK.%26aulast%3DBlack%26aufirst%3DL.%2BJ.%26aulast%3DThompson%26aufirst%3DA.%2BR.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DClemens%26aufirst%3DJ.%2BA.%26atitle%3DAntiestrogens.%25202.%2520Structure%25E2%2580%2593activity%2520studies%2520in%2520a%2520series%2520of%25203-aroyl-2-arylbenzo%255Bb%255Dthiophene%2520derivatives%2520leading%2520to%2520%2528LY%2520156758%2529%252C%2520a%2520remarkably%2520effective%2520estrogen%2520antagonist%2520with%2520only%2520minimal%2520intrinsic%2520estrogenicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26issue%3D8%26spage%3D1057%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Biskobing, D. M.</span><span> </span><span class="NLM_article-title">Update on bazedoxifene: a novel selective estrogen receptor modulator</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=18044180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=299-303&issue=3&author=D.+M.+Biskobing&title=Update+on+bazedoxifene%3A+a+novel+selective+estrogen+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Update on bazedoxifene: a novel selective estrogen receptor modulator</span></div><div class="casAuthors">Biskobing, Diane M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-303</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  In the elderly population, osteoporosis is a significant clin. problem leading to disability and even death.  Many patients remain untreated, despite effective therapies, because of patients' unwillingness to take current therapies or inability to tolerate the therapies.  For this reason, ongoing research continues to search for more effective and tolerable osteoporosis agents.  Bazedoxifene is a selective estrogen receptor modulator (SERM) currently in development for osteoporosis prevention was recently submitted to the FDA.  Preclin. and clin. studies with bazedoxifene demonstrate more tissue selectivity than other SERMs.  In particular, bazedoxifene has minimal if any agonist activity in the uterus and is able to antagonize effects of estrogen on the uterus.  Animal studies and early clin. studies suggest effects in the bone similar to other SERMs with prevention of postmenopausal bone loss.  Until more data on efficacy and safety are published, however, its role in osteoporosis is unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZX945tpaALVg90H21EOLACvtfcHk0li3AT-xNl9r5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrJ&md5=34159432bbf900fbca5d17947e954847</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiskobing%26aufirst%3DD.%2BM.%26atitle%3DUpdate%2520on%2520bazedoxifene%253A%2520a%2520novel%2520selective%2520estrogen%2520receptor%2520modulator%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26issue%3D3%26spage%3D299%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Barton, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, J. K.</span><span> </span><span class="NLM_article-title">Identification of three distinct receptor binding sites of murine interleukin-11</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">5755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=5755&author=V.+A.+Bartonauthor=K.+R.+Hudsonauthor=J.+K.+Heath&title=Identification+of+three+distinct+receptor+binding+sites+of+murine+interleukin-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DV.%2BA.%26aulast%3DHudson%26aufirst%3DK.%2BR.%26aulast%3DHeath%26aufirst%3DJ.%2BK.%26atitle%3DIdentification%2520of%2520three%2520distinct%2520receptor%2520binding%2520sites%2520of%2520murine%2520interleukin-11%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D5755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T. J.</span><span> </span><span class="NLM_article-title">Drug and drug candidate building block analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci900398f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOisrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=55-67&author=J.+Wangauthor=T.+J.+Hou&title=Drug+and+drug+candidate+building+block+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Drug and Drug Candidate Building Block Analysis</span></div><div class="casAuthors">Wang, Junmei; Hou, Tingjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-67</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug likeness anal. is widely used in modern drug design.  However, most drug likeness filters, represented by Lipinski's "Rule of 5", are based on drugs' simple structural features and some physiochem. properties.  In this study, we conducted thorough structural analyses for two drug datasets.  The first dataset, ADDS, is composed of 1240 FDA-approved drugs, and the second drug dataset, EDDS, is a nonredundant collection of FDA-approved drugs and exptl. drugs in different phases of clin. trials from several drug databases (6932 entries).  For each mol., all possible fragments were enumerated using a brutal force approach.  Three kinds of building blocks, namely, the drug scaffold, ring system, and the small fragment, were identified and ranked according to the frequencies of their occurrence in drug mols.  The major finding is that most top fragments are essentially common for both drug datasets; the top 50 fragments cover 52.6% and 48.6% drugs for ADDS and EDDS, resp.  The identified building blocks were further ranked according to their relative hit rates in the drug datasets and in a screening dataset, which is a nonredundant collection of screening compds. from many resources.  In comparison with the previous reports in the field, we have identified many more high-quality building blocks.  The results obtained in this study could provide useful hints to medicinal chemists in designing drug-like compds. as well as prioritizing screening libraries to filter out those mols. lack of functional building blocks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUmeynz19y1LVg90H21EOLACvtfcHk0li3AT-xNl9r5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOisrbI&md5=9981fa62c5476e8063370bb7a659a752</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fci900398f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900398f%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DT.%2BJ.%26atitle%3DDrug%2520and%2520drug%2520candidate%2520building%2520block%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D55%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolkis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banco, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neveu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djoumbou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, D. S.</span><span> </span><span class="NLM_article-title">DrugBank 3.0: a comprehensive resource for “omics” research on drugs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D1035-D1041&author=C.+Knoxauthor=V.+Lawauthor=T.+Jewisonauthor=P.+Liuauthor=S.+Lyauthor=A.+Frolkisauthor=A.+Ponauthor=K.+Bancoauthor=C.+Makauthor=V.+Neveuauthor=Y.+Djoumbouauthor=R.+Eisnerauthor=A.+C.+Guoauthor=D.+S.+Wishart&title=DrugBank+3.0%3A+a+comprehensive+resource+for+%E2%80%9Comics%E2%80%9D+research+on+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DLaw%26aufirst%3DV.%26aulast%3DJewison%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DFrolkis%26aufirst%3DA.%26aulast%3DPon%26aufirst%3DA.%26aulast%3DBanco%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DNeveu%26aufirst%3DV.%26aulast%3DDjoumbou%26aufirst%3DY.%26aulast%3DEisner%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DWishart%26aufirst%3DD.%2BS.%26atitle%3DDrugBank%25203.0%253A%2520a%2520comprehensive%2520resource%2520for%2520%25E2%2580%259Comics%25E2%2580%259D%2520research%2520on%2520drugs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD1035%26epage%3DD1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bolton, E; Wang, Y; Thiessen, P. A; Bryant, S. H.</span><span> </span><span class="NLM_article-title">PubChem: Integrated Platform of Small Molecules and Biological Activities</span>. In  <span class="citation_source-book">Annual Reports in Computational Chemistry</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">4</span>, Chapter 12.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1016%2FS1574-1400%2808%2900012-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E+Bolton&author=Y+Wang&author=P.+A+Thiessen&author=S.+H.+Bryant&title=Annual+Reports+in+Computational+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1574-1400%2808%2900012-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1574-1400%252808%252900012-1%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DE%26atitle%3DPubChem%253A%2520Integrated%2520Platform%2520of%2520Small%2520Molecules%2520and%2520Biological%2520Activities%26btitle%3DAnnual%2520Reports%2520in%2520Computational%2520Chemistry%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2008%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlschlegel, J. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span> </span><span class="NLM_article-title">Target identification using drug affinity responsive target stability (DARTS)</span> <span class="citation_source-journal">Curr. Protoc. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=163-180&author=B.+Lomenickauthor=G.+Jungauthor=J.+A+Wohlschlegelauthor=J.+Huang&title=Target+identification+using+drug+affinity+responsive+target+stability+%28DARTS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DJung%26aufirst%3DG.%26aulast%3DWohlschlegel%26aufirst%3DJ.%2BA%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DTarget%2520identification%2520using%2520drug%2520affinity%2520responsive%2520target%2520stability%2520%2528DARTS%2529%26jtitle%3DCurr.%2520Protoc.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D3%26spage%3D163%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span> </span><span class="NLM_article-title">Identification of direct protein targets of small molecules</span> <span class="citation_source-journal">ACS Chem Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100294v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=34-46&author=B.+Lomenickauthor=R.+W.+Olsenauthor=J.+Huang&title=Identification+of+direct+protein+targets+of+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Direct Protein Targets of Small Molecules</span></div><div class="casAuthors">Lomenick, Brett; Olsen, Richard W.; Huang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-46</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Small-mol. target identification is a vital and daunting task for the chem. biol. community as well as for researchers interested in applying the power of chem. genetics to impact biol. and medicine.  To overcome this "target ID" bottleneck, new technologies are being developed that analyze protein-drug interactions, such as drug affinity responsive target stability (DARTS), which aims to discover the direct binding targets (and off targets) of small mols. on a proteome scale without requiring chem. modification of the compd.  Here, the authors review the DARTS method, discuss why it works, and provide new perspectives for future development in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGootJ9jC5FFCrVg90H21EOLACvtfcHk0ljkbtfY4P1PsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsrrN&md5=f7878ba616630f1bb09f3d6f1af37f47</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb100294v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100294v%26sid%3Dliteratum%253Aachs%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DR.%2BW.%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520direct%2520protein%2520targets%2520of%2520small%2520molecules%26jtitle%3DACS%2520Chem%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D34%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aghajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warburton, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Target identification using drug affinity responsive target stability (DARTS)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">21984</span><span class="NLM_x">–</span> <span class="NLM_lpage">21989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1073%2Fpnas.0910040106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=19995983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1aiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=21984-21989&author=B.+Lomenickauthor=R.+Haoauthor=N.+Jonaiauthor=R.+M.+Chinauthor=M.+Aghajanauthor=S.+Warburton&title=Target+identification+using+drug+affinity+responsive+target+stability+%28DARTS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Target identification using drug affinity responsive target stability (DARTS)</span></div><div class="casAuthors">Lomenick, Brett; Hao, Rui; Jonai, Nao; Chin, Randall M.; Aghajan, Mariam; Warburton, Sarah; Wang, Jianing; Wu, Raymond P.; Gomez, Fernando; Loo, Joseph A.; Wohlschlegel, James A.; Vondriska, Thomas M.; Pelletier, Jerry; Herschman, Harvey R.; Clardy, Jon; Clarke, Catherine F.; Huang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21984-21989, S21984/1-S21984/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Identifying the mol. targets for the beneficial or detrimental effects of small-mol. drugs is an important and currently unmet challenge.  We have developed a method, drug affinity responsive target stability (DARTS), which takes advantage of a redn. in the protease susceptibility of the target protein upon drug binding.  DARTS is universally applicable because it requires no modification of the drug and is independent of the mechanism of drug action.  We demonstrate use of DARTS to identify known small-mol.-protein interactions and to reveal the eukaryotic translation initiation machinery as a mol. target for the longevity-enhancing plant natural product resveratrol.  We envisage that DARTS will also be useful in global mapping of protein-metabolite interaction networks and in label-free screening of unlimited varieties of compds. for development as mol. imaging agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBFsvOPfmmaLVg90H21EOLACvtfcHk0ljkbtfY4P1PsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1aiug%253D%253D&md5=0f14bce633a1ce0af6d95ad13876e405</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0910040106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0910040106%26sid%3Dliteratum%253Aachs%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DR.%26aulast%3DJonai%26aufirst%3DN.%26aulast%3DChin%26aufirst%3DR.%2BM.%26aulast%3DAghajan%26aufirst%3DM.%26aulast%3DWarburton%26aufirst%3DS.%26atitle%3DTarget%2520identification%2520using%2520drug%2520affinity%2520responsive%2520target%2520stability%2520%2528DARTS%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D21984%26epage%3D21989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande1, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1158%2F1535-7163.MCT-12-1082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=23536726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=937-949&author=S.+Xuauthor=F.+Grande1author=A.+Garofaloauthor=N.+Neamati&title=Discovery+of+a+novel+orally+active+small-molecule+gp130+inhibitor+for+the+treatment+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer</span></div><div class="casAuthors">Xu, Shili; Grande, Fedora; Garofalo, Antonio; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-949</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Interleukin (IL)-6 and Stat3 play key roles in ovarian cancer progression.  However, the role of glycoprotein 130 (gp130), the signal transducer of this signaling axis, is not well-established.  Currently, there are no small-mol. inhibitors of gp130 under clin. development.  In this study, we show that gp130 is an attractive drug target in ovarian cancer due to its role in promoting cancer progression via the activation of its downstream Stat3 signaling.  We also present preclin. studies of SC144, the 1st-in-class orally active small-mol. gp130 inhibitor.  SC144 shows greater potency in human ovarian cancer cell lines than in normal epithelial cells.  SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, abrogates Stat3 phosphorylation and nuclear translocation, and further inhibits the expression of downstream target genes.  In addn., SC144 shows potent inhibition of gp130 ligand-triggered signaling.  Oral administration of SC144 delays tumor growth in a mouse xenograft model of human ovarian cancer without significant toxicity to normal tissues.  Mol Cancer Ther; 12(6); 937-49. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjGt-WKRmr7Vg90H21EOLACvtfcHk0li0SOwd69HaIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOks7s%253D&md5=789989a2a5cf8c4e68657e5521d7e831</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-1082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-1082%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DGrande1%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520orally%2520active%2520small-molecule%2520gp130%2520inhibitor%2520for%2520the%2520treatment%2520of%2520ovarian%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D937%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.</span><span> </span><span class="NLM_article-title">Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation</span> <span class="citation_source-journal">Reproduction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=341-349&issue=2&author=H.+Songauthor=H.+Lim&title=Evidence+for+heterodimeric+association+of+leukemia+inhibitory+factor+%28LIF%29+receptor+and+gp130+in+the+mouse+uterus+for+LIF+signaling+during+blastocyst+implantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DH.%26atitle%3DEvidence%2520for%2520heterodimeric%2520association%2520of%2520leukemia%2520inhibitory%2520factor%2520%2528LIF%2529%2520receptor%2520and%2520gp130%2520in%2520the%2520mouse%2520uterus%2520for%2520LIF%2520signaling%2520during%2520blastocyst%2520implantation%26jtitle%3DReproduction%26date%3D2006%26volume%3D131%26issue%3D2%26spage%3D341%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gearing, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thut, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VandeBos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimpel, S. D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, P. B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckmann, M. P.</span><span> </span><span class="NLM_article-title">Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1991&pages=2839&issue=10&author=D.+P.+Gearingauthor=C.+J.+Thutauthor=T.+VandeBosauthor=S.+D+Gimpelauthor=P.+B+Delaneyauthor=J.+Kingauthor=V.+Priceauthor=D.+Cosmanauthor=M.+P.+Beckmann&title=Leukemia+inhibitory+factor+receptor+is+structurally+related+to+the+IL-6+signal+transducer%2C+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGearing%26aufirst%3DD.%2BP.%26aulast%3DThut%26aufirst%3DC.%2BJ.%26aulast%3DVandeBos%26aufirst%3DT.%26aulast%3DGimpel%26aufirst%3DS.%2BD%26aulast%3DDelaney%26aufirst%3DP.%2BB%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DV.%26aulast%3DCosman%26aufirst%3DD.%26aulast%3DBeckmann%26aufirst%3DM.%2BP.%26atitle%3DLeukemia%2520inhibitory%2520factor%2520receptor%2520is%2520structurally%2520related%2520to%2520the%2520IL-6%2520signal%2520transducer%252C%2520gp130%26jtitle%3DEMBO%2520J.%26date%3D1991%26volume%3D10%26issue%3D10%26spage%3D2839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Li, H.</span><span> </span><span class="NLM_article-title">Multiple Ligand Simultaneous Docking (MLSD) and Its Applications to Fragment Based Drug Design and Drug Repositioning</span>. Ph.D. Dissertation, The Ohio State University,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Li&title=Multiple+Ligand+Simultaneous+Docking+%28MLSD%29+and+Its+Applications+to+Fragment+Based+Drug+Design+and+Drug+Repositioning"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26atitle%3DMultiple%2520Ligand%2520Simultaneous%2520Docking%2520%2528MLSD%2529%2520and%2520Its%2520Applications%2520to%2520Fragment%2520Based%2520Drug%2520Design%2520and%2520Drug%2520Repositioning%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4700</span><span class="NLM_x">–</span> <span class="NLM_lpage">4705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4700-4705&author=H.+Songauthor=R.+Wangauthor=S.+Wangauthor=J.+Lin&title=A+low-molecular-weight+compound+discovered+through+virtual+database+screening+inhibits+Stat3+function+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520low-molecular-weight%2520compound%2520discovered%2520through%2520virtual%2520database%2520screening%2520inhibits%2520Stat3%2520function%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D4700%26epage%3D4705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutzen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foust, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhasin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A novel small molecule, LLL12, inhibits STAT3. Phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=39-50&author=L.+Linauthor=B.+Hutzenauthor=P.+K.+Liauthor=S.+Ballauthor=M.+Zuoauthor=S.+DeAngelisauthor=E.+Foustauthor=M.+Soboauthor=L.+Friedmanauthor=D.+Bhasinauthor=L.+Cenauthor=C.+Liauthor=J.+Lin&title=A+novel+small+molecule%2C+LLL12%2C+inhibits+STAT3.+Phosphorylation+and+activities+and+exhibits+potent+growth-suppressive+activity+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DHutzen%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DBall%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DM.%26aulast%3DDeAngelis%26aufirst%3DS.%26aulast%3DFoust%26aufirst%3DE.%26aulast%3DSobo%26aufirst%3DM.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DCen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small%2520molecule%252C%2520LLL12%252C%2520inhibits%2520STAT3.%2520Phosphorylation%2520and%2520activities%2520and%2520exhibits%2520potent%2520growth-suppressive%2520activity%2520in%2520human%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D39%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Reed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=450-455&author=S.+Reedauthor=H.+Liauthor=C.+Liauthor=J.+Lin&title=Celecoxib+inhibits+STAT3+phosphorylation+and+suppresses+cell+migration+and+colony+forming+ability+in+rhabdomyosarcoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DCelecoxib%2520inhibits%2520STAT3%2520phosphorylation%2520and%2520suppresses%2520cell%2520migration%2520and%2520colony%2520forming%2520ability%2520in%2520rhabdomyosarcoma%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D407%26spage%3D450%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Boulanger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankovich, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortemme, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=577-589&author=M.+J.+Boulangerauthor=A.+J.+Bankovichauthor=T.+Kortemmeauthor=D.+Bakerauthor=K.+C.+Garcia&title=Convergent+mechanisms+for+recognition+of+divergent+cytokines+by+the+shared+signaling+receptor+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoulanger%26aufirst%3DM.%2BJ.%26aulast%3DBankovich%26aufirst%3DA.%2BJ.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DConvergent%2520mechanisms%2520for%2520recognition%2520of%2520divergent%2520cytokines%2520by%2520the%2520shared%2520signaling%2520receptor%2520gp130%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26spage%3D577%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Jochems, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerquist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkansson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsten, H.</span><span> </span><span class="NLM_article-title">Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1111%2Fj.1365-2249.2008.03660.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=18435803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVOiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2008&pages=593-597&issue=3&author=C.+Jochemsauthor=M.+Lagerquistauthor=C.+H%C3%A5kanssonauthor=C.+Ohlssonauthor=H.+Carlsten&title=Long-term+anti-arthritic+and+anti-osteoporotic+effects+of+raloxifene+in+established+experimental+postmenopausal+polyarthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis</span></div><div class="casAuthors">Jochems, C.; Lagerquist, M.; Haakansson, C.; Ohlsson, C.; Carlsten, H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-597</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Both estrogen deficiency and the inflammatory disease contribute to the generalized bone loss seen in postmenopausal rheumatoid arthritis (RA).  Oestradiol and the selective estrogen receptor modulator raloxifene have been shown to ameliorate the disease in collagen-induced arthritis (CIA), a well-established animal model for human RA.  The aim of this study was to investigate whether raloxifene-treatment would be beneficial in long-term treatment of established CIA, both regarding anti-arthritic and anti-osteoporotic properties.  Female dil. brown agouti mice were ovariectomized and CIA was induced.  Raloxifene or vehicle treatment was administered 5 days per wk, and the clin. arthritis score was evaluated continuously.  At termination, bone mineral d. was analyzed, paws were collected for histol. examn. and sera were analyzed for markers of bone and cartilage turnover, as well as antibodies to type II collagen and levels of interleukin (IL)-6.  Treatment with raloxifene is beneficial in long-term treatment of established CIA.  It hampers the disease severity and frequency, protects the joints from destruction and protects against the development of osteoporosis.  The proinflammatory cytokine IL-6 was down-regulated in raloxifene-treated mice compared with controls.  The serum levels of antibodies to collagen were not affected by raloxifene-treatment.  Long-term treatment with raloxifene has both anti-arthritic and anti-osteoporotic effects in established exptl. postmenopausal polyarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtOOWA2BVgj7Vg90H21EOLACvtfcHk0lj6UV4-xOugvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVOiu74%253D&md5=640fb9961ffdfd5f38291efdd44e6120</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2008.03660.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2008.03660.x%26sid%3Dliteratum%253Aachs%26aulast%3DJochems%26aufirst%3DC.%26aulast%3DLagerquist%26aufirst%3DM.%26aulast%3DH%25C3%25A5kansson%26aufirst%3DC.%26aulast%3DOhlsson%26aufirst%3DC.%26aulast%3DCarlsten%26aufirst%3DH.%26atitle%3DLong-term%2520anti-arthritic%2520and%2520anti-osteoporotic%2520effects%2520of%2520raloxifene%2520in%2520established%2520experimental%2520postmenopausal%2520polyarthritis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2008%26volume%3D152%26issue%3D3%26spage%3D593%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Gianni, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzaniga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietropaolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandurra, R.</span><span> </span><span class="NLM_article-title">Raloxifene modulates interleukin-6 and tumor necrosis factor-α synthesis in vivo: results from a pilot clinical study</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">6097</span><span class="NLM_x">–</span> <span class="NLM_lpage">6099</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1210%2Fjc.2004-0795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=15579764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSit77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=6097-6099&author=W.+Gianniauthor=A.+Ricciauthor=P.+Gazzanigaauthor=M.+Bramaauthor=M.+Pietropaoloauthor=S.+Votanoauthor=R.+Scandurra&title=Raloxifene+modulates+interleukin-6+and+tumor+necrosis+factor-%CE%B1+synthesis+in+vivo%3A+results+from+a+pilot+clinical+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Raloxifene modulates interleukin-6 and tumor necrosis factor-α synthesis in vivo: Results from a pilot clinical study</span></div><div class="casAuthors">Gianni, Walter; Ricci, Andrea; Gazzaniga, Paola; Brama, Marina; Pietropaolo, Maria; Votano, Sergio; Patane, Francesco; Agliano, Anna Maria; Spera, Giovanni; Marigliano, Vincenzo; Ammendola, Sergio; Agnusdei, Donato; Migliaccio, Silvia; Scandurra, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6097-6099</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Raloxifene (RAL), a selective estrogen receptor modulator, is indicated for the prevention and treatment of postmenopausal osteoporosis.  RAL, by decreasing bone turnover, prevents bone loss and microarchitecture damage, reducing the incidence of osteoporotic fractures.  Our previous in vitro data demonstrated that RAL modulates osteoclast activity by, at least in part, an IL-6- and TNF-α-dependent mechanism.  In this study we evaluated the effects of RAL treatment (60 mg/d) on circulating levels of these cytokines in 14 postmenopausal women with osteoporosis.  Lumbar bone d. (detd. by dual energy x-ray absorptiometry) and IL-6 and TNF-α levels were measured before and after 6 and 24 mo of therapy.  After 24 mo, RAL increased bone d.  IL-6 and TNF-α expression, elevated before treatment, significantly decreased (50% and 30%, resp.) after 6 mo.  This effect was sustained up to the end of the treatment (75% and 35%, resp.).  Thus, our data show that RAL can modulate circulating levels of cytokines involved in osteoclastogenesis and bone resorption, suggesting that modulation of sol. factors could play a pivotal role in the mechanisms of the osteoprotective effect of RAL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV24SJrBuhBLVg90H21EOLACvtfcHk0lj6UV4-xOugvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSit77F&md5=c76624bf35b0c2089d3351c0d30542bc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1210%2Fjc.2004-0795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2004-0795%26sid%3Dliteratum%253Aachs%26aulast%3DGianni%26aufirst%3DW.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DGazzaniga%26aufirst%3DP.%26aulast%3DBrama%26aufirst%3DM.%26aulast%3DPietropaolo%26aufirst%3DM.%26aulast%3DVotano%26aufirst%3DS.%26aulast%3DScandurra%26aufirst%3DR.%26atitle%3DRaloxifene%2520modulates%2520interleukin-6%2520and%2520tumor%2520necrosis%2520factor-%25CE%25B1%2520synthesis%2520in%2520vivo%253A%2520results%2520from%2520a%2520pilot%2520clinical%2520study%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab%26date%3D2004%26volume%3D89%26spage%3D6097%26epage%3D6099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ozmen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirmaz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aydin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kafesciler, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guclu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hekimsoy, Z.</span><span> </span><span class="NLM_article-title">Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis</span> <span class="citation_source-journal">Eur. Cytokine Network</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=17400536" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=31-36&author=B.+Ozmenauthor=C.+Kirmazauthor=K.+Aydinauthor=S.+O.+Kafescilerauthor=F.+Gucluauthor=Z.+Hekimsoy&title=Influence+of+the+selective+oestrogen+receptor+modulator+%28raloxifene+hydrochloride%29+on+IL-6%2C+TNF-alpha%2C+TGF-beta1+and+bone+turnover+markers+in+the+treatment+of+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOzmen%26aufirst%3DB.%26aulast%3DKirmaz%26aufirst%3DC.%26aulast%3DAydin%26aufirst%3DK.%26aulast%3DKafesciler%26aufirst%3DS.%2BO.%26aulast%3DGuclu%26aufirst%3DF.%26aulast%3DHekimsoy%26aufirst%3DZ.%26atitle%3DInfluence%2520of%2520the%2520selective%2520oestrogen%2520receptor%2520modulator%2520%2528raloxifene%2520hydrochloride%2529%2520on%2520IL-6%252C%2520TNF-alpha%252C%2520TGF-beta1%2520and%2520bone%2520turnover%2520markers%2520in%2520the%2520treatment%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DEur.%2520Cytokine%2520Network%26date%3D2007%26volume%3D18%26spage%3D31%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Viereck, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaschke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederkleine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siggelkow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emons, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, L. C.</span><span> </span><span class="NLM_article-title">Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">4206</span><span class="NLM_x">–</span> <span class="NLM_lpage">4213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1210%2Fjc.2002-021877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=12970288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=4206-4213&author=V.+Viereckauthor=C.+Grundkerauthor=S.+Blaschkeauthor=B.+Niederkleineauthor=H.+Siggelkowauthor=K.-H.+Froschauthor=D.+Raddatzauthor=G.+Emonsauthor=L.+C.+Hofbauer&title=Raloxifene+concurrently+stimulates+osteoprotegerin+and+inhibits+interleukin-6+production+by+human+trabecular+osteoblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts</span></div><div class="casAuthors">Viereck, Volker; Gruendker, Carsten; Blaschke, Sabine; Niederkleine, Britta; Siggelkow, Heide; Frosch, Karl-Heinz; Raddatz, Dirk; Emons, Guenter; Hofbauer, Lorenz C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4206-4213</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Raloxifene reduces bone loss and prevents vertebral fractures in postmenopausal women.  Its skeletal effects are mediated by estrogen receptors (ER) and their modulation of paracrine osteoblastic factors.  Receptor activator of nuclear factor-κB ligand is essential for osteoclasts and enhances bone resorption, whereas osteoprotegerin (OPG) neutralizes receptor activator of nuclear factor-κB ligand.  Here, we assessed the effects of raloxifene on OPG prodn. in human osteoblasts (hOB).  Raloxifene enhanced gene expression of ER-α and progesterone receptor.  Moreover, raloxifene increased OPG mRNA levels and protein secretion by hOB in a dose- and time-dependent fashion by 2- to 4-fold with a max. effect at 10-7 M and after 72 h (P < 0.001).  Treatment with the ER antagonist ICI 182,780 abrogated the effects of raloxifene on OPG prodn.  Moreover, raloxifene enhanced osteoblastic differentiation markers, type 1 collagen secretion, and alk. phosphatase activity by 3- and 2-fold, resp. (P < 0.001).  In addn., raloxifene inhibited expression of the bone-resorbing cytokine IL-6 by 25-45% (P < 0.001).  In conclusion, our data suggest that raloxifene stimulates OPG prodn. and inhibits IL-6 prodn. by hOB.  Because OPG prodn. increases with osteoblastic maturation, enhancement of OPG prodn. by raloxifene could be related to its stimulatory effects on osteoblastic differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfK7P_so5vqbVg90H21EOLACvtfcHk0liNk3vSkibzjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlagsr4%253D&md5=638d91614906c8a947e1f38d666a0a03</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1210%2Fjc.2002-021877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2002-021877%26sid%3Dliteratum%253Aachs%26aulast%3DViereck%26aufirst%3DV.%26aulast%3DGrundker%26aufirst%3DC.%26aulast%3DBlaschke%26aufirst%3DS.%26aulast%3DNiederkleine%26aufirst%3DB.%26aulast%3DSiggelkow%26aufirst%3DH.%26aulast%3DFrosch%26aufirst%3DK.-H.%26aulast%3DRaddatz%26aufirst%3DD.%26aulast%3DEmons%26aufirst%3DG.%26aulast%3DHofbauer%26aufirst%3DL.%2BC.%26atitle%3DRaloxifene%2520concurrently%2520stimulates%2520osteoprotegerin%2520and%2520inhibits%2520interleukin-6%2520production%2520by%2520human%2520trabecular%2520osteoblasts%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26spage%3D4206%26epage%3D4213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Jochems, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallkopf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerquist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsten, H.</span><span> </span><span class="NLM_article-title">Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3261</span><span class="NLM_x">–</span> <span class="NLM_lpage">3270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1002%2Fart.22873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=17907171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=3261-3270&author=C.+Jochemsauthor=U.+Islanderauthor=A.+Kallkopfauthor=M.+Lagerquistauthor=C.+Ohlssonauthor=H.+Carlsten&title=Role+of+raloxifene+as+a+potent+inhibitor+of+experimental+postmenopausal+polyarthritis+and+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis</span></div><div class="casAuthors">Jochems, Caroline; Islander, Ulrika; Kallkopf, Anna; Lagerquist, Marie; Ohlsson, Claes; Carlsten, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3261-3270</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: In postmenopausal rheumatoid arthritis (RA), both estrogen deficiency and the inflammatory disease contribute to the development of generalized osteoporosis.  Hormone replacement therapy (HRT) with estradiol preserves bone mineral d. (BMD) and ameliorates arthritis, but long-term therapy is no longer an option due to significant side effects.  We therefore used a mouse model of human RA to test the hypothesis that a selective estrogen receptor modulator (SERM), the raloxifene analog LY117018, could be beneficial in the treatment of both arthritis and osteoporosis.  Methods: Female DBA/1 mice were ovariectomized and arthritis was induced with collagen immunization.  Mice received an injection of raloxifene, estradiol, or vehicle control, administered prophylactically or therapeutically, and thereafter the clin. arthritis score was evaluated continuously.  At termination, BMD was analyzed with peripheral quant. computed tomog.  Paws were collected for histol., and sera were analyzed for cytokines and markers of bone and cartilage turnover.  Levels of cytokine mRNA (mRNA) were investigated with real-time polymerase chain reaction.  Results: Treatment with raloxifene dramatically decreased the frequency and severity of arthritis.  Effective preservation of bone and cartilage was seen in raloxifene-exposed mice, as demonstrated by increased BMD and decreased serum levels of cartilage oligomeric matrix protein in the raloxifene-treated mice compared with controls.  Decreased levels of mRNA for both tumor necrosis factor α and RANKL in spleen cells from raloxifene-treated arthritic mice indicated an immunosuppressive action of this SERM.  Conclusion: In a well-established model of postmenopausal RA, the raloxifene analog LY117018 potently inhibits the progression of arthritis and the assocd. development of osteoporosis, both in a prophylactic and in a therapeutic regimen.  Since long-term HRT has been assocd. with significant side effects, raloxifene may be a useful adjuvant treatment for postmenopausal RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGF84a2x-SdLVg90H21EOLACvtfcHk0liNk3vSkibzjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rtLnJ&md5=86f644c62f173056640c413ba95fdbd5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fart.22873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22873%26sid%3Dliteratum%253Aachs%26aulast%3DJochems%26aufirst%3DC.%26aulast%3DIslander%26aufirst%3DU.%26aulast%3DKallkopf%26aufirst%3DA.%26aulast%3DLagerquist%26aufirst%3DM.%26aulast%3DOhlsson%26aufirst%3DC.%26aulast%3DCarlsten%26aufirst%3DH.%26atitle%3DRole%2520of%2520raloxifene%2520as%2520a%2520potent%2520inhibitor%2520of%2520experimental%2520postmenopausal%2520polyarthritis%2520and%2520osteoporosis%26jtitle%3DArthritis%2520Rheum.%26date%3D2007%26volume%3D56%26spage%3D3261%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Edwards, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, E.</span><span> </span><span class="NLM_article-title">The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1287</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401144z&amp;key=10.1007%2Fs00198-010-1192-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401144z&amp;key=20229200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401144z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotleqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=1287-1293&issue=8&author=C.+J.+Edwardsauthor=E.+Williams&title=The+role+of+interleukin-6+in+rheumatoid+arthritis-associated+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis</span></div><div class="casAuthors">Edwards, C. J.; Williams, E.</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1287-1293</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Introduction Osteoporosis is highly prevalent in patients with rheumatoid arthritis (RA) and is a frequent cause of fractures, disability, reduced quality of life and increased use of healthcare resources.  Discussion Factors assocd. with the development of osteoporosis and fractures in patients with RA include disease activity, inflammation, gender, age, low body mass and glucocorticoid exposure.  Several processes contribute towards the pathol. of RA-assocd. osteoporosis, and increased osteoclast activation and subsequent bone resorption mediated by pro-inflammatory cytokines are thought to play major roles.  Given the key effects of interleukin-6 (IL-6) in both RA and osteoporosis, and its ability to modulate other inflammatory mediators, IL-6 may be an important factor specifically assocd. with osteoporosis in patients with RA.  Conclusion The development of agents that modulate the actions of IL-6 and those of other pro-inflammatory mediators of bone loss may provide alternative osteoporosis management strategies for patients with RA than existing general osteoporosis therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYyuGAMDkCMrVg90H21EOLACvtfcHk0ljP0MSLAZFSow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotleqsrY%253D&md5=360e4b2cd93c3e585084a1a0221b3f1a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00198-010-1192-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00198-010-1192-7%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520interleukin-6%2520in%2520rheumatoid%2520arthritis-associated%2520osteoporosis%26jtitle%3DOsteoporosis%2520Int.%26date%3D2010%26volume%3D21%26issue%3D8%26spage%3D1287%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lipsky, P. E.</span><span> </span><span class="NLM_article-title">Interleukin-6 and rheumatic diseases</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=S4&issue=Suppl.+2&author=P.+E.+Lipsky&title=Interleukin-6+and+rheumatic+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26atitle%3DInterleukin-6%2520and%2520rheumatic%2520diseases%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2006%26volume%3D8%26issue%3DSuppl.%25202%26spage%3DS4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1P9M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1P9M','PDB','1P9M'); return false;">PDB: 1P9M</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401144z&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-3%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm401144z%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401144z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0ae200b89d1fb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
